med history te med history co med history cod …...2013-0016 doses # 2 and #3 at ≥ age 7 years; #...

CDC_Test_ID Test_Case_Name DOB genderMed_History_Text

Med_History_Code

Med_History_Code_Sys Series_Status

Date_Administred_1 Vaccine_Name_1 CVX_1 MVX_1 Evaluation_Status_1

2013-0001 Newborn Testing 12/04/2019 F Not complete2013-0002 DTaP #2 at age 10 weeks-5 days 09/30/2019 F Not complete 11/08/2019 DTaP, unspecified formulation 107 Valid2013-0003 DTaP #2 at 10 wks-4 days 09/29/2019 F Not complete 11/10/2019 DTaP, unspecified formulation 107 Valid2013-0004 DTaP # 2 at age 10 weeks 09/25/2019 F Not complete 11/06/2019 DTaP, unspecified formulation 107 Valid2013-0005 DTaP # 2 at age 4 months 08/04/2019 F Not complete 10/04/2019 DTaP, unspecified formulation 107 Valid2013-0007 # 2 (Tdap) to child age 7. DTaP # 1 given before age 12 months. Forecast # 3 (Td) in 4 weeks. 12/04/2012 F Not complete 02/04/2013 DTaP, unspecified formulation 107 Valid2013-0008 # 2 (Tdap) to child age 7. DTaP # 1 at ≥ 12 months. Forecast dose 3 for 6 months. 12/04/2012 F Not complete 12/04/2013 DTaP, unspecified formulation 107 Valid2013-0010 # 1 (Td) to # 2 (Tdap) interval 28-4 days in child age > 7 years. Forecast # 3 in six months. 08/07/2011 F Not complete 11/10/2019 TD(GENERIC) 09 MBL Valid2013-0011 #3 at age 14 weeks-5 days 09/02/2019 F Not complete 10/14/2019 DTaP, unspecified formulation 107 Valid2013-0012 Age 6. No vaccinations. Forecast DTaP. 12/04/2013 F Not complete2013-0013 #3 at age 14 weeks-4 days 09/01/2019 F Not complete 10/13/2019 DTaP, unspecified formulation 107 Valid2013-0014 #3 at age 14 weeks 08/28/2019 F Not complete 10/09/2019 DTaP, unspecified formulation 107 Valid2013-0015 #3 at age 6 months 06/04/2019 F Not complete 08/04/2019 DTaP, unspecified formulation 107 Valid2013-0016 Doses # 2 and #3 at ≥ age 7 years; # 1 at age < 12 mo. Forecast # 4 in 6 mo. 11/04/2012 F Not complete 07/04/2013 DTaP, unspecified formulation 107 Valid

2013-0017 Doses # 2 and # 3 at ≥7 years old; dose # 1 at ≥ 12 months old. 02/15/2012 F Not complete 04/17/2013 DTaP, unspecified formulation 107 Valid

2013-0019 1 Tdap, 2 Td with appropriate intervals to child ≥ age 7 05/04/2012 F Not complete 05/05/2019 BOOSTRIX 115 SKB Valid2013-0020 1 Tdap, 2 Td to child ≥ 7 years old with 6 mo-5 day interval between doses 2 and 3. 05/04/2011 F Not complete 05/04/2019 BOOSTRIX 115 SKB Valid

2013-0021 1 Tdap, 2 Td to child ≥ 7 years old with 6 mo-4 day interval between doses 2 and 3. 04/04/2012 F Not complete 04/04/2019 TD(GENERIC) 09 MBL Valid2013-0022 Age 7. Two DTaP˂ 12 months old. Needs Tdap. 12/04/2012 F Not complete 03/02/2013 DTaP, unspecified formulation 107 Valid2013-0023 Age 7. No vaccinations. Forecast Tdap. 12/04/2012 F Not complete2013-0024 Age 7. Two DTaP˂ 12 mos old & 1 ≥ 12 mo. Needs Tdap. 12/04/2012 F Not complete 03/04/2013 DTaP, unspecified formulation 107 Valid2013-0025 #4 at age 12 mo-5 days 12/09/2018 F Not complete 02/09/2019 DTaP, unspecified formulation 107 Valid2013-0026 #4 at age 12 mo-4 days 12/08/2018 F Not complete 02/08/2019 DTaP, unspecified formulation 107 Valid2013-0027 #4 at age 12 months old 12/04/2018 F Not complete 02/04/2019 DTaP, unspecified formulation 107 Valid

2013-0028 #4 at age 4 is UTD until age 11. 12/04/2015 F Not complete 02/29/2016 DTaP, unspecified formulation 107 Valid

2013-0029 5 year old with no previous DTP product receives 4 vaccinations prior to age 7 years 09/29/2013 F Not complete 09/29/2018 DTaP, unspecified formulation 107 Valid2013-0030 #5 at age 4 years-5 days 12/09/2015 F Not complete 02/09/2016 DTaP, unspecified formulation 107 Valid

2013-0031 #5 at age 4 years-4 days 12/08/2015 F Not complete 02/08/2016 DTaP, unspecified formulation 107 Valid

2013-0032 # 5 at age 4 years 12/04/2015 F Not complete 02/04/2016 DTaP, unspecified formulation 107 Valid2013-0033 DTaP #1 at age 6 weeks-5 days 10/28/2019 F Not complete 12/04/2019 DTaP, unspecified formulation 107 Not Valid2013-0034 # 6 DTaP before age 4. Nothing more until Tdap at age 7 even if some are invalid. 06/04/2016 F Not complete 08/04/2016 DTaP, unspecified formulation 107 Valid

2013-0035 Adolescent with Td but no Tdap. 03/26/2007 F Not complete 05/26/2007 DTaP, unspecified formulation 107 Valid2013-0036 Invalid age for dose # 1 in first of series 06/04/2019 F Not complete 07/04/2019 DTaP, unspecified formulation 107 Not Valid2013-0037 Invalid age for dose # 2 in midst of others 06/04/2019 F Not complete 08/03/2019 DTaP, unspecified formulation 107 Valid2013-0038 Invalid age for dose #3 in midst of others 12/03/2018 F Not complete 01/14/2019 DTaP, unspecified formulation 107 Valid

2013-0039 Invalid age for dose # 4 in midst of others 12/04/2015 F Not complete 02/04/2016 DTaP, unspecified formulation 107 Valid2013-0040 Invalid age dose 5 in midst of others 12/04/2008 F Not complete 02/05/2009 DTaP, unspecified formulation 107 Valid2013-0041 Dose 1 to dose 2 interval 28-5 days 09/11/2019 F Not complete 11/11/2019 DTaP, unspecified formulation 107 Valid2013-0042 Dose 1 to dose 2 interval 28-4 days 09/10/2019 F Not complete 11/10/2019 DTaP, unspecified formulation 107 Valid2013-0043 Dose 1 to dose 2 interval 28 days 08/12/2019 F Not complete 11/05/2019 DTaP, unspecified formulation 107 Valid2013-0044 DTaP #1 at age 6 weeks-4 days 10/27/2019 F Not complete 12/04/2019 DTaP, unspecified formulation 107 Valid2013-0045 Dose 2 to dose 3 interval 28-5 days 07/11/2019 F Not complete 09/11/2019 DTaP, unspecified formulation 107 Valid2013-0046 Dose 2 to dose 3 interval 28-4 days 08/22/2019 F Not complete 10/01/2019 DTaP, unspecified formulation 107 Valid2013-0047 Dose 2 to dose 3 interval 28 days 08/27/2019 F Not complete 10/06/2019 DTaP, unspecified formulation 107 Valid2013-0049 Dose 3 to dose 4 interval 6 months-4 days 12/02/2018 F Not complete 02/03/2019 DTaP, unspecified formulation 107 Valid2013-0050 Dose 3 to dose 4 interval 6 months 11/28/2018 F Not complete 01/29/2019 DTaP, unspecified formulation 107 Valid2013-0052 Dose 3 to dose 4 interval 4 months 12/04/2018 F Not complete 02/04/2019 DTaP, unspecified formulation 107 Valid2013-0053 Invalid dose 1 to dose 2 interval in midst of other vaccines 11/30/2018 F Not complete 01/30/2019 DTaP, unspecified formulation 107 Valid2013-0054 Invalid dose 2 to dose 3 interval in midst of other vaccines. 10/02/2018 F Not complete 12/02/2018 DTaP, unspecified formulation 107 Valid2013-0055 DTaP #1 at age 6 weeks 10/23/2019 F Not complete 12/04/2019 DTaP, unspecified formulation 107 Valid2013-0056 Invalid dose 3 to dose 4 interval in midst of other vaccinations 12/04/2018 F Not complete 05/04/2019 DTaP, unspecified formulation 107 Valid2013-0057 Invalid dose 4 to dose 5 interval in midst of others 12/03/2008 F Not complete 02/03/2009 DTaP, unspecified formulation 107 Valid2013-0058 Tdap as dose #1 11/04/2018 F Not complete 01/04/2019 BOOSTRIX 115 SKB Not Valid2013-0059 Tdap as dose #2 12/04/2018 F Not complete 02/04/2019 DTaP, unspecified formulation 107 Valid2013-0060 Tdap as dose 3 to child under age 4=invalid as DTaP 3 03/04/2019 F Not complete 06/04/2019 DTaP, unspecified formulation 107 Valid2013-0061 Tdap as dose 4 to age 15 months=valid as DTaP 08/30/2018 F Not complete 11/30/2018 DTaP, unspecified formulation 107 Valid2013-0062 Tdap as dose 5 to age 4 years-5 days=invalid as dose 5 of DTaP 12/09/2015 F Not complete 02/29/2016 DTaP, unspecified formulation 107 Valid

2013-0063 Tdap as dose 5 to age 4-4 days. Counts as valid DTaP. Child will need another Tdap in adolescence. 12/08/2015 F Not complete 02/28/2016 DTaP, unspecified formulation 107 Valid

2013-0064 Tdap as dose 5 to age 4 years old=valid as DTaP 5. 12/04/2015 F Not complete 02/24/2016 DTaP, unspecified formulation 107 Valid2013-0065 Tdap as dose 1 at age 7 years old 12/04/2012 F Not complete 12/04/2019 BOOSTRIX 115 SKB Valid2013-0066 DTaP # 1 at age 2 months 10/04/2019 F Not complete 12/04/2019 DTaP, unspecified formulation 107 Valid2013-0067 Tdap as dose 2 at age ≥7 years 10/06/2012 F Not complete 11/06/2019 TD(GENERIC) 09 MBL Valid

2013-0068 Tdap as dose 3 to ≥ 7 years old 04/26/2012 F Not complete 05/06/2019 DTaP, unspecified formulation 107 Valid2013-0069 Tdap at age 7 years-5 days. Current age 7 years 12/04/2012 F Not complete 11/29/2019 BOOSTRIX 115 SKB Not Valid2013-0070 Tdap at age 11 to child up-to-date with DTaP 09/28/2008 F Not complete 11/30/2008 DTaP, unspecified formulation 107 Valid

2013-0074 4 doses of Tetramune to child 05/05/1995 F Not complete 07/05/1995 DTP-Hib 22 Valid2013-0075 4 doses of Tetramune with a DTaP booster. Forecast Tdap. 12/12/1999 F Not complete 02/15/2000 DTP-Hib 22 Valid2013-0076 4 Tetramune and Tdap at age 11=UTD for 10 years 03/03/1996 F Not complete 05/05/1996 DTP-Hib 22 Valid2013-0077 DTaP #1 at age 6.5 years. 06/04/2013 F Not complete 12/04/2019 DTaP, unspecified formulation 107 Valid2013-0078 TriHibit as primary dose. DTaP=valid. 05/01/2011 F Not complete 07/01/2011 TRIHIBIT 50 PMC Valid2013-0079 TriHibit as valid dose 4 of DTaP 02/02/2008 F Not complete 04/04/2008 DTaP, unspecified formulation 107 Valid2013-0080 TriHibit as valid dose 5 of DTaP 10/08/2006 F Not complete 11/29/2006 PEDIARIX 110 SKB Valid2013-0081 Pentavalente (Mexico) DTaP/IPV/HIB counts as valid. 09/25/2018 F Not complete 01/25/2019 DTAP/IPV/HIB - non-US 170 Valid2013-0082 Kinrix at age 2 months as Dose 1 of DTaP. Off label but valid. 10/04/2019 F Not complete 12/04/2019 KINRIX 130 SKB Valid2013-0083 Kinrix at age 4 months as dose 2 of DTaP. Off label but valid. 08/04/2019 F Not complete 10/10/2019 DTaP, unspecified formulation 107 Valid2013-0084 Kinrix at age 6 months as dose 3 of DTaP. Off label but valid. 06/04/2019 F Not complete 08/06/2019 DTaP, unspecified formulation 107 Valid2013-0085 Kinrix at age 12 months as dose 4 of DTaP=valid 12/04/2018 F Not complete 02/06/2019 DTaP, unspecified formulation 107 Valid

2013-0086 Kinrix at age 4 to child with appropriate DTaP=UTD until adolescence 12/04/2015 F Not complete 02/06/2016 PEDIARIX 110 SKB Valid2013-0087 Kinrix at age 4 years-5 days 12/09/2015 F Not complete 02/01/2016 PEDIARIX 110 SKB Valid2013-0088 DTaP # 1 at age 7 years (off label but counts as valid). 12/04/2012 F Not complete 12/04/2019 DTaP, unspecified formulation 107 Valid

2013-0089 Kinrix at age 4 years -4 days 12/08/2015 F Not complete 01/27/2016 PEDIARIX 110 SKB Valid2013-0090 Newborn forecasting 12/04/2019 F Not complete2013-0091 # 2 Pediarix at 6 yrs 11.5 mo 12/19/2012 F Not complete 12/04/2015 PEDIARIX 110 SKB Valid2013-0092 # 2 Pediarix at 7 yrs; # 1 at less than 12 mo. 12/04/2012 F Not complete 03/04/2013 PEDIARIX 110 SKB Valid2013-0093 # 2 Pediarix at 7 yrs; # 1 ≥ 12 mo. Need 6 mo interval from 2 to 3. 12/04/2012 F Not complete 01/04/2014 PEDIARIX 110 SKB Valid2013-0094 # 1 and 2 Pediarix at ≥7 yrs with 28 day interval. Off label but does not need repeating. 11/06/2012 F Not complete 11/06/2019 PEDIARIX 110 SKB Valid2013-0095 # 3 Pediarix at 14 wks-5 days 09/02/2019 F Not complete 10/10/2019 PEDIARIX 110 SKB Valid2013-0096 # 3 Pediarix at 14 wks-4 days. 09/01/2019 F Not complete 10/11/2019 PEDIARIX 110 SKB Valid2013-0097 #3 Pediarix at age 24 weeks- 5 days 06/24/2019 F Not complete 08/05/2019 PEDIARIX 110 SKB Valid2013-0099 # 3 Pediarix at 6 yrs 11.5 mo 12/16/2012 F Not complete 10/14/2015 PEDIARIX 110 SKB Valid2013-0100 # 4 Pediarix at 1 yr -5 days. 12/09/2018 F Not complete 02/09/2019 PEDIARIX 110 SKB Valid2013-0101 # 1 Pediarix at 6 wks-5 days 10/28/2019 F Not complete 12/04/2019 PEDIARIX 110 SKB Not Valid2013-0102 # 4 Pediarix at 1 yr -4 days 12/08/2018 F Not complete 02/08/2019 PEDIARIX 110 SKB Valid2013-0103 # 4 Pediarix at 3 yrs 11.5 mo. 12/20/2015 F Not complete 02/20/2016 PEDIARIX 110 SKB Valid

2013-0104 # 4 Pediarix at 4 yrs=complete until age 11 12/04/2015 F Not complete 04/07/2016 PEDIARIX 110 SKB Valid2013-0105 # 5 Pediarix at 4 yrs -5 days. 12/09/2015 F Not complete 02/09/2016 PEDIARIX 110 SKB Valid

2013-0106 # 5 Pediarix at 4 yrs -4 days 12/08/2015 F Not complete 02/08/2016 PEDIARIX 110 SKB Valid

2013-0107 # 5 Pediarix at 6 yrs 11.5 mo 12/20/2012 F Not complete 02/20/2013 PEDIARIX 110 SKB Valid

2013-0108 # 5 Pediarix at 7 yrs. Off label but valid. 12/04/2012 F Not complete 03/04/2013 PEDIARIX 110 SKB Valid2013-0109 Invalid age dose 1 as first of others. 09/04/2019 F Not complete 10/11/2019 PEDIARIX 110 SKB Not Valid2013-0110 Invalid age dose 2 in midst of others 06/04/2019 F Not complete 07/12/2019 PEDIARIX 110 SKB Valid2013-0111 invalid age dose 3 in midst of others 12/04/2018 F Not complete 01/17/2019 PEDIARIX 110 SKB Valid2013-0112 # 1 Pediarix at 6 wks-4 days 10/27/2019 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid2013-0113 dose 1 to 2 Pediarix, interval 28-5 days 09/09/2019 F Not complete 11/11/2019 PEDIARIX 110 SKB Valid2013-0114 dose 1 to 2 Pediarix, interval 28-4 days 09/12/2019 F Not complete 11/10/2019 PEDIARIX 110 SKB Valid2013-0115 dose 2 to 3 Pediarix, interval 28-5 days 07/11/2019 F Not complete 09/11/2019 PEDIARIX 110 SKB Valid2013-0116 dose 2 to 3 Pediarix, interval 28-4 days. 07/10/2019 F Not complete 09/10/2019 PEDIARIX 110 SKB Valid2013-0117 dose 3 to 4 Pediarix, interval 6m-5 days 10/04/2018 F Not complete 12/04/2018 PEDIARIX 110 SKB Valid2013-0118 dose 3 to 4 Pediarix, interval 6m-4 days 10/04/2018 F Not complete 12/04/2018 PEDIARIX 110 SKB Valid2013-0120 dose 3 to 4 Pediarix, interval 4 mo 10/04/2018 F Not complete 12/04/2018 PEDIARIX 110 SKB Valid


Med_History_Code



2013-0121 invalid dose 1-2 interval in midst of others 08/04/2019 F Not complete 10/04/2019 PEDIARIX 110 SKB Valid2013-0122 invalid dose 2-3 interval in midst of others 12/04/2018 F Not complete 02/04/2019 PEDIARIX 110 SKB Valid2013-0123 # 1 Pediarix at 6 wks 10/23/2019 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid

2013-0124 invalid dose 3-4 interval in midst of others 12/02/2015 F Not complete 02/02/2016 PEDIARIX 110 SKB Valid2013-0127 # 1 Pediarix at 6 yrs 11.5 mo 12/19/2012 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid2013-0128 # 1 Pediarix at 7 years 12/04/2012 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid2013-0129 # 2 Pediarix at 10 wks-5 days. 09/30/2019 F Not complete 11/07/2019 PEDIARIX 110 SKB Valid2013-0130 # 2 Pediarix at 10 wks-4 days 09/29/2019 F Not complete 11/10/2019 PEDIARIX 110 SKB Valid2013-0131 # 2 Pediarix at 10 wks 09/25/2019 F Not complete 11/06/2019 PEDIARIX 110 SKB Valid2013-0132 Newborn 12/04/2019 F Not complete

2013-0133 # 2 Pentacel at 6 yrs 11.5 mo. Off label but counts. Current Age 7 years 12/04/2012 F Not complete 08/25/2015 PENTACEL 120 PMC Valid2013-0134 # 2 Pentacel at 7 yrs; # 1 at age < 12 mo 11/30/2012 F Not complete 05/09/2013 INFANRIX 20 SKB Valid2013-0135 # 2 Pentacel at 7 yrs; # 1 at age ≥ 12 mo. 11/30/2012 F Not complete 02/02/2014 PENTACEL 120 PMC Valid2013-0136 # 3 Pentacel at 14 wks-5 days 09/02/2019 F Not complete 10/10/2019 PENTACEL 120 PMC Valid2013-0137 # 3 Pentacel at 14 wks-4 days 09/01/2019 F Not complete 10/09/2019 PENTACEL 120 PMC Valid2013-0138 # 3 Pentacel at 6 yrs 11.5 mo 12/19/2012 F Not complete 02/13/2013 DTaP-Hib-IPV 120 Valid2013-0139 # 4 Pentacel at 1 yr -5 days. 12/09/2018 F Not complete 02/09/2019 PENTACEL 120 PMC Valid2013-0140 # 4 Pentacel at 1 yr -4 days 12/08/2018 F Not complete 02/08/2019 PENTACEL 120 PMC Valid2013-0141 # 4 Pentacel at age 12 mo 12/04/2018 F Not complete 02/04/2019 PENTACEL 120 PMC Valid

2013-0142 # 4 Pentacel at 4 yrs 12/04/2015 F Not complete 04/13/2016 PENTACEL 120 PMC Valid

2013-0143 # 5 Pentacel at ≥ 4 yrs 11/12/2015 F Not complete 10/12/2016 PENTACEL 120 PMC Valid

2013-0144 # 4 Pentacel at 5 yrs=off label but counts. 12/04/2014 F Not complete 04/04/2015 PENTACEL 120 PMC Valid2013-0145 invalid age dose 2 in midst of others 12/02/2018 F Not complete 01/09/2019 PENTACEL 120 PMC Valid2013-0146 invalid age dose 3 in midst of others 10/28/2018 F Not complete 12/05/2018 PENTACEL 120 PMC Valid2013-0147 dose 1 to 2 Pentacel, interval 28-5 days 09/17/2019 F Not complete 11/11/2019 PENTACEL 120 PMC Valid2013-0148 dose 1 to 2 Pentacel, interval 28-4 days 09/08/2019 F Not complete 11/10/2019 PENTACEL 120 PMC Valid2013-0149 dose 2 to 3 Pentacel, interval 28-5 days 07/11/2019 F Not complete 09/11/2019 PENTACEL 120 PMC Valid2013-0150 dose 2 to 3 Pentacel, interval 28-4 days 07/10/2019 F Not complete 09/10/2019 PENTACEL 120 PMC Valid2013-0152 # 1 Pentacel at 6 wks-4 days 10/27/2019 F Not complete 12/04/2019 PENTACEL 120 PMC Valid2013-0153 dose 3 to 4 Pentacel, interval 6m-4 days 10/08/2018 F Not complete 12/08/2018 PENTACEL 120 PMC Valid2013-0155 dose 3 to 4 Pentacel, interval 4 mo. 11/04/2018 F Not complete 01/04/2019 PENTACEL 120 PMC Valid2013-0156 invalid dose 1-2 interval in midst of others 06/13/2019 F Not complete 08/13/2019 PENTACEL 120 PMC Valid2013-0157 invalid dose 2-3 interval in midst of others 12/01/2018 F Not complete 02/01/2019 PENTACEL 120 PMC Valid2013-0161 # 1 Pentacel at 6 wks 10/23/2019 F Not complete 12/04/2019 PENTACEL 120 PMC Valid2013-0162 # 1 Pentacel at 6 yrs 11.5 mo 12/16/2012 F Not complete 12/04/2019 PENTACEL 120 PMC Valid2013-0163 # 1 Pentacel at 7 yrs. Off label use but counts as dose 1. 12/04/2012 F Not complete 12/04/2019 PENTACEL 120 PMC Valid2013-0164 # 2 Pentacel at 10 wks-5 days 09/30/2019 F Not complete 11/07/2019 PENTACEL 120 PMC Valid2013-0165 # 2 Pentacel at 10 wks-4 days 09/29/2019 F Not complete 11/06/2019 PENTACEL 120 PMC Valid2013-0166 # 2 Pentacel at 6 yrs . Off label but counts. 12/04/2013 F Not complete 12/04/2014 PENTACEL 120 PMC Valid2016-0001 Dose #1 received at 4 months, dose #2 received at 8 months, dose #3 received at 2 years, and dose #4 received at 3 years. Current Age is 7 yrs. 12/04/2012 F Not complete 04/04/2013 DTaP, unspecified formulation 107 Valid2016-0002 Dose #1 received at 2 years, dose #2 received at 3 years, and dose #3 received at 4 years. Current age 7 yrs 12/04/2012 F Not complete 02/04/2015 DTaP, unspecified formulation 107 Valid2016-0003 3 Dose received at < 12 months. Current age is 7 years. 12/04/2012 F Not complete 02/04/2013 DTaP, unspecified formulation 107 Valid2016-0004 Dose #1 given at < 12 months. Current age is 7. 12/04/2012 F Not complete 05/04/2013 DTaP, unspecified formulation 107 Valid2016-0005 Dose #1 given at 3 months, dose #2 given at 1 year, dose #3 given at 2 years, and dose # 4 given at 3years. Current age is 7 yrs 12/04/2012 F Not complete 03/04/2013 DTaP, unspecified formulation 107 Valid2016-0006 Dose #1 given at 5 months, dose #2 given at 1 year, dose #3 given at 2 years. Current age is 7 yrs 12/04/2012 F Not complete 05/04/2013 DTaP, unspecified formulation 107 Valid2016-0007 Dose #1 at 9 months, dose #2 at 2 years, and dose #3 at 5 years. Current Age is 7 yrs 12/04/2012 F Not complete 09/04/2013 DTaP, unspecified formulation 107 Valid2016-0008 Dose 1 given at < 12 mo Dose 2 given at 2 yrs Current age 7 yrs 12/04/2012 F Not complete 02/04/2013 DTaP, unspecified formulation 107 Valid2016-0009 3 doses at < 12 mos, 1 dose at 1.5 yrs. Current Age is 7 yrs. 12/04/2012 F Not complete 02/04/2013 DTaP, unspecified formulation 107 Valid2016-0010 Dose 1 and 2 given at < 12 months of age. Dose # 3 given at 2 years and dose #4 given at 3 years. Current age is 7 years. 12/04/2012 F Not complete 03/04/2013 DTaP, unspecified formulation 107 Valid2017-0003 DTaP - Dose 3 to dose 4 interval 4 months-4 days 11/04/2018 F Not complete 01/04/2019 DTaP, unspecified formulation 107 Valid2017-0005 DTaP - Dose 3 to dose 4 interval 4 months-5 days 11/04/2018 F Not complete 01/04/2019 DTaP, unspecified formulation 107 Valid

2013-0167 Newborn 08/01/2019 F Not complete

2013-0168 # 1 to # 2 interval 28 days 05/01/2018 F Not complete 12/01/2018 influenza, unspecified formulation 88 Valid

2013-0169 Child under 9 needs two in first season 09/01/2012 F Not complete 09/01/2019 Afluria, preservative free 140 SEQ Valid

2013-0170 Child under 9 received only one in first season 04/04/2013 F Not complete 10/15/2019 influenza, unspecified formulation 88 Valid

2013-0171 Child under 9 received two in first season 05/10/2013 F Complete 08/01/2019 influenza, unspecified formulation 88 Valid

2013-0172 Invalid dose 1st season 05/01/2019 F Not complete 10/01/2019 FLUZONE 141 PMC Not Valid

2013-0178 # 1 at 6 mo-4 days 04/01/2019 F Not complete 09/27/2019 influenza, unspecified formulation 88 Valid

2013-0179 # 1 at 6 mo 04/01/2019 F Not complete 10/01/2019 influenza, unspecified formulation 88 Valid

2013-0183 # 1 to # 2 interval 23 days 02/01/2019 F Not complete 09/01/2019 influenza, unspecified formulation 88 Valid

2013-0184 # 1 to # 2 interval 24 days 01/09/2019 F Complete 09/01/2019 influenza, unspecified formulation 88 Valid

2016-0012 Child under 9 received one in previous season and one in current season 06/01/2018 M Not complete 12/01/2018 influenza, unspecified formulation 88 Valid

2018-0024 Patient 9 years or older with no current seasonal dose 08/10/2009 M Not complete2018-0025 Patient 9 years or older with one current seasonal dose 08/10/2010 M Complete 09/10/2019 influenza, unspecified formulation 88 Valid2018-0026 Child under 9 years with dose in current season and two doses in previous different seasons 03/06/2016 M Complete 09/15/2016 influenza, unspecified formulation 88 Valid2019-0004 Child received first dose at 9 years. Series complete 08/10/2010 M Complete 08/18/2019 influenza, unspecified formulation 88 Valid2019-0005 Child entered season at 8 years of age, received dose before 9. Forecast another dose 09/01/2010 M Not complete 08/31/2019 influenza, unspecified formulation 88 Valid2019-0015 Adult with no previous of the Influenza vaccine 09/01/1982 M Not complete2019-0016 Adult with a dose of the influenza vaccine 09/01/1982 M Complete 09/01/2019 influenza, injectable, quadrivalent 1582013-0185 Infant forecasting 12/04/2019 F Not complete2013-0186 Dose 1 to dose 2 interval 6 months. Series complete. 04/04/2018 F Complete 06/04/2019 Hep A, unspecified formulation 85 Valid2013-0188 Adult dose mistakenly given to a child. Counts as valid. 12/04/2018 F Not complete 12/04/2019 HAVRIX-ADULT 52 SKB Valid2013-0189 Dose # 1 at age 12 months-5 days 12/09/2018 F Not complete 12/04/2019 Hep A, unspecified formulation 85 Not Valid2013-0190 Dose # 1 at age 12 months-4 days 12/08/2018 F Not complete 12/04/2019 Hep A, unspecified formulation 85 Valid2013-0191 Dose # 1 at age 12 months. 12/04/2018 F Not complete 12/04/2019 Hep A, unspecified formulation 85 Valid2013-0192 Dose 1 to dose 2 interval 6 mo-5 days=invalid 06/09/2018 F Not complete 06/09/2019 Hep A, unspecified formulation 85 Valid2013-0193 Dose 1 to Dose 2 interval 6 mo-4 days. Series complete. 06/08/2015 F Complete 06/08/2019 Hep A, unspecified formulation 85 Valid2013-0194 Dose # 2 at 18 months=series complete. 06/04/2018 F Complete 06/04/2019 Hep A, unspecified formulation 85 Valid2013-0196 Dose 1 to dose 2 interval 6 mo-5 days 04/04/2018 F Not complete 06/04/2019 Hep A, unspecified formulation 85 Valid

2013-0197 Dose 1 to dose 2 interval 6 months-4 days. Series complete. 04/04/2018 F Complete 06/04/2019 Hep A, unspecified formulation 85 Valid2013-0198 Newborn Testing. No vaccinations to date. 12/04/2019 F Not complete2013-0199 Dose 1 to dose 2 interval 28-5 days 10/11/2019 F Not complete 11/11/2019 RECOMBIVAX-PEDS 08 MSD Valid2013-0200 Dose 1 to dose 2 interval 28-4 days 11/10/2019 F Not complete 11/10/2019 RECOMBIVAX-PEDS 08 MSD Valid2013-0201 Dose 1 to dose 2 interval 28 days 11/06/2019 F Not complete 11/06/2019 RECOMBIVAX-PEDS 08 MSD Valid

2013-0202 Dose 2 to dose 3 interval 8 wks-5 days. 4th dose needed. 04/14/2019 F Not complete 07/14/2019 RECOMBIVAX-PEDS 08 MSD Valid2013-0203 Dose 2 to dose 3 interval 8 wks-4 days. Series complete 04/23/2019 F Complete 05/11/2019 Hep B, adolescent or pediatric 08 Valid2013-0204 Dose 2 to dose 3 interval is 8 weeks. Series complete. 04/04/2019 F Complete 06/04/2019 Hep B, adolescent or pediatric 08 Valid

2013-0205 Dose 1 to dose 3 interval 16 weeks-5 days. 4th dose needed 05/19/2019 F Not complete 08/19/2019 RECOMBIVAX-PEDS 08 MSD Valid2013-0206 Dose 1 to dose 3 interval 16 weeks-4 days. Series complete. 05/21/2019 F Complete 08/18/2019 RECOMBIVAX-PEDS 08 MSD Valid2013-0207 Dose 1 to dose 3 interval 16 weeks. Series complete. 05/14/2019 F Complete 08/14/2019 Hep B, adolescent or pediatric 08 Valid2013-0208 Recombivax Hep B ages 11-15. Dose 2 recommended in 4-6 months. 05/14/2007 F Not complete 12/04/2019 RECOMBIVAX-ADULT 43 MSD Valid2013-0209 Dose # 1 at age 0 days. 12/04/2019 F Not complete 12/04/2019 Hep B, unspecified formulation 45 Valid2013-0210 Doses 1 and 2 of Recombvx at ages 11-15 years with ≥ 4 mo interval = series complete. 01/28/2007 F Complete 08/03/2019 RECOMBIVAX-ADULT 43 MSD Valid2013-0211 Dose 1 to dose 2 Recombivax interval 4 months-5 days. Two dose adolescent schedule no longer applies. 08/09/2008 F Not complete 08/09/2019 RECOMBIVAX-ADULT 43 MSD Valid

2013-0212 Dose 2 to dose 3 interval 8 wks-5 days in adolescent with two Recombivax not meeting rules for two dose adoles. 4th dose needed 03/04/2006 F Not complete 07/04/2019 RECOMBIVAX-ADULT 43 MSD Valid2013-0213 Hep at birth. Comvax at 6 wks and 6 mo. Hep series complete. 02/04/2004 F Complete 02/04/2004 RECOMBIVAX-PEDS 08 MSD Valid2013-0216 Hep B at birth. Comvax at 4 weeks and 6 months. Series complete for Hep B. 02/02/2006 F Complete 02/02/2006 Hep B, unspecified formulation 45 Valid2013-0219 Hep B at birth. Comvax at 5 mo and 8 wks-4 days later. Series complete for Hep B. 05/05/2006 F Complete 05/05/2006 RECOMBIVAX-PEDS 08 MSD Valid2013-0220 Dose # 1 at age 1 day 12/03/2019 F Not complete 12/04/2019 RECOMBIVAX-PEDS 08 MSD Valid2013-0221 Hep at birth. Comvax at 5 mo and 8 wks later. Series complete for Hep B. 06/06/2006 F Complete 06/06/2006 RECOMBIVAX-PEDS 08 MSD Valid

2013-0222 Dose 1 to dose 3 interval of Comvax 16 wks-5 days. 4th dose needed 05/15/2002 F Not complete 08/01/2002 COMVAX 51 MSD Valid2013-0223 Dose 1 to dose 3 interval of Comvax 16 wks-4 days=valid Hep B # 3. Hep B series complete. 07/07/2006 F Complete 10/18/2006 COMVAX 51 MSD Valid


Med_History_Code



2013-0224 Dose 1 to dose 3 interval of Comvax is 16 weeks. Series complete for Hep B. 08/08/2006 F Complete 10/31/2006 COMVAX 51 MSD Valid2013-0225 Comvax given at birth. 10/10/2006 F Not complete 10/10/2006 COMVAX 51 MSD Valid2013-0227 Dose # 2 at 28-5 days 11/11/2019 F Not complete 11/11/2019 RECOMBIVAX-PEDS 08 MSD Valid2013-0228 Dose # 2 at 28-4 days 11/10/2019 F Not complete 11/10/2019 RECOMBIVAX-PEDS 08 MSD Valid2013-0229 Dose # 2 at 28 days 11/06/2019 F Not complete 11/06/2019 RECOMBIVAX-PEDS 08 MSD Valid

2013-0230 Dose # 3 at age 24 weeks-5 days. 4th dose needed. 06/24/2019 F Not complete 06/24/2019 ENGERIX B-PEDS 08 SKB Valid2013-0231 Dose # 3 at age 24 weeks-4 days. Series complete. 06/23/2019 F Complete 06/23/2019 RECOMBIVAX-PEDS 08 MSD Valid2013-0232 Dose # 3 at 24 weeks. Series complete. 06/19/2019 F Complete 06/19/2019 RECOMBIVAX-PEDS 08 MSD Valid2013-0233 Newborn forecasting 12/04/2019 F Not complete2013-0234 # 2 Pediarix at 6 yrs 11.5 mo 12/20/2012 F Not complete 12/05/2015 PEDIARIX 110 SKB Valid2013-0235 # 2 Pediarix at 7 yrs; # 1 at less than 12 mo. 12/04/2012 F Not complete 03/04/2013 PEDIARIX 110 SKB Valid2013-0236 # 2 Pediarix at 7 yrs; # 1 ≥ 12 mo. 12/04/2012 F Not complete 01/04/2014 PEDIARIX 110 SKB Valid2013-0237 # 1 and 2 Pediarix at ≥7 yrs with 28 day interval. 11/06/2012 F Not complete 11/06/2019 PEDIARIX 110 SKB Valid2013-0238 # 3 Pediarix at 14 wks-5 days 09/02/2019 F Not complete 10/10/2019 PEDIARIX 110 SKB Valid2013-0239 # 3 Pediarix at 14 wks-4 days 09/01/2019 F Not complete 10/11/2019 PEDIARIX 110 SKB Valid2013-0241 # 3 Pediarix at 24 weeks-4 days. Valid for dose 3 06/23/2019 F Complete 08/04/2019 Hep B, adolescent or pediatric 08 Valid2013-0243 # 4 Pediarix at 1 yr -5 days 12/09/2018 F Complete 02/09/2019 PEDIARIX 110 SKB Valid2013-0244 # 1 Pediarix at 6 wks-5 days 10/28/2019 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid2013-0245 # 4 Pediarix at 1 yr -4 days 12/08/2018 F Complete 02/08/2019 PEDIARIX 110 SKB Valid2013-0246 # 4 Pediarix at 3 yrs 11.5 mo. 12/20/2015 F Complete 02/20/2016 PEDIARIX 110 SKB Valid2013-0247 # 4 Pediarix at 4 yrs 12/04/2015 F Complete 04/07/2016 PEDIARIX 110 SKB Valid2013-0248 # 5 Pediarix at 4 yrs -5 days 12/09/2015 F Complete 02/09/2016 PEDIARIX 110 SKB Valid2013-0249 # 5 Pediarix at 4 yrs -4 days 12/08/2015 F Complete 02/08/2016 PEDIARIX 110 SKB Valid2013-0250 # 5 Pediarix at 6 yrs 11.5 mo 12/20/2012 F Complete 02/20/2013 PEDIARIX 110 SKB Valid2013-0251 # 5 Pediarix at 7 yrs 12/04/2012 F Complete 03/04/2013 PEDIARIX 110 SKB Valid2013-0255 # 1 Pediarix at 6 wks-4 days 10/27/2019 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid2013-0256 dose 1 to 2 Pediarix, interval 28-5 days 09/11/2019 F Not complete 11/11/2019 PEDIARIX 110 SKB Valid2013-0257 dose 1 to 2 Pediarix, interval 28-4 days 09/10/2019 F Not complete 11/10/2019 PEDIARIX 110 SKB Valid

2013-0258 dose 2 to 3 Pediarix, interval 8 weeks-5 days. 4th dose needed. 06/19/2019 F Not complete 08/12/2019 PEDIARIX 110 SKB Valid2013-0259 dose 2 to 3 Pediarix, interval 8 weeks-4 days 06/19/2019 F Complete 08/13/2019 PEDIARIX 110 SKB Valid2013-0260 dose 3 to 4 Pediarix, interval 6m-5 days 10/04/2018 F Complete 12/04/2018 PEDIARIX 110 SKB Valid2013-0261 dose 3 to 4 Pediarix, interval 6m-4 days 10/04/2018 F Complete 12/04/2018 PEDIARIX 110 SKB Valid2013-0262 dose 3 to 4 Pediarix, interval 4 mo-1 day 10/04/2018 F Complete 12/04/2018 PEDIARIX 110 SKB Valid2013-0263 dose 3 to 4 Pediarix, interval 4 mo 10/04/2018 F Complete 12/04/2018 PEDIARIX 110 SKB Valid2013-0264 invalid dose 1-2 interval in midst of others 08/04/2019 F Not complete 10/04/2019 PEDIARIX 110 SKB Valid2013-0266 # 1 Pediarix at 6 wks 10/23/2019 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid2013-0267 # 1 Pediarix at 6 yrs 11.5 mo 12/19/2012 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid2013-0268 # 1 Pediarix at 7 yrs 12/04/2012 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid2013-0269 # 2 Pediarix at 10 wks-5 days 09/30/2019 F Not complete 11/07/2019 PEDIARIX 110 SKB Valid2013-0270 # 2 Pediarix at 10 wks-4 days 09/29/2019 F Not complete 10/29/2019 PEDIARIX 110 SKB Valid2013-0271 # 2 Pediarix at 10 wks 09/25/2019 F Not complete 10/25/2019 PEDIARIX 110 SKB Valid2016-0022 Hep B- Dose #4 administered < 8 weeks after dose #3. 04/13/2019 F Complete 07/13/2019 RECOMBIVAX-PEDS 08 MSD Valid2017-0002 Hep B- Dose #4 administered at 24 weeks of age and at least 16 weeks from dose #1. 03/21/2019 F Complete 06/21/2019 PEDIARIX 110 SKB Valid2018-0015 Hep B: Patient is 18 years and has received the first dose of the Hep B (Heplisav) vaccine 12/04/2001 F Not complete 12/04/2019 Hep B, adjuvanted 189 Valid2018-0016 Hep B: Patient is 18 years and has received the second dose of the Hep B (Heplisav) vaccine at 4 weeks. 11/06/2001 F Complete 11/06/2019 Hep B, adjuvanted 189 Valid2018-0017 Hep B: Patient is 18 years and has received the second dose of the Hep B (Heplisav) vaccine at 4 weeks - 5 days 11/11/2001 F Not complete 11/11/2019 Hep B, adjuvanted 189 Valid2018-0018 Hep B: Patient is 18 years and has received the second dose of the Hep B (Heplisav) vaccine at 4 weeks - 4 days. 11/10/2001 F Complete 11/10/2019 Hep B, adjuvanted 189 Valid2018-0019 Hep B: Patient is 18 years - 4 days with first dose of Heplisav 12/08/2001 F Not complete 12/04/2019 Hep B, adjuvanted 189 Valid2018-0020 Hep B: Patient is 18 years and has received a previous dose of Hep B vaccine and one dose of Heplisav B vaccine 12/04/2001 F Not complete 12/04/2016 RECOMBIVAX-PEDS 08 MSD Valid

2018-0021 Hep B: Patient is 18 years and has received a previous dose of Hep B vaccine and two doses of Hep B (Heplisav) vaccine 10/09/2001 F Complete 10/09/2016 Hep B, adolescent or pediatric 08 Valid

2018-0022 Hep B: Patient is 18 years - 5 days with first dose of Hep B (Hepislav) vaccine 12/09/2001 F Not complete 12/04/2019 HEPLISAV-B 189 DVX Not Valid2018-0023 Hep B: Patient is 18 years and has received a dose of Hep B (Heplisav) vaccine, and one dose of Hep B (alum) 11/06/2001 M Not complete 11/06/2019 HEPLISAV-B 189 DVX Valid2013-0273 Child<2 months, no shots, #1 forecasted at 2 months of age 12/04/2019 F Not complete2013-0274 # 1 at 6 wks-5 days 10/28/2019 F Not complete 12/04/2019 ACTHIB 48 PMC Not Valid2013-0275 # 1 at 6 wks-4 days 10/27/2019 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0276 # 1 at 6 wks -3 days 10/26/2019 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0277 # 1 at 3 months 09/04/2019 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0278 #1 at 3 months and 3 days-catchup- #2 recommended at +28 days 09/01/2019 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0279 #1 at 6 months - catchup- #2 recommended at +28 days 06/04/2019 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0280 #1 at 7 and <11 months - catchup- drop to 3 dose schedule 05/04/2019 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0281 #1 at 12 months, drop to 2-dose schedule 12/04/2018 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0282 #1 at 15m -drop to 1 dose schedule 09/04/2018 F Complete 12/04/2019 ACTHIB 48 PMC Valid2013-0283 #1 at 3 years -drop to 1 dose schedule 12/04/2016 F Complete 12/04/2019 ACTHIB 48 PMC Valid

2013-0284 #1 at 5 years 12/04/2014 F Aged out 12/04/2019 ACTHIB 48 PMC Extraneous

2013-0285 #1 at 6 years 12/04/2013 F Aged out 12/04/2019 ACTHIB 48 PMC Extraneous2013-0286 # 2 at 10 wks-5 days 09/30/2019 F Not complete 11/07/2019 ACTHIB 48 PMC Valid2013-0287 # 2 at 10 wks-4 days 09/29/2019 F Not complete 11/06/2019 ACTHIB 48 PMC Valid2013-0288 # 2 at 10 wks -3 days 09/28/2019 F Not complete 11/05/2019 ACTHIB 48 PMC Valid2013-0289 # 2 at 4 months 08/04/2019 F Not complete 10/04/2019 ACTHIB 48 PMC Valid2013-0290 #2 at 5 months 07/04/2019 F Not complete 09/04/2019 ACTHIB 48 PMC Valid2013-0291 #2 at 5 months and 3 days-catchup-#3 at +28 days 07/01/2019 F Not complete 09/01/2019 ACTHIB 48 PMC Valid

2013-0292 #2 at 12 m - 5 days 12/09/2018 F Not complete 02/09/2019 ACTHIB 48 PMC Valid2013-0293 #2 at 12 m - 4 days 12/08/2018 F Not complete 02/08/2019 ACTHIB 48 PMC Valid2013-0294 #2 at 15 months 09/04/2018 F Complete 11/04/2018 ACTHIB 48 PMC Valid

2013-0295 #2 at 5 years 12/04/2014 F Aged out 02/04/2015 ACTHIB 48 PMC Valid2013-0296 dose 1 to 2, interval 4 weeks -5 days 09/11/2019 F Not complete 11/11/2019 ACTHIB 48 PMC Valid2013-0297 dose 1 to 2, interval 4 weeks -4 days 09/10/2019 F Not complete 11/10/2019 ACTHIB 48 PMC Valid2013-0298 dose 1 to 2, interval 25 days 09/09/2019 F Not complete 11/09/2019 ACTHIB 48 PMC Valid2013-0299 #3 at 14 weeks-5 days 09/02/2019 F Not complete 10/10/2019 ACTHIB 48 PMC Valid2013-0300 #3 at 6 months 06/04/2019 F Not complete 08/04/2019 ACTHIB 48 PMC Valid2013-0301 Dose 2 to 3, interval 4 weeks-5 days 07/11/2019 F Not complete 09/11/2019 ACTHIB 48 PMC Valid2013-0302 Dose 2 to 3, interval 4 weeks -4 days 07/10/2019 F Not complete 09/10/2019 ACTHIB 48 PMC Valid2013-0303 Dose 2 to 3, interval 4 weeks 07/06/2019 F Not complete 09/06/2019 ACTHIB 48 PMC Valid2013-0304 #4 at 12 months - 5 days of age, interval between #3-4 >8 weeks 12/09/2018 F Not complete 02/09/2019 ACTHIB 48 PMC Valid2013-0305 #4 at 12 months - 4 days of age, interval between #3-4 >8 weeks 12/08/2018 F Complete 02/08/2019 ACTHIB 48 PMC Valid2013-0306 #4 at 12 months - 3 days of age, interval between #3-4 >8 weeks 12/07/2018 F Complete 02/07/2019 ACTHIB 48 PMC Valid2013-0307 #4 at 15 months of age, interval between #3-4 > 8 weeks 09/04/2018 F Complete 11/04/2018 ACTHIB 48 PMC Valid2013-0308 #4 at 12 months of age, interval between #3-4 8 weeks -5 days 12/04/2018 F Not complete 02/04/2019 ACTHIB 48 PMC Valid2013-0309 #4 at 12 months of age, interval between #3-4 8 weeks -4 days 12/04/2018 F Complete 02/04/2019 ACTHIB 48 PMC Valid2013-0310 # 4 at 15 months of age 09/04/2018 F Complete 11/04/2018 ACTHIB 48 PMC Valid

2013-0313 #4 at 5 years 12/04/2014 F Aged out 02/04/2015 ACTHIB 48 PMC Valid

2013-0314 #4 at 7 years 12/04/2013 F Aged out 02/04/2014 ACTHIB 48 PMC Valid2013-0315 Child<2 months, no shots, #1 forecasted at 2 months of age 12/04/2019 F Not complete2013-0317 # 2 at 10 wks-4 days, PRP-OMP series 09/29/2019 F Not complete 11/06/2019 PEDVAXHIB 49 MSD Valid2013-0318 # 2 at 10 wks-3 days, PRP-OMP series 09/28/2019 F Not complete 11/05/2019 PEDVAXHIB 49 MSD Valid2013-0319 # 2 at 12 months 12/04/2018 F Not complete 02/04/2019 ACTHIB 48 PMC Valid2013-0320 #3 at 5m (#1, #2 at 2 and 4m) 07/04/2019 F Not complete 09/04/2019 ACTHIB 48 PMC Valid2013-0321 #3 at 10 months and 9 days (#1,2 at 2 and 3 m) 01/25/2019 F Not complete 03/25/2019 ACTHIB 48 PMC Valid2013-0322 #3 at 11 months 01/04/2019 F Not complete 03/04/2019 ACTHIB 48 PMC Valid2013-0323 #3 at 12 months -5 days 12/09/2018 F Not complete 02/09/2019 ACTHIB 48 PMC Valid

2013-0324 #3 at 12 months - 3 days 12/07/2018 F Complete 02/07/2019 ACTHIB 48 PMC Valid2013-0325 #3 at 15 months 09/04/2018 F Complete 11/04/2018 ACTHIB 48 PMC Valid2013-0326 #3 at 59 months 12/05/2014 F Complete 02/05/2015 ACTHIB 48 PMC Valid2013-0327 #1 at 7 months-5 days 05/09/2019 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0328 #1 at 7 months- 3 days 05/07/2019 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0329 Dose 2 to 3, interval 8 weeks -3 days, #3 after 12 months of age 11/28/2018 F Complete 01/28/2019 ACTHIB 48 PMC Valid2013-0330 # 1 at 7 months -4 days 05/08/2019 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0331 # 1 at 12 months minus 5 days 12/09/2018 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0332 # 1 at 12 months -4 days 12/08/2018 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0333 # 1 at 12 months -3 days 12/07/2018 F Not complete 12/04/2019 ACTHIB 48 PMC Valid


Med_History_Code



2013-0334 #2 at 7 m and 23 days (#1 at 7 m) 04/11/2019 F Not complete 11/11/2019 ACTHIB 48 PMC Valid2013-0335 #2 at 7 m and 24 days (#1 at 7 m) 04/10/2019 F Not complete 11/10/2019 ACTHIB 48 PMC Valid2013-0336 #2 at 11 m (#1 at 7 m) 01/04/2019 F Not complete 08/04/2019 ACTHIB 48 PMC Valid2013-0337 #2 at 12 m (#1 at 7 m) 12/04/2018 F Not complete 07/04/2019 ACTHIB 48 PMC Valid2013-0338 #3 at 365 d -5 days (#1 at 7m, #2 at 8m) 12/09/2018 F Not complete 07/09/2019 ACTHIB 48 PMC Valid2013-0339 #3 at 365 d -4 days (#1 at 7m, #2 at 8m) 12/08/2018 F Complete 07/08/2019 ACTHIB 48 PMC Valid2013-0340 #3 at 365 days - 3 days (#1 at 7m, #2 at 8m) 12/07/2018 F Complete 07/07/2019 ACTHIB 48 PMC Valid2013-0341 #3 at 59 months (#1 at 7m, #2 at 8m) 01/04/2015 F Complete 08/04/2015 ACTHIB 48 PMC Valid

2013-0342 #3 at 5 years (#1 at 7m, #2 at 8m) 12/04/2014 F Aged out 07/04/2015 ACTHIB 48 PMC Valid2013-0343 Dose 2 to 3, interval 8 weeks-5 days, #3 after 12 months of age 10/27/2018 F Not complete 12/27/2018 ACTHIB 48 PMC Valid2013-0344 Dose 2 to 3, interval 8 weeks -4 days, #3 after 12 months of age 10/27/2018 F Complete 12/27/2018 ACTHIB 48 PMC Valid2013-0346 #1 at 15 months -5 days 09/09/2018 F Not complete 12/04/2019 ACTHIB 48 PMC Valid2013-0347 #1 at 15 months -4 days 09/08/2018 F Complete 12/04/2019 ACTHIB 48 PMC Valid2013-0348 Dose 1 to 2 at 8 weeks -5 days (#1 at 1 year) 10/14/2018 F Not complete 10/14/2019 ACTHIB 48 PMC Valid2013-0349 Dose 1 to 2 at 8 weeks -4 days (#1 at >=1 year) 10/13/2018 F Complete 10/13/2019 HIBERIX 48 SKB Valid2013-0350 Dose 1 to 2 at 8 weeks - 3 days (#1 at >=1 year) 10/12/2018 F Complete 10/12/2019 ACTHIB 48 PMC Valid2013-0351 # 3 (#1 at one year, #2 at 15 months) 07/09/2018 F Complete 07/09/2019 ACTHIB 48 PMC Valid2013-0352 # 1 at 15 m - 3 days 09/07/2018 F Complete 12/04/2019 ACTHIB 48 PMC Valid2013-0353 # 1 at 5 years - 1 day 12/05/2014 F Complete 12/04/2019 ACTHIB 48 PMC Valid2013-0354 #2 at 2 years, #1 at 15 m 12/04/2017 F Complete 03/04/2019 ACTHIB 48 PMC Valid2013-0355 #2 at 5 months 07/04/2019 F Not complete 09/04/2019 ACTHIB 48 PMC Valid2013-0356 # 2 Pentacel at 6 yrs 11.5 mo. 12/20/2012 F Complete 09/10/2015 PENTACEL 120 PMC Valid2013-0357 # 3 Pentacel at 14 wks-5 days 09/02/2019 F Not complete 10/10/2019 PENTACEL 120 PMC Valid2013-0358 invalid age dose 1 as first of others 06/04/2019 F Not complete 07/09/2019 PENTACEL 120 PMC Not Valid2013-0359 dose 1 to 2 Pentacel, interval 28-4 days 09/08/2019 F Not complete 11/10/2019 PENTACEL 120 PMC Valid2013-0360 dose 2 to 3 Pentacel, interval 28-5 days 07/11/2019 F Not complete 09/11/2019 PENTACEL 120 PMC Valid2013-0365 # 1 Pentacel at 6 wks 10/23/2019 F Not complete 12/04/2019 PENTACEL 120 PMC Valid2013-0366 # 1 Pentacel at 6 wks-4 days 10/27/2019 F Not complete 12/04/2019 PENTACEL 120 PMC Valid2013-0367 # 1 Pentacel at 6 wks-5 days. 10/28/2019 F Not complete 12/04/2019 PENTACEL 120 PMC Not Valid2013-0368 # 2 Pentacel at 10 wks-4 days 09/29/2019 F Not complete 11/06/2019 PENTACEL 120 PMC Valid2013-0369 # 2 Pentacel at 10 wks-5 days 09/30/2019 F Not complete 11/07/2019 PENTACEL 120 PMC Valid2013-0370 # 3 Pentacel at 14 wks-4 days 09/01/2019 F Not complete 10/09/2019 PENTACEL 120 PMC Valid2013-0371 # 4 Pentacel ≥ age 12 mo 12/04/2018 F Complete 02/04/2019 PENTACEL 120 PMC Valid2013-0372 # 4 Pentacel at 1 yr -4 days 12/08/2018 F Complete 02/08/2019 PENTACEL 120 PMC Valid2013-0373 # 4 Pentacel at 1 yr -5 days. 12/09/2018 F Not complete 02/09/2019 PENTACEL 120 PMC Valid2013-0374 # 4 Pentacel at 4 yrs 11/30/2015 F Complete 04/08/2016 PENTACEL 120 PMC Valid

2013-0375 # 4 Pentacel at 5 yrs=off label but counts. 12/04/2014 F Aged out 04/04/2015 PENTACEL 120 PMC Valid2013-0376 # 5 Pentacel at ≥ 4 yrs is off label but counts 11/12/2015 F Complete 10/12/2016 PENTACEL 120 PMC Valid2013-0378 dose 1 to 2 Pentacel, interval 28-5 days 09/17/2019 F Not complete 11/11/2019 PENTACEL 120 PMC Valid2013-0379 dose 2 to 3 Pentacel, interval 28-4 days 07/10/2019 F Not complete 09/10/2019 PENTACEL 120 PMC Valid2013-0380 invalid age dose 2 in midst of others 12/02/2018 F Complete 01/09/2019 PENTACEL 120 PMC Valid2013-0381 invalid age dose 3 in midst of others 10/28/2018 F Complete 12/05/2018 PENTACEL 120 PMC Valid2013-0382 invalid dose 1-2 interval in midst of others 06/13/2019 F Not complete 08/13/2019 PENTACEL 120 PMC Valid2013-0383 Newborn 12/04/2019 F Not complete

2013-0384 Pentacel at 6 yrs 12/04/2013 F Aged out 05/13/2014 PENTACEL 120 PMC Valid2013-0392 #1 @ 9 yrs - 4 days, female, gardasil 12/08/2010 F Not complete 12/04/2019 HPV9 165 Valid2013-0394 #1 @ 9 yrs - 0 days, female, gardasil 12/04/2010 F Not complete 12/04/2019 HPV9 165 Valid2013-0395 #1 @ 11 yrs - 0 days, female, gardasil 12/04/2008 F Not complete 12/04/2019 HPV9 165 Valid2013-0396 #1 @ 9 yrs - 4 days, male, gardasil 12/08/2010 M Not complete 12/04/2019 HPV9 165 Valid2013-0398 #1 @ 9 yrs - 0 days, male, gardasil 12/04/2010 M Not complete 12/04/2019 HPV9 165 Valid2013-0399 #1 @ 11 yrs - 0 days, male, gardasil 12/04/2008 M Not complete 12/04/2019 HPV9 165 Valid2013-0400 #2 @ 9 yrs, 4 wks - 4 days, female, gardasil 11/10/2010 F Not complete 11/06/2019 HPV9 165 Valid2013-0402 #2 @ 9 yrs, 4 wks - 0 days, female gardasil 11/06/2010 F Not complete 11/06/2019 HPV9 165 Valid2013-0403 #2 @ 11 yrs + 2 mo, female, gardasil 10/04/2008 F Not complete 10/04/2019 HPV9 165 Valid2013-0404 #2 @ 9 yrs, 4 wks - 4 days, male, gardasil 11/10/2010 M Not complete 11/07/2019 HPV9 165 Valid

2013-0405 #2 @ 9 yrs, 4 wks - 5 days, male gardasil 11/15/2010 M Not complete 11/11/2019 HPV9 165 Valid2013-0406 #2 @ 9 yrs, 4 wks - 0 days, male gardasil 11/06/2010 M Not complete 11/06/2019 HPV9 165 Valid2013-0407 #2 @ 11 yrs + 2 mo, male, gardasil 10/04/2008 M Not complete 10/04/2019 HPV9 165 Valid2013-0409 #3 @ 9 yrs, 16 weeks - 1 days, female, gardasil 05/01/2002 F Complete 04/30/2011 GARDASIL 62 MSD Valid2013-0410 #3 @ 9 yrs, 24 weeks, 0 days, female, gardasil 06/19/2010 F Complete 06/19/2019 HPV9 165 Valid2013-0411 #3 @ 11 yrs + 6 mo, female, gardasil 06/04/2008 F Complete 06/04/2019 HPV9 165 Valid2013-0413 #3 @ 9 yrs, 16 weeks - 1 days, male, gardasil 05/01/2002 M Complete 04/30/2011 GARDASIL 62 MSD Valid2013-0414 #3 @ 9 yrs, 24 weeks, 0 days, male, gardasil 06/19/2010 M Complete 06/19/2019 HPV9 165 Valid2013-0415 #3 @ 11 yrs + 6 mo, male, gardasil 06/04/2008 M Complete 06/04/2019 HPV9 165 Valid

2013-0416 Any dose 26 yrs, female, gardasil 12/03/1993 F Not complete 12/04/2019 HPV9 165 Valid2013-0418 #1 @ 9 yrs - 4 days, female, Cervarix 05/01/2002 F Not complete 04/27/2011 CERVARIX 118 SKB Valid2013-0421 #1 @ 9 yrs - 0 days, female, Cervarix 05/01/2002 F Not complete 05/01/2011 CERVARIX 118 SKB Valid2013-0422 #1 @ 11 yrs - 0 days, female, Cervarix 05/01/2000 F Not complete 05/01/2011 CERVARIX 118 SKB Valid2013-0423 #1 @ 9 yrs - 4 days, male, Cervarix 05/01/2002 M Not complete 04/28/2011 CERVARIX 118 SKB Not Valid2013-0424 #1 @ 9 yrs - 5 days, male, Cervarix 05/01/2002 M Not complete 04/27/2011 CERVARIX 118 SKB Not Valid2013-0425 #1 @ 9 yrs - 0 days, male, Cervarix 05/01/2002 M Not complete 05/01/2011 CERVARIX 118 SKB Not Valid2013-0426 #1 @ 11 yrs - 0 days, male, Cervarix 05/01/2000 M Not complete 05/01/2011 CERVARIX 118 SKB Not Valid2013-0427 #2 @ 9 yrs, 4 wks - 4 days, female, Cervarix 05/01/2002 F Not complete 04/28/2011 CERVARIX 118 SKB Valid2013-0428 #2 @ 9 yrs, 4 wks - 0 days, female Cervarix 05/01/2002 F Not complete 05/01/2011 CERVARIX 118 SKB Valid2013-0429 #2 @ 11 yrs + 2 mo, female, Cervarix 05/01/2000 F Not complete 05/01/2011 CERVARIX 118 SKB Valid2013-0430 #2 @ 9 yrs, 4 wks - 4 days, male, Cervarix 05/01/2002 M Not complete 04/28/2011 CERVARIX 118 SKB Not Valid2013-0433 #3 @ 9 yrs, 24 weeks, 0 days, female, Cervarix 05/01/2002 F Complete 05/01/2011 CERVARIX 118 SKB Valid2013-0434 #3 @ 11 yrs + 6 mo, female, Cervarix 05/01/2000 F Complete 05/01/2011 CERVARIX 118 SKB Valid2013-0437 #3 @ 9 yrs, 24 weeks, 0 days, male, Cervarix 05/01/2002 M Not complete 05/01/2011 CERVARIX 118 SKB Not Valid2013-0438 #3 @ 11 yrs + 6 mo, male, Cervarix 05/01/2000 M Not complete 05/01/2011 CERVARIX 118 SKB Not Valid

2013-0439 Any dose 26 yrs, female, Cervarix 05/01/1986 F Not complete 05/02/2012 CERVARIX 118 SKB Valid2013-0440 #2 with interval of 4 weeks from #1 11/06/2008 F Not complete 11/06/2019 HPV9 165 Valid2013-0441 #2 with interval of 4 weeks - 4 days from #1 11/10/2008 F Not complete 11/10/2019 HPV9 165 Valid2013-0442 #2 with interval of 4 weeks - 5 days from #1 11/11/2008 F Not complete 11/11/2019 HPV9 165 Valid2013-0443 #2 with interval of 2 mo from #1 10/04/2008 F Not complete 10/04/2019 HPV9 165 Valid2013-0444 #3 with interval of 12 weeks from #2 05/01/2002 F Complete 05/01/2011 HPV, unspecified formulation 137 Valid2013-0445 #3 with interval of 12 weeks - 4 days from #2 05/01/2000 F Complete 05/01/2011 HPV, unspecified formulation 137 Valid2013-0446 #3 with interval of 12 weeks - 5 days from #2 08/11/2008 F Not complete 08/11/2019 HPV9 165 Valid2013-0447 #3 with interval of 4 mo from #2 06/04/2008 F Complete 06/04/2019 HPV9 165 Valid2013-0448 #3 with interval of 24 weeks from #1 06/19/2009 F Complete 06/19/2019 HPV9 165 Valid2013-0450 #3 with interval of 16 weeks from #1 05/01/2000 F Complete 05/01/2010 HPV, unspecified formulation 137 Valid2013-0451 #1 @ 8 yrs - 5 days, #2 @ 9 yrs - 5 days 12/09/2010 F Not complete 12/04/2018 HPV9 165 Not Valid2013-0452 #1 @ 9 yrs - 5 days, #2 @ 9 yrs - 4 days 12/08/2010 F Not complete 12/03/2019 HPV9 165 Not Valid2013-0453 #1 @ 9 yrs, #2 @ 9 yrs + 2 weeks 11/20/2010 F Not complete 11/20/2019 HPV9 165 Valid2013-0454 #1 @ 9 yrs, #2 @ 12 yrs, 2 mo, 3 days 10/01/2007 F Complete 10/01/2016 HPV9 165 Valid2013-0455 #1 @ 9 yrs, #2 @ 11 yr, 6 mo 06/04/2008 F Complete 06/04/2017 HPV9 165 Valid2013-0456 #1 @ 8 yrs - 5 days, #2 @ 9 yrs - 6 days, #3 @ 9 yrs - 5 days 12/09/2010 F Not complete 12/04/2018 HPV9 165 Not Valid2013-0457 #1 @ 8 yrs - 5 days, #2 @ 9 yrs - 6 days, #3 @ 9 yrs - 0 days 12/04/2010 F Not complete 11/29/2018 HPV9 165 Not Valid2013-0458 #1 @ 9 yrs - 5 days, #2 @ 9 yrs + 4 weeks, #3 @ 9 yrs, 8 weeks 10/09/2010 F Not complete 10/04/2019 HPV9 165 Not Valid2013-0459 #1 @ 9 yrs - 5 days, #2 @ 9 yrs + 4 weeks, #3 @ 9 yrs, 8 weeks, #4 @ 9 yrs, 24 weeks 05/01/2002 F Complete 04/26/2011 HPV, unspecified formulation 137 Not Valid2013-0460 Adolescent male, no HPV yet given. 01/08/2011 M Not complete2013-0462 # 2 at age 9 years 4 weeks-4 days 11/10/2010 F Not complete 11/09/2019 HPV9 165 Valid2013-0463 # 2 at age 9 years 4 weeks 11/06/2010 F Not complete 11/06/2019 HPV9 165 Valid2013-0465 # 3 at age 9 years 16 weeks-1 days. 12/01/2001 F Complete 11/30/2010 HPV, unspecified formulation 137 Valid2013-0466 # 3 at age 9 years 16 weeks 12/01/2002 F Complete 12/01/2011 HPV, unspecified formulation 137 Valid

2013-0467 # 2 at age 26 yrs 11 months 15 days; forecast # 3; female 12/19/1992 F Aged out 12/19/2017 HPV9 165 Valid2013-0468 Dose 1 to dose 2 interval 28-5 days 11/11/2007 F Not complete 11/11/2019 HPV9 165 Valid2013-0469 Dose 1 to dose 2 interval 28 days 11/06/2007 F Not complete 11/06/2019 HPV9 165 Valid2013-0470 Adolescent female, no HPV yet given. 06/27/2011 F Not complete2013-0471 Dose 2 to dose 3 interval 12 weeks-5 days 07/16/2009 F Not complete 07/16/2019 HPV9 165 Valid2013-0472 Dose 2 to dose 3 interval 12 weeks-4 days 09/16/2000 F Complete 09/20/2010 HPV, unspecified formulation 137 Valid2013-0473 Dose 2 to dose 3 interval 12 weeks 09/16/2000 F Complete 09/20/2010 HPV, unspecified formulation 137 Valid

2013-0474 Dose 1 to dose 3 interval 16 weeks -5 days 03/21/1996 F Not complete 04/18/2008 HPV, unspecified formulation 137 Valid2013-0475 Dose 1 to dose 3 interval 16 weeks=valid when administered prior to 12/16/2016 03/21/1996 F Complete 04/18/2008 HPV, unspecified formulation 137 Valid2013-0476 # 2 to # 3 interval 12 wks-4 days 12/20/2005 F Complete 06/20/2019 HPV9 165 Valid2013-0477 Invalid dose 1 of three doses given 02/20/2010 F Complete 01/30/2019 HPV9 165 Not Valid2013-0478 Invalid dose 2 in midst of others 04/04/2008 F Complete 06/04/2019 HPV9 165 Valid2013-0480 Adult female age 27 years, No Doses 12/04/1992 F Aged out


Med_History_Code



2013-0481 Male age 27. HPV not recommended. 12/04/1992 M Aged out2013-0482 Female, age 14. HPV recommended 12/04/2005 F Not complete2013-0483 HPV bivalent to male adolescent. Not valid. Forecast quadrivalent 06/18/2000 M Not complete 06/20/2011 CERVARIX 118 SKB Not Valid2013-0484 # 1 at age 9 years-5 days 12/09/2010 F Not complete 12/04/2019 HPV9 165 Not Valid2013-0485 # 1 at age 9 years-4 days 12/08/2010 F Not complete 12/04/2019 HPV9 165 Valid2013-0486 # 1 at age 9 years 12/04/2010 F Not complete 12/04/2019 HPV9 165 Valid2016-0013 Female age 26, No HPV doses 12/04/1993 F Not complete2016-0015 Adolescent child with first dose of HPV vaccine at 13 years and second dose after 15 years of age. 11/04/2004 M Complete 11/18/2017 Gardasil 9 165 MSD Valid2016-0016 Adolescent child age 15 with no previous doses. 07/04/2004 F Not complete2016-0017 Adolescent child age 15 with one dose of the HPV vaccine 07/04/2004 F Not complete 12/04/2019 Gardasil 9 165 MSD Valid2016-0018 Adolescent child age 15 with two previous doses of the HPV vaccine. 06/06/2004 F Not complete 11/06/2019 Gardasil 9 165 MSD Valid2016-0019 Adolescent child age 15 with three doses of the HPV vaccine 01/04/2004 F Complete 06/04/2019 Gardasil 9 165 MSD Valid2016-0020 Adolescent child with a history of 2 doses of the HPV vaccine 1st dose given at 11 years and the 2nd dose give at 2 months later. 09/04/2007 M Not complete 10/04/2019 Gardasil 9 165 MSD Valid2016-0021 Adolescent child 15 years -1 days with no previous history of HPV vaccine 12/05/2004 M Not complete2016-0023 Adolescent child age 11 with 2nd dose of HPV at 5 months - 5 days 05/19/2008 F Not complete 07/07/2019 Gardasil 9 165 MSD Valid2016-0024 Adolescent child age 11 with 2nd dose of HPV at 5 months - 4 days 05/18/2008 F Complete 07/06/2019 Gardasil 9 165 MSD Valid2017-0001 Child is age 9 with 3rd dose of HPV at 5 months from first dose 04/04/2010 F Complete 07/04/2019 Gardasil 9 165 MSD Valid2019-0006 Any dose 26 years, Male, gardasil 12/04/1993 M Not complete 12/04/2019 HPV9 165 Valid2019-0007 Male age 26, No HPV doses 12/04/1993 M Not complete2013-0487 #1 @ 11 yrs, 0 days, MCV4 12/04/2008 F Not complete 12/04/2019 MENACTRA 114 PMC Valid2013-0488 #2 @ 16 yr - 4 days, MCV4 12/08/2003 F Complete 12/08/2014 MENACTRA 114 PMC Valid2013-0489 #2 @ 10 16 yr - 5 days, MCV4 12/09/2003 F Not complete 12/09/2014 MENACTRA 114 PMC Valid2013-0491 #2 @ 16 years, MCV4 12/04/2003 F Complete 12/04/2014 MENACTRA 114 PMC Valid2013-0495 #2 with interval of 5 years of #1 12/04/2001 F Complete 12/04/2014 MENACTRA 114 PMC Valid

2013-0497 #1 @ 10 yrs - 1 day, #2 @ 10 yrs + 8 weeks - 5 days 10/14/2009 F Not complete 10/13/2019 MENACTRA 114 PMC Not Valid

2013-0498 #1 @ 10 yrs - 1 day, #2 @ 10 yrs + 8 weeks 10/09/2009 F Not complete 10/08/2019 MENACTRA 114 PMC Not Valid

2013-0499 #1 @ 10 yrs, MCV4 12/04/2009 F Not complete 12/04/2019 MENACTRA 114 PMC Valid2013-0500 #1 @ 10 yrs - 1 day, MCV4 12/05/2009 F Not complete 12/04/2019 MENACTRA 114 PMC Not Valid

2013-0501 #1 @ 10 yrs - 1 day, #2 @ 10 yrs, 8 weeks - 4 days 10/13/2009 F Not complete 10/12/2019 MENACTRA 114 PMC Not Valid2013-0502 10 year old 12/04/2009 F Not complete2013-0503 Dose 1 to dose 2 interval 8 wks-5 days 08/14/2008 F Not complete 10/14/2019 meningococcal MCV4, unspecified formulation 147 Valid2013-0504 Dose 1 to dose 2 interval 8 wks-4 days 10/23/2003 F Complete 10/10/2019 meningococcal MCV4, unspecified formulation 147 Valid2013-0505 Dose 1 to dose 2 interval 8 weeks 10/15/2003 F Complete 10/04/2019 meningococcal MCV4, unspecified formulation 147 Valid2013-0507 # 1 at age 11 years 12/04/2008 F Not complete 12/04/2019 meningococcal MCV4, unspecified formulation 147 Valid2013-0508 age 22. No doses; No forecast 12/04/1997 F Aged out2013-0509 # 1 at age 15 years 11/26/2004 F Not complete 12/04/2019 meningococcal MCV4, unspecified formulation 147 Valid2013-0510 # 1 at age 16 years -5 days 12/09/2003 F Not complete 12/04/2019 meningococcal MCV4, unspecified formulation 147 Valid2013-0511 # 1 at age 16 years -4 days 12/08/2003 F Complete 12/04/2019 meningococcal MCV4, unspecified formulation 147 Valid2013-0512 # 1 at age 16 years 12/04/2003 F Complete 12/04/2019 meningococcal MCV4, unspecified formulation 147 Valid2013-0523 #1 at 15 months 09/04/2018 F Not complete 12/04/2019 M-M-R II 03 MSD Valid2013-0524 #2 at 4 years 12/04/2015 F Complete 03/04/2017 M-M-R II 03 MSD Valid2013-0525 #1 at 7 years 12/04/2012 F Not complete 12/04/2019 M-M-R II 03 MSD Valid2013-0528 5 single antigen doses: 1 Measles; 2 Mumps; 2 Rubella 10/04/2014 F Not complete 10/04/2015 mumps 07 Valid2013-0530 4 single antigen doses: 1 Measles; 2 Mumps; 1 Rubella 12/04/2014 F Not complete 12/04/2015 mumps 07 Valid2013-0531 1 single antigen dose at 12M: 1 Measles 12/04/2018 F Not complete 12/04/2019 ATTENUVAX 05 MSD Valid2013-0534 2 single antigen doses: 1 Measles; 1 Mumps 10/26/2018 F Not complete 10/26/2019 ATTENUVAX 05 MSD Valid

2013-0535 7 single antigen doses: 2 Measles; 3 Mumps; 2 Rubella 09/04/2014 F Complete 09/04/2015 mumps 07 Valid2013-0536 3 single antigen doses: 1 Measles; 1 Mumps; 1 Rubella 08/11/2018 F Not complete 08/11/2019 mumps 07 Valid2013-0537 3 single antigen doses on same day: 1 Measles; 1 Mumps; 1 Rubella 12/04/2018 F Not complete 12/04/2019 mumps 07 Valid2013-0538 6 single antigen doses: 2 Measles; 2 Mumps; 2 Rubella 10/09/2014 F Complete 10/09/2015 mumps 07 Valid2013-0539 3 single antigen doses: 2 Measles; 1 Rubella 12/22/2017 F Not complete 01/30/2019 ATTENUVAX 05 MSD Valid2013-0540 MMR # 1 at 12 months-5 days 12/09/2018 F Not complete 12/04/2019 M-M-R II 03 MSD Not Valid2013-0541 MMR # 1 at 12 months-4 days 12/08/2018 F Not complete 12/04/2019 M-M-R II 03 MSD Valid2013-0542 MMR # 1 at 12 months 12/04/2018 F Not complete 12/04/2019 M-M-R II 03 MSD Valid2013-0543 Newborn forecasting 12/04/2019 F Not complete2013-0544 Dose 1 to dose 2 interval 28 days 11/06/2017 F Complete 11/06/2019 M-M-R II 03 MSD Valid2013-0545 MMR and VZ given at age 12 months 12/04/2018 F Not complete 12/04/2019 M-M-R II 03 MSD Valid2013-0546 Doses 1 and 2 of MMR and VZ at ages 12 and 13 months 11/04/2018 F Complete 11/04/2019 M-M-R II 03 MSD Valid2013-0547 VZ to MMR interval 28-1 day = invalid MMR 11/05/2018 F Not complete 11/07/2019 VARIVAX 21 MSD Valid2013-0548 VZ given at age 12 mo; MMR at age 12 mo+28 days 11/06/2018 F Not complete 11/06/2019 VARIVAX 21 MSD Valid2013-0549 Dose 1 MMRV at 12 m-5 days 12/09/2018 F Not complete 12/04/2019 PROQUAD 94 MSD Not Valid2013-0550 Dose 1 MMRV at 12 m-4 days 12/08/2018 F Not complete 12/04/2019 PROQUAD 94 MSD Valid2013-0551 Dose 1 to dose 2 MMRV interval 28 days age < 15 months old= valid MMR 11/06/2018 F Complete 11/06/2019 PROQUAD 94 MSD Valid2013-0552 Dose 1 to 2 MMRV interval 28 days in child ≥ 15 months old=valid MMR 11/06/2016 F Complete 11/06/2019 PROQUAD 94 MSD Valid2013-0554 Dose 1 to 2 MMRV interval 28-4 days 10/10/2018 F Not complete 11/10/2019 PROQUAD 94 MSD Valid2013-0555 MMR to MMRV interval 28 days=valid MMR # 2 11/06/2018 F Complete 11/06/2019 M-M-R II 03 MSD Valid2013-0556 MMR to MMRV interval 24 days=not valid MMR # 2 10/10/2018 F Not complete 11/10/2019 M-M-R II 03 MSD Valid2013-0557 MMRV to MMR interval 28 days=valid MMR dose 2 10/06/2018 F Complete 11/06/2019 PROQUAD 94 MSD Valid2013-0558 Dose 1 to dose 2 interval 4 wks between VZ and MMRV in any age child=valid MMR 10/27/2018 F Not complete 11/06/2019 VARIVAX 21 MSD Valid2013-0559 28 day interval between invalid VZ and subsequent MMRV=valid MMR and VZ 11/11/2018 F Not complete 11/06/2019 VARIVAX 21 MSD Not Valid2013-0562 Interval of < 24 days between an invalid MMR and a subsequent MMRV=no valid MMR's 11/16/2018 F Not complete 11/11/2019 M-M-R II 03 MSD Not Valid2013-0563 Interval of < 24 days between an invalid VZ and a subsequent MMRV=no valid MMR or VZ 11/16/2018 F Not complete 11/11/2019 VARIVAX 21 MSD Not Valid2013-0565 Correctly administered single antigen M, M and R followed by MMR=series complete 11/28/2016 F Complete 02/03/2018 mumps 07 Valid2013-0570 Dose 2 at age 13 mo -5 days 11/09/2018 F Not complete 11/07/2019 M-M-R II 03 MSD Valid2013-0571 Dose 2 at age 13 mo - 4 days 11/08/2018 F Complete 11/08/2019 M-M-R II 03 MSD Valid2013-0572 Dose 2 at age 13 mo 11/04/2018 F Complete 11/04/2019 M-M-R II 03 MSD Valid2013-0573 Dose 1 to dose 2 interval 28 days-5 days 08/11/2017 F Not complete 11/11/2019 M-M-R II 03 MSD Valid2013-0574 Dose 1 to dose 2 interval 28-4 days 10/10/2018 F Complete 11/10/2019 M-M-R II 03 MSD Valid2015-0024 MMR: Patient is born before 01/01/1957 06/12/1956 F Immune2019-0017 Adult with no previous doses of the MMR vaccine 12/04/1984 M Not complete2019-0018 Adult with a dose of the MMR vaccine 12/04/1984 M Complete 12/04/2019 MMR 03 Valid2019-0019 Adolescent with no dose of MMR vaccine 12/04/2003 F Not complete2019-0020 Adolescent with 2nd dose of MMR vaccine at 4 weeks 11/06/2003 F Complete 11/06/2019 MMR 03 Valid2019-0021 Adolescent with 2nd dose of MMR vaccine at 4 weeks - 5 days 11/11/2003 F Not complete 11/11/2019 MMR 03 Valid2019-0022 Adolescent with 2nd dose of MMR vaccine at 4 weeks - 4 days 11/10/2003 F Complete 11/10/2019 MMR 03 Valid2013-0575 Newborn Testing 12/04/2019 F Not complete2013-0576 Dose # 1 PCV 13 at age 18 months 06/04/2018 F Not complete 12/04/2019 PREVNAR 13 133 PFR Valid2013-0577 Dose # 1 of PCV 7 at age 24 months. Need one dose PCV 13. 03/01/2008 F Not complete 03/01/2010 PREVNAR 7 100 WAL Valid2013-0578 Dose # 1 of PCV 13 at age 24 months. Series complete. 12/04/2017 F Complete 12/04/2019 PREVNAR 13 133 PFR Valid2013-0579 Dose # 2 PCV 13 at age 10 weeks-5 days 09/30/2019 F Not complete 11/07/2019 PREVNAR 13 133 PFR Valid2013-0580 Dose # 2 PCV 13 at age 10 weeks-4 days 09/29/2019 F Not complete 11/07/2019 PREVNAR 13 133 PFR Valid2013-0581 Dose PCV 13 # 2 at age 10 weeks 09/25/2019 F Not complete 11/06/2019 PREVNAR 13 133 PFR Valid2013-0582 Dose # 2 PCV 13 at age 4 months 08/04/2019 F Not complete 10/04/2019 PREVNAR 13 133 PFR Valid2013-0583 Dose # 1 PCV 13 at age7 months, dose # 2 at age 8 mos and current age ≥ 12 mos. 12/04/2018 F Not complete 07/04/2019 PREVNAR 13 133 PFR Valid2013-0584 Dose # 1 PCV 13 at 12 mo; dose # 2 at 1 yr 8 wks-5 days 10/14/2018 F Not complete 10/14/2019 PREVNAR 13 133 PFR Valid2013-0585 Dose # 1 PCV 13 at age 12 mos; # 2 at 1 yr 8 wks-4 days 10/13/2018 F Complete 10/13/2019 PREVNAR 13 133 PFR Valid2013-0587 Dose # 1 PCV 13 at age 12 months; # 2 at age 14 mos. Series complete. 10/04/2018 F Complete 10/04/2019 PREVNAR 13 133 PFR Valid2013-0588 Dose # 1 PCV 13 at 24 mo-5 days. Valid but child needs another. 12/09/2017 F Not complete 12/04/2019 PREVNAR 13 133 PFR Valid2013-0589 Dose 1 PCV 13 at 24 m-4 days. Series complete. 12/08/2017 F Complete 12/04/2019 PREVNAR 13 133 PFR Valid2013-0590 Dose # 3 PCV 13 at age 14 weeks-5 days. 09/02/2019 F Not complete 10/11/2019 PREVNAR 13 133 PFR Valid2013-0591 Dose # 3 PCV 13 at age 14 weeks-4 days. 09/01/2019 F Not complete 10/10/2019 PREVNAR 13 133 PFR Valid2013-0592 Dose # 3 PCV 13 at age 14 weeks 08/28/2019 F Not complete 10/09/2019 PREVNAR 13 133 PFR Valid2013-0593 Dose # 3 PCV 13 at 6 mo. 06/04/2019 F Not complete 08/04/2019 PREVNAR 13 133 PFR Valid2013-0594 Mixed vaccines: dose # 1 PCV 7 at 6 mo; # 2 PCV 13 at 8 mo; # 3 PCV 13 at 12 months. Series complete. 03/04/2010 F Complete 09/04/2010 PREVNAR 7 100 WAL Valid2013-0595 Mixed vaccines: dose # 1 PCV 7 at 7 mo; # 2 PCV 7 at 8 mo; #3 PCV 13 at 12 months. Series complete. 06/01/2009 F Complete 01/01/2010 PREVNAR 7 100 WAL Valid2013-0596 Dose # 1 PCV 13 at age 6 weeks-5 days 10/28/2019 F Not complete 12/04/2019 PREVNAR 13 133 PFR Not Valid2013-0597 Dose # 1 PCV 13 at 6 mo; # 2 at 11 mo, # 3 at 12 mo 12/04/2018 F Not complete 06/04/2019 PREVNAR 13 133 PFR Valid2013-0598 Dose # 4 PCV 13 at age 12 mo-5 days 12/09/2018 F Not complete 02/09/2019 PREVNAR 13 133 PFR Valid2013-0599 Dose # 4 PCV 13 at age 12 months-4 days. Series complete. 12/08/2018 F Complete 02/08/2019 PREVNAR 13 133 PFR Valid2013-0600 Dose # 4 PCV 13 at 1 year. Series complete. 12/04/2018 F Complete 02/04/2019 PREVNAR 13 133 PFR Valid

2013-0601 4 doses of PCV 7, no PCV 13. Needs one PCV 13. 06/01/2009 F Not complete 08/01/2009 PREVNAR 7 100 WAL Valid2013-0602 Dose 1 invalid (age) as first of others 06/04/2019 F Not complete 07/05/2019 PREVNAR 13 133 PFR Not Valid2013-0603 Dose 2 invalid (age) in midst of others. 07/04/2019 F Not complete 08/13/2019 PREVNAR 13 133 PFR Valid2013-0604 Dose # 3 invalid (age) in midst of others. Four valid doses not required in this scenario. 11/22/2018 F Complete 01/02/2019 PREVNAR 13 133 PFR Valid2013-0605 Dose 1 to dose 2 interval 28-5 days. 09/11/2019 F Not complete 11/11/2019 PREVNAR 13 133 PFR Valid2013-0606 Dose 1 to dose 2 interval 28-4 days 09/10/2019 F Not complete 11/10/2019 PREVNAR 13 133 PFR Valid2013-0607 Dose # 1 PCV 13 at age 6 weeks-4 days 10/27/2019 F Not complete 12/04/2019 PREVNAR 13 133 PFR Valid2013-0608 Dose 1 PCV 13 to dose 2 interval 28 days 09/06/2019 F Not complete 11/06/2019 PREVNAR 13 133 PFR Valid2013-0609 Dose 2 to dose 3 interval 28-5 days 07/11/2019 F Not complete 09/11/2019 PREVNAR 13 133 PFR Valid2013-0610 Dose 2 to dose 3 PCV 13 interval 28-4 days 06/10/2019 F Not complete 08/10/2019 PREVNAR 13 133 PFR Valid2013-0611 Dose 2 to dose 3 PCV 13 interval 28 days 06/06/2019 F Not complete 08/06/2019 PREVNAR 13 133 PFR Valid2013-0612 Dose 3 PCV 13 to dose 4 interval 8 weeks-5 days 11/14/2018 F Not complete 05/14/2019 PREVNAR 13 133 PFR Valid


Med_History_Code



2013-0613 Dose 3 PCV 13 to dose 4 interval 8 wks-4 days. Series complete. 11/13/2018 F Complete 05/13/2019 PREVNAR 13 133 PFR Valid2013-0614 Dose 3 PCV 13 to dose 4 interval 8 weeks. Series complete. 11/09/2018 F Complete 05/09/2019 PREVNAR 13 133 PFR Valid2013-0615 Invalid dose 2 (interval) in midst of others 12/04/2018 F Complete 01/21/2019 PREVNAR 13 133 PFR Valid2013-0616 Invalid dose 3 (interval) in midst of others 11/04/2018 F Complete 03/04/2019 PREVNAR 13 133 PFR Valid2013-0617 InValid dose 4 (interval) in midst of others 09/16/2018 F Complete 11/16/2018 PREVNAR 13 133 PFR Valid2013-0618 Dose # 1 PCV 13 at age 6 weeks 10/23/2019 F Not complete 12/04/2019 PREVNAR 13 133 PFR Valid2013-0619 4 doses of PCV 7 and 1 dose of PCV 13=series complete 06/06/2008 F Complete 08/06/2008 PREVNAR 7 100 WAL Valid2013-0622 Dose # 1 PCV 13 at age 2 months 10/04/2019 F Not complete 12/04/2019 PREVNAR 13 133 PFR Valid2013-0624 Dose # 1 PCV 13 at age 11 months 01/04/2019 F Not complete 12/04/2019 PREVNAR 13 133 PFR Valid2013-0625 Dose # 1 PCV 13 at age 12 months 12/04/2018 F Not complete 12/04/2019 PREVNAR 13 133 PFR Valid2015-0021 Pneumococcal: Patient has received PCV13 and PPSV23 11/28/1953 F Complete 12/04/2018 PREVNAR 13 133 PFR Valid2015-0022 Adult Patient has received PCV13 but has no history of PPSV23 12/04/1954 F Not complete 12/04/2019 PREVNAR 13 133 PFR Valid2015-0023 Adult Patient has received PPSV23 at age 65 but has no history of PCV13. 11/18/1954 F Complete 12/04/2019 PNEUMOVAX 23 33 MSD Valid2019-0008 Adult Patient 65 years with no history of PPSV23 vaccine 12/04/1954 M Not complete2019-0009 Adult Patient 65 years with a dose of PPSV23 vaccine 12/04/1954 M Complete 12/04/2019 pneumococcal polysaccharide PPV23 33 Valid2013-0626 Newborn Testing 12/04/2019 F Not complete2013-0627 Dose # 2 at age 10 weeks 09/25/2019 F Not complete 11/06/2019 IPOL 10 PMC Valid2013-0628 Dose # 2 at age 4 months 08/04/2019 F Not complete 10/04/2019 IPOL 10 PMC Valid2013-0629 Dose # 2 at age 3 years 9 months 03/04/2016 F Not complete 05/04/2016 IPOL 10 PMC Valid

2013-0630 Dose # 2 at age 4 years 0 months 12/04/2015 F Not complete 12/04/2017 IPOL 10 PMC Valid2013-0631 Dose # 3 at age 14 weeks-5 days 09/02/2019 F Not complete 10/10/2019 IPOL 10 PMC Valid2013-0632 Dose # 3 at age 14 weeks - 4 days 09/01/2019 F Not complete 10/13/2019 IPOL 10 PMC Valid2013-0633 Dose # 3 at age 14 weeks 08/28/2019 F Not complete 10/09/2019 IPOL 10 PMC Valid2013-0634 Dose # 3 at age 6 months 06/04/2019 F Not complete 08/04/2019 IPOL 10 PMC Valid2013-0635 Dose # 3 at age 3 yrs 11.5 months old. 12/19/2015 F Not complete 02/19/2016 IPOL 10 PMC Valid2013-0636 Dose # 3 at age 4 years-5 days. Is valid as a dose but child will need another. 12/09/2015 F Not complete 02/09/2016 IPOL 10 PMC Valid

2013-0637 # 1 and # 2 at ≥ 4 years. 11/06/2015 F Not complete 11/06/2019 IPOL 10 PMC Valid2013-0638 Dose # 3 at 4 years-4 days but not six months after dose 2. Child will need another. 12/08/2015 F Not complete 12/08/2016 IPOL 10 PMC Valid2013-0639 Dose # 3 at 4 years-4 days and ≥ 6 months since dose 2. Series complete. 12/08/2015 F Complete 12/08/2016 IPOL 10 PMC Valid

2013-0640 Dose # 3 at age 4 years but < 6 months after dose 2. Valid but child will need a dose # 4. 12/04/2015 F Not complete 12/04/2016 IPOL 10 PMC Valid2013-0641 Dose # 3 at 4 years 0 months and ≥ 6 mo since dose 2. Series complete. 12/04/2015 F Complete 02/04/2016 IPOL 10 PMC Valid2013-0642 Dose # 4 at age 18 months. 06/04/2018 F Not complete 08/04/2018 IPOL 10 PMC Valid2013-0643 Dose # 4 at age 4 yrs-5 days 12/09/2015 F Not complete 03/09/2016 IPOL 10 PMC Valid2013-0644 Dose # 4 at age 4 years-4 days. Series complete. 12/08/2015 F Complete 03/08/2016 IPOL 10 PMC Valid2013-0645 Dose # 4 at age 4 years 0 days. Series complete. 12/04/2015 F Complete 02/04/2016 IPOL 10 PMC Valid2013-0646 Invalid dose 1 (age) as first of others 05/27/2019 F Not complete 06/27/2019 IPOL 10 PMC Not Valid2013-0647 Invalid dose # 2 (age) in midst of others 06/04/2019 F Not complete 07/12/2019 IPOL 10 PMC Valid2013-0648 Invalid dose 3 (age) in midst of others. No additional dose required. The next dose was at age 4 and ≥ 6 months since previous dose. Series complete. 12/04/2015 F Complete 01/15/2016 IPOL 10 PMC Valid2013-0649 Dose 1 to dose 2 interval 28-5 days 09/11/2019 F Not complete 11/11/2019 IPOL 10 PMC Valid2013-0650 Dose 1 to dose2 interval 28-4 days 09/10/2019 F Not complete 11/10/2019 IPOL 10 PMC Valid2013-0651 Dose 1 to dose 2 interval 28 days 09/06/2019 F Not complete 11/06/2019 IPOL 10 PMC Valid2013-0652 Dose 2 to dose 3 interval 28-5 days 07/11/2019 F Not complete 09/11/2019 IPOL 10 PMC Valid2013-0653 Dose 2 to dose 3 interval 28-4 days 08/28/2019 F Not complete 10/07/2019 IPOL 10 PMC Valid2013-0654 Dose 2 to dose 3 interval 28 days 07/06/2019 F Not complete 09/06/2019 IPOL 10 PMC Valid

2013-0655 Dose 3 to dose 4 interval 6 m-5 days 11/04/2015 F Not complete 11/04/2016 IPOL 10 PMC Valid2013-0656 Dose 3 to dose 4 interval 6 months-4 days. Series complete. 12/04/2015 F Complete 12/04/2016 IPOL 10 PMC Valid2013-0657 Dose 3 to dose 4 interval 6 months. Series complete. 11/30/2015 F Complete 11/30/2016 IPOL 10 PMC Valid2013-0658 Dose # 1 at age 6 weeks-5 days 10/28/2019 F Not complete 12/04/2019 IPOL 10 PMC Not Valid2013-0659 Invalid dose 1 to dose 2 interval in midst of others. 06/04/2019 F Not complete 08/04/2019 IPOL 10 PMC Valid2013-0660 Invalid dose 3 (interval) in midst of others makes no difference in forecasting if # 4 is ≥ 4 years old and ≥ 6 months after previous dose. Series complete. 12/02/2015 F Complete 02/02/2016 IPOL 10 PMC Valid

2013-0661 Mixed OPV/IPV where # 3 is after age 4 and ≥ 6 months after previous dose. Patient Complete 10/16/2011 F Complete 12/16/2011 OPV 02 Valid

2013-0662 4 doses of mixed OPV/IPV with one after age 4=polio series complete 04/13/2011 F Complete 06/13/2011 OPV 02 Valid2013-0664 Dose 1 given as Kinrix at age 2 mos. Off-label but valid as IPV # 1. 10/04/2019 F Not complete 12/04/2019 KINRIX 130 SKB Valid2013-0665 Dose 2 given as Kinrix at age 4 mo. Off label but valid as IPV 2. 08/04/2019 F Not complete 10/10/2019 IPOL 10 PMC Valid2013-0666 Dose 3 given as Kinrix at age 6 mos. Off label but valid. 06/04/2019 F Not complete 08/06/2019 IPOL 10 PMC Valid

2013-0667 Kinrix at 12 months old. 11/09/2018 F Not complete 01/11/2019 IPOL 10 PMC Valid2013-0668 Kinrix at age 4 years as dose 4=polio series complete 12/04/2015 F Complete 02/06/2016 PEDIARIX 110 SKB Valid2013-0669 Dose # 1 at age 6 weeks-4 days 10/27/2019 F Not complete 12/04/2019 IPOL 10 PMC Valid

2013-0670 Kinrix as dose 4 at age 4 years-5 days 12/09/2015 F Not complete 02/01/2016 PEDIARIX 110 SKB Valid2013-0671 Kinrix as dose 4 at age 4 years-4 days= polio series complete 12/08/2015 F Complete 01/27/2016 PEDIARIX 110 SKB Valid2013-0672 Dose # 1 at age 6 weeks 10/23/2019 F Not complete 12/04/2019 IPOL 10 PMC Valid2013-0673 Dose # 1 at age 2 months 10/04/2019 F Not complete 12/04/2019 IPOL 10 PMC Valid2013-0674 Dose # 2 at age 10 weeks-5 days 09/30/2019 F Not complete 11/07/2019 IPOL 10 PMC Valid2013-0675 Dose # 2 at age 10 weeks-4 days 09/29/2019 F Not complete 11/10/2019 IPOL 10 PMC Valid2013-0676 Newborn forecasting 12/04/2019 F Not complete2013-0677 # 2 Pediarix at 6 yrs 11.5 mo 12/20/2012 F Not complete 12/05/2015 PEDIARIX 110 SKB Valid2013-0678 # 2 Pediarix at 7 yrs; # 1 at less than 12 mo. 12/04/2012 F Not complete 03/04/2013 PEDIARIX 110 SKB Valid2013-0679 # 2 Pediarix at 7 yrs; # 1 ≥ 12 mo. 12/04/2012 F Not complete 01/04/2014 PEDIARIX 110 SKB Valid2013-0680 # 1 and 2 Pediarix at ≥7 yrs with 28 day interval. Off label 11/06/2012 F Not complete 11/06/2019 PEDIARIX 110 SKB Valid

2013-0681 # 3 Pediarix at 14 wks-5 days 09/02/2019 F Not complete 10/10/2019 PEDIARIX 110 SKB Valid2013-0682 # 3 Pediarix at 14 wks-4 days. 09/01/2019 F Not complete 10/11/2019 PEDIARIX 110 SKB Valid2013-0683 # 3 Pediarix at 24 weeks-5 days. 06/24/2019 F Not complete 08/05/2019 PEDIARIX 110 SKB Valid2013-0684 # 3 Pediarix at 24 weeks-4 days. 06/23/2019 F Not complete 08/04/2019 PEDIARIX 110 SKB Valid2013-0685 # 3 Pediarix at 6 yrs 11.5 mo 12/16/2012 F Complete 10/14/2015 PEDIARIX 110 SKB Valid2013-0686 # 4 Pediarix at 1 yr -5 days. 12/09/2018 F Not complete 02/09/2019 PEDIARIX 110 SKB Valid2013-0687 # 1 Pediarix at 6 wks-5 days 10/28/2019 F Not complete 12/04/2019 PEDIARIX 110 SKB Not Valid2013-0688 # 4 Pediarix at 1 yr -4 days 12/08/2018 F Not complete 02/08/2019 PEDIARIX 110 SKB Valid2013-0689 # 4 Pediarix at 3 yrs 11.5 mo. 12/20/2015 F Not complete 02/20/2016 PEDIARIX 110 SKB Valid2013-0690 # 4 Pediarix at 4 yrs 12/04/2015 F Complete 04/07/2016 PEDIARIX 110 SKB Valid2013-0691 # 5 Pediarix at 4 yrs -5 days. 12/09/2015 F Not complete 02/09/2016 PEDIARIX 110 SKB Valid2013-0692 # 5 Pediarix at 4 yrs -4 days 12/08/2015 F Complete 02/08/2016 PEDIARIX 110 SKB Valid2013-0693 # 5 Pediarix at 6 yrs 11.5 mo 12/20/2012 F Complete 02/20/2013 PEDIARIX 110 SKB Valid2013-0694 # 5 Pediarix at 7 yrs. Off label 12/04/2012 F Complete 03/04/2013 PEDIARIX 110 SKB Valid2013-0695 Invalid age dose 1 as first of others. 09/04/2019 F Not complete 10/10/2019 PEDIARIX 110 SKB Not Valid

2013-0696 Invalid age dose 2 in midst of others 06/04/2019 F Not complete 07/12/2019 PEDIARIX 110 SKB Valid2013-0697 invalid age dose 3 in midst of others 12/04/2018 F Not complete 01/17/2019 PEDIARIX 110 SKB Valid2013-0698 # 1 Pediarix at 6 wks-4 days 10/27/2019 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid2013-0699 dose 1 to 2 Pediarix, interval 28-5 days 09/09/2019 F Not complete 11/11/2019 PEDIARIX 110 SKB Valid

2013-0700 dose 1 to 2 Pediarix, interval 28-4 days 09/10/2019 F Not complete 11/10/2019 PEDIARIX 110 SKB Valid2013-0701 dose 2 to 3 Pediarix, interval 28-5 days 07/11/2019 F Not complete 09/11/2019 PEDIARIX 110 SKB Valid2013-0702 dose 2 to 3 Pediarix, interval 28-4 days 07/10/2019 F Not complete 09/10/2019 PEDIARIX 110 SKB Valid2013-0704 dose 3 to 4 Pediarix, interval 6m-4 days 10/08/2018 F Not complete 12/08/2018 PEDIARIX 110 SKB Valid

2013-0707 invalid dose 1-2 interval in midst of others 08/04/2019 F Not complete 10/04/2019 PEDIARIX 110 SKB Valid2013-0708 invalid dose 2-3 interval in midst of others 12/04/2018 F Not complete 02/04/2019 PEDIARIX 110 SKB Valid2013-0709 # 1 Pediarix at 6 wks 10/23/2019 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid2013-0712 # 1 Pediarix at 6 yrs 11.5 mo 12/19/2012 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid2013-0713 # 1 Pediarix at 7 yrs 12/04/2012 F Not complete 12/04/2019 PEDIARIX 110 SKB Valid2013-0714 # 2 Pediarix at 10 wks-5 days 09/30/2019 F Not complete 11/07/2019 PEDIARIX 110 SKB Valid2013-0715 # 2 Pediarix at 10 wks-4 days 09/29/2019 F Not complete 11/08/2019 PEDIARIX 110 SKB Valid2013-0716 # 2 Pediarix at 10 wks 09/25/2019 F Not complete 11/04/2019 PEDIARIX 110 SKB Valid2013-0717 Newborn 12/04/2019 F Not complete2013-0718 # 2 Pentacel at 6 yrs 11.5 mo. Off label but counts. 12/20/2012 F Not complete 09/10/2015 PENTACEL 120 PMC Valid2013-0719 Pentacel at 7 yrs; # 1 at age < 12 mo. Off label use. 12/04/2012 F Not complete 05/13/2013 IPOL 10 PMC Valid2013-0720 # 2 Pentacel at 7 yrs; # 1 at age ≥ 12 mo. 12/04/2012 F Not complete 02/07/2014 IPOL 10 PMC Valid

2013-0721 # 3 Pentacel at 14 wks-5 days 09/02/2019 F Not complete 10/10/2019 PENTACEL 120 PMC Valid2013-0722 # 3 Pentacel at 14 wks-4 days 09/01/2019 F Not complete 10/09/2019 PENTACEL 120 PMC Valid2013-0723 # 3 Pentacel at 6 yrs 11.5 mo 12/19/2012 F Complete 02/19/2013 IPOL 10 PMC Valid2013-0724 # 4 Pentacel at 1 yr -5 days. 12/09/2018 F Not complete 02/09/2019 PENTACEL 120 PMC Valid2013-0725 # 4 Pentacel at 1 yr -4 days 12/08/2018 F Not complete 02/08/2019 PENTACEL 120 PMC Valid2013-0726 # 4 Pentacel ≥ age 12 mo 12/04/2018 F Not complete 02/04/2019 PENTACEL 120 PMC Valid2013-0727 # 4 Pentacel at 4 yrs 12/04/2015 F Complete 04/13/2016 PENTACEL 120 PMC Valid2013-0728 # 1 Pentacel at 6 wks-5 days 10/28/2019 F Not complete 12/04/2019 PENTACEL 120 PMC Not Valid2013-0729 # 5 Pentacel at ≥ 4 yrs 11/13/2015 F Complete 10/13/2016 PENTACEL 120 PMC Valid


Med_History_Code



2013-0730 # 4 Pentacel at 5 yrs=off label 12/02/2014 F Complete 04/02/2015 PENTACEL 120 PMC Valid2013-0731 invalid age dose 1 as first of others 06/04/2019 F Not complete 07/09/2019 PENTACEL 120 PMC Not Valid2013-0732 invalid age dose 2 in midst of others 12/02/2018 F Not complete 01/09/2019 PENTACEL 120 PMC Valid2013-0733 invalid age dose 3 in midst of others 10/28/2018 F Not complete 12/05/2018 PENTACEL 120 PMC Valid2013-0734 dose 1 to 2 Pentacel, interval 28-5 days 09/17/2019 F Not complete 11/11/2019 PENTACEL 120 PMC Valid2013-0735 dose 1 to 2 Pentacel, interval 28-4 days 09/08/2019 F Not complete 11/10/2019 PENTACEL 120 PMC Valid2013-0736 dose 2 to 3 Pentacel, interval 28-5 days 07/11/2019 F Not complete 09/11/2019 PENTACEL 120 PMC Valid2013-0737 dose 2 to 3 Pentacel, interval 28-4 days 07/10/2019 F Not complete 09/10/2019 PENTACEL 120 PMC Valid2013-0739 # 1 Pentacel at 6 wks-4 days 10/27/2019 F Not complete 12/04/2019 PENTACEL 120 PMC Valid2013-0740 dose 3 to 4 Pentacel, interval 6m-4 days 10/08/2018 F Not complete 12/08/2018 PENTACEL 120 PMC Valid2013-0743 invalid dose 1-2 interval in midst of others 06/13/2019 F Not complete 08/13/2019 PENTACEL 120 PMC Valid2013-0744 invalid dose 2-3 interval in midst of others 12/01/2018 F Not complete 02/01/2019 PENTACEL 120 PMC Valid2013-0747 # 1 Pentacel at 6 wks 10/23/2019 F Not complete 12/04/2019 PENTACEL 120 PMC Valid2013-0748 # 1 Pentacel at 6 yrs 11.5 mo 12/16/2012 F Not complete 12/04/2019 PENTACEL 120 PMC Valid2013-0749 # 1 Pentacel at 7 yrs. Off label 12/04/2012 F Not complete 12/04/2019 PENTACEL 120 PMC Valid2013-0750 # 2 Pentacel at 10 wks-5 days 09/30/2019 F Not complete 11/07/2019 PENTACEL 120 PMC Valid2013-0751 # 2 Pentacel at 10 wks-4 days 09/29/2019 F Not complete 11/06/2019 PENTACEL 120 PMC Valid2013-0752 # 2 Pentacel at 6 yrs . Off label 12/04/2013 F Not complete 12/04/2014 PENTACEL 120 PMC Valid2013-0753 Newborn forecast 12/04/2019 F Not complete2013-0754 Dose # 3 Rotateq at age 14 weeks 08/28/2019 F Complete 10/09/2019 ROTATEQ 116 MSD Valid2013-0755 Dose # 3 Rotateq at age 6 months 06/04/2019 F Complete 08/04/2019 ROTATEQ 116 MSD Valid2013-0756 Dose 1 to dose 2 Rotateq interval 28-5 days 09/23/2019 F Not complete 11/11/2019 ROTATEQ 116 MSD Valid2013-0757 Dose 1 to dose 2 Rotateq interval 28-4 days 09/22/2019 F Not complete 11/10/2019 ROTATEQ 116 MSD Valid2013-0758 Dose 1 to dose 2 Rotateq interval 28 days 09/18/2019 F Not complete 11/06/2019 ROTATEQ 116 MSD Valid2013-0759 Dose 2 to dose 3 Rotateq interval 28-5 days 08/10/2019 F Not complete 10/06/2019 ROTATEQ 116 MSD Valid2013-0760 Dose 2 to dose 3 Rotateq interval 28-4 days 08/09/2019 F Complete 10/05/2019 ROTATEQ 116 MSD Valid2013-0761 Dose 2 to dose 3 Rotateq interval 28 days 08/05/2019 F Complete 10/01/2019 ROTATEQ 116 MSD Valid2013-0762 Dose # 1 Rotarix at age 6 weeks-5 days 10/28/2019 F Not complete 12/04/2019 ROTARIX 119 SKB Not Valid2013-0763 Dose # 1 Rotarix at age 6 weeks-4 days 10/27/2019 F Not complete 12/04/2019 ROTARIX 119 SKB Valid2013-0764 Dose # 1 Rotateq at age 6 weeks-5 days 10/28/2019 F Not complete 12/04/2019 ROTATEQ 116 MSD Not Valid2013-0765 Dose # 1 Rotarix at age 6 weeks 10/23/2019 F Not complete 12/04/2019 ROTARIX 119 SKB Valid2013-0766 Dose # 2 Rotarix at age 10 weeks-5 days 09/30/2019 F Not complete 11/09/2019 ROTARIX 119 SKB Valid2013-0767 Dose # 2 Rotarix at age 10 weeks-4 days 09/29/2019 F Complete 11/10/2019 ROTARIX 119 SKB Valid2013-0768 Dose # 2 Rotarix at age 10 weeks 09/25/2019 F Complete 11/06/2019 ROTARIX 119 SKB Valid2013-0769 Dose 1 to dose 2 Rotarix interval 28-5 days 09/11/2019 F Not complete 11/11/2019 ROTARIX 119 SKB Valid2013-0770 Dose 1 to dose 2 Rotarix interval 28-4 days 09/10/2019 F Complete 11/10/2019 ROTARIX 119 SKB Valid2013-0771 Dose 1 to dose 2 Rotarix interval 28 days 09/06/2019 F Complete 11/06/2019 ROTARIX 119 SKB Valid2013-0772 ≥15 weeks old with no rota vax: no forecast for rotavirus 08/21/2019 F Aged out2013-0773 Dose # 1 ≥ 15 weeks old 08/17/2019 F Not complete 12/04/2019 ROTARIX 119 SKB Valid2013-0774 8 months old with only one rota vax 04/04/2019 F Not complete 07/04/2019 ROTARIX 119 SKB Valid2013-0775 Dose # 1 Rotateq at age 6 weeks-4 days 10/27/2019 F Not complete 12/04/2019 ROTATEQ 116 MSD Valid2013-0776 Rotateq at 2 months; rotarix at 4 mo 08/04/2019 F Not complete 10/04/2019 ROTATEQ 116 MSD Valid2013-0777 Rotatrix at 2 mo; rotateq at 4 mo 08/04/2019 F Not complete 10/04/2019 ROTARIX 119 SKB Valid2013-0778 Unspecified rotavirus at 2 and 4 mo 08/04/2019 F Not complete 10/04/2019 rotavirus, unspecified formulation 122 Valid2013-0781 Dose # 1 Rotateq at age 6 weeks 10/23/2019 F Not complete 12/04/2019 ROTATEQ 116 MSD Valid2013-0782 Dose # 2 Rotateq at age 10 weeks-5 days 09/30/2019 F Not complete 11/09/2019 ROTATEQ 116 MSD Valid2013-0783 Dose # 2 Rotateq at age 10 weeks-4 days 09/29/2019 F Not complete 11/10/2019 ROTATEQ 116 MSD Valid2013-0784 Dose # 2 Rotateq at age 10 weeks 09/25/2019 F Not complete 11/06/2019 ROTATEQ 116 MSD Valid2013-0785 Dose # 3 Rotateq at age 14 weeks-5 days 09/02/2019 F Not complete 10/11/2019 ROTATEQ 116 MSD Valid2013-0786 Dose # 3 Rotateq at age 14 weeks-4 days 09/01/2019 F Complete 10/13/2019 ROTATEQ 116 MSD Valid2013-0789 #1 at 15 months 09/04/2018 F Not complete 12/04/2019 VARIVAX 21 MSD Valid2013-0795 No doses of Varicella: current age 13Y -1D 12/05/2006 F Not complete2013-0798 #1 at 1 year 12/04/2018 F Not complete 12/04/2019 VARIVAX 21 MSD Valid2013-0803 # 1 at 12 months-5 days 12/09/2018 F Not complete 12/04/2019 VARIVAX 21 MSD Not Valid2013-0804 VAR # 1 at 12 months-4 days 12/08/2018 F Not complete 12/04/2019 VARIVAX 21 MSD Valid2013-0806 Newborn forecasting 12/04/2019 F Not complete2013-0807 # 2 at age 13 years + 28 days 11/06/2006 F Complete 11/06/2019 VARIVAX 21 MSD Valid2013-0808 Dose 1 to dose 2 interval 28-1 days in child < 13 years 11/06/2018 F Not complete 11/07/2019 VARIVAX 21 MSD Valid2013-0809 Dose 1 to dose 2 interval 28 days in child < 13 yrs old 09/06/2010 F Complete 11/06/2019 VARIVAX 21 MSD Valid2013-0810 Dose 1 to dose 2 interval 28-5 days in child ≥ 13 yrs old 08/11/2006 F Not complete 11/11/2019 VARIVAX 21 MSD Valid2013-0811 Dose 1 to dose 2 interval 28-4 days in child ≥ 13 years old 08/10/2006 F Complete 11/10/2019 VARIVAX 21 MSD Valid2013-0812 Dose 1 to dose 2 interval 28 days in child ≥ 13 years old 06/06/2006 F Complete 11/06/2019 VARIVAX 21 MSD Valid2013-0813 VZ and MMR given on same day at age 12 months 12/04/2018 F Not complete 12/04/2019 M-M-R II 03 MSD Valid2013-0814 Doses 1 and 2 of VZ and MMR given at ages 12 months and 4 weeks later 11/06/2018 F Not complete 11/06/2019 M-M-R II 03 MSD Valid2013-0815 MMR to VZ interval 28-1 day = invalid VZ. 11/07/2018 F Not complete 11/07/2019 M-M-R II 03 MSD Valid2013-0816 MMR given at age 12 mo; VZ at age 12 mo+28 days 11/06/2018 F Not complete 11/06/2019 M-M-R II 03 MSD Valid2013-0817 # 1 at age 12 mo-5 days 12/09/2018 F Not complete 12/04/2019 VARIVAX 21 MSD Not Valid2013-0818 # 1 MMRV at 12 m-5 days 12/09/2018 F Not complete 12/04/2019 PROQUAD 94 MSD Not Valid2013-0819 # 1 MMRV at 12 m-4 days 12/08/2018 F Not complete 12/04/2019 PROQUAD 94 MSD Valid2013-0820 # 1 MMRV at 12 months 12/04/2018 F Not complete 12/04/2019 PROQUAD 94 MSD Valid2013-0821 Dose 1 to dose 2 MMRV interval 28 days in child < 15 months 10/06/2018 F Complete 11/06/2019 PROQUAD 94 MSD Valid2013-0822 Dose 1 to dose 2 MMRV interval 28 days in child ≥ 15 months old=valid VZ 08/23/2018 F Complete 11/06/2019 PROQUAD 94 MSD Valid2013-0823 Dose 1 to dose 2 MMRV interval 28-1 days 10/12/2015 F Not complete 11/06/2019 PROQUAD 94 MSD Valid2013-0824 MMR to MMRV interval 28 days=valid VZ # 1 11/06/2018 F Not complete 11/06/2019 M-M-R II 03 MSD Valid2013-0825 MMR to MMRV interval 27 days=invalid as VZ # 1 11/06/2018 F Not complete 11/07/2019 M-M-R II 03 MSD Valid2013-0826 Dose 1 to dose 2 MMRV interval 12 weeks in child < 13 years old 03/04/2016 F Complete 09/04/2019 PROQUAD 94 MSD Valid2013-0827 Dose 1 to dose 2 interval of 4 wks between VZ and MMRV in any age child=both valid 10/27/2018 F Complete 11/06/2019 VARIVAX 21 MSD Valid2013-0829 28 day interval between invalid VZ and subsequent MMRV=valid VZ 11/11/2018 F Not complete 11/06/2019 VARIVAX 21 MSD Not Valid2013-0831 Interval of < 24 days between an invalid VZ and a subsequent MMRV=not valid VZ 11/15/2018 F Not complete 11/10/2019 VARIVAX 21 MSD Not Valid2013-0832 LAIV given at age 3 years; VZ at age 3 years + 27 days 11/07/2016 F Not complete 11/07/2019 Flumist quadrivalent 149 MED Valid2013-0833 LAIV given at age 3 years; VZ at age 3 years + 28 days 11/06/2016 F Not complete 11/06/2019 Flumist quadrivalent 149 MED Valid2013-0840 # 1 MMR at 12.5 mo; VZ not given=need 28 day interval for VZ 11/19/2018 F Not complete 12/04/2019 M-M-R II 03 MSD Valid2013-0842 # 2 at age 12 mo+ 4 Weeks 11/06/2018 F Not complete 11/06/2019 VARIVAX 21 MSD Valid2013-0843 # 2 at age 15 mo. 09/04/2018 F Complete 09/04/2019 VARIVAX 21 MSD Valid2013-0844 # 1 at age ≥ 13 years old 12/01/2006 F Not complete 12/04/2019 VARIVAX 21 MSD Valid2015-0001 Varicella: Zoster dose in lieu of first dose of Varicella for adult patient 12/04/1983 F Not complete 12/04/2019 ZOSTAVAX 121 MSD Valid2015-0002 Varicella: Adult patient has received 2 doses of the Varicella Vaccine at least 4 weeks apart 10/30/1996 F Complete 10/30/2019 VARIVAX 21 MSD Valid2019-0023 Adult patient with no doses of the Varicella vaccine. 12/04/1997 F Not complete2019-0024 Adult patient with dose #2 at 4 weeks 11/06/1988 F Complete 11/06/2019 varicella 21 Valid2019-0025 Adult patient with dose #2 at 4 weeks - 4 days 11/10/1988 F Complete 11/10/2019 varicella 21 Valid2019-0026 Adult patient with dose #2 at 4 weeks - 5 days 11/11/1988 F Not complete 11/11/2019 varicella 21 Valid

2015-0013 Zoster: Zoster Dose administered at 50 years of age 12/04/1969 F Not complete 12/04/2019 ZOSTAVAX 121 MSD Valid

2015-0014 Zoster: Zoster Dose administered at 60 years of age 11/20/1959 F Not complete 12/04/2019 ZOSTAVAX 121 MSD Valid

2015-0016 Zoster: Patient is overdue at 62 years of age for Zoster dose 11/18/1957 F Not complete

2015-0018 Zoster: MMR to Zoster interval 28 days 11/06/1966 F Not complete 11/06/2019 M-M-R II 03 MSD Valid

2015-0019 Zoster: MMR to Zoster interval 28 - 1 days 11/07/1968 F Not complete 11/07/2019 M-M-R II 03 MSD Valid2018-0001 Zoster: Patient has received dose 1 of the RZV (Shingrix) series 12/04/1969 F Not complete 12/04/2019 zoster recombinant 187 Valid2018-0002 Zoster: Dose #2 of the RZV (Shringrix) vaccine administered at two months after dose #1 10/09/1969 M Complete 10/09/2019 zoster recombinant 187 Valid2018-0003 Zoster: Dose #2 (Shingrix) administered at 4 weeks after dose #1 11/06/1969 F Complete 11/06/2019 zoster recombinant 187 Valid2018-0004 Zoster: Dose #2 of Shingrix administered at one year after dose #1 12/04/1967 F Complete 12/04/2018 zoster recombinant 187 Valid

2018-0005 Zoster: Dose #2 (Shingrix) administered at 4 weeks - 1 days after dose #1 11/06/1969 M Complete 11/06/2019 zoster recombinant 187 Valid2018-0006 Zoster: Patient is 50 with no previous history of Shringrix vaccine 12/04/1969 F Not complete

2018-0008 Zoster: Dose #1 of RZV administered 4 weeks after previous dose of ZVL 11/06/1969 F Not complete 11/06/2019 ZOSTAVAX 121 MSD Valid2018-0009 Zoster: ZVL and RZV (Shingrix) vaccine doses administered on the same day/time 12/04/1969 F Not complete 12/04/2019 zoster live 121 Valid2018-0011 Zoster: Dose #1 of Shingrix 8 weeks after Dose #2 of Varicella vaccine 11/09/1969 F Not complete 10/09/2016 VARIVAX 21 MSD Valid2018-0012 Zoster: Dose #1 of Shingrix, 4 weeks after Dose #2 of Varicella vaccine 11/06/1969 F Not complete 11/06/2016 VARIVAX 21 MSD Valid2018-0013 Zoster: Dose #1 of RZV administered 8 weeks after previous dose of ZVL 10/09/1968 F Not complete 10/09/2019 ZOSTAVAX 121 MSD Valid2018-0014 Zoster: Patient has received all three doses of the zoster vaccine 10/09/1968 F Complete 10/09/2018 ZOSTAVAX 121 MSD Valid2019-0001 Zoster: Dose #2 (Shingrix) administered at 4 weeks - 5 days after dose #1 11/06/1969 M Not complete 11/06/2019 zoster recombinant 187 Valid2019-0002 Zoster: Dose #2 (Shingrix) administered at 4 weeks - 4 days after dose #1 11/06/1969 M Complete 11/06/2019 zoster recombinant 187 Valid2019-0003 Zoster: Dose #1 of RZV administered 0 Days after previous dose of ZVL 10/09/1968 F Not complete 10/09/2019 ZOSTAVAX 121 MSD Valid

Evaluation_Reason_1Date_Administred_2 Vaccine_Name_2 CVX_2 MVX_2 Evaluation_Status_2 Evaluation_Reason_2 Date_Administred_3 Vaccine_Name_3 CVX_3 MVX_3 Evaluation_Status_3 Evaluation_Reason_3

Date_Administred_4 Vaccine_Name_4 CVX_4 MVX_4 Evaluation_Status_4 Evaluation_Reason_4 Date_Administred_5

12/04/2019 DTaP, unspecified formulation 107 Not Valid Age: Too Young12/04/2019 DTaP, unspecified formulation 107 Valid12/04/2019 DTaP, unspecified formulation 107 Valid12/04/2019 DTaP, unspecified formulation 107 Valid12/04/2019 BOOSTRIX 115 SKB Valid12/04/2019 BOOSTRIX 115 SKB Valid12/04/2019 BOOSTRIX 115 SKB Valid11/11/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Not Valid Age: Too Young

11/08/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid11/06/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid09/04/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid11/04/2019 TD(GENERIC) 09 MBL Valid 12/04/2019 BOOSTRIX 115 SKB Valid

02/23/2019 TD(GENERIC) 09 MBL Valid 12/04/2019 BOOSTRIX 115 SKB Valid

06/04/2019 TD(GENERIC) 09 MBL Valid 12/04/2019 TD(GENERIC) 09 MBL Valid06/04/2019 TD(GENERIC) 09 MBL Valid 11/29/2019 TD(GENERIC) 09 MBL Not Valid Interval: too short

06/04/2019 BOOSTRIX 115 SKB Valid 11/30/2019 TD(GENERIC) 09 MBL Valid06/08/2013 DTaP, unspecified formulation 107 Valid

07/04/2013 DTaP, unspecified formulation 107 Valid 12/06/2014 DTaP, unspecified formulation 107 Valid04/09/2019 DTaP, unspecified formulation 107 Valid 06/05/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Not Valid Age: Too Young04/08/2019 DTaP, unspecified formulation 107 Valid 06/05/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid04/04/2019 DTaP, unspecified formulation 107 Valid 06/04/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid

04/29/2016 DTaP, unspecified formulation 107 Valid 06/29/2016 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid

11/29/2018 DTaP, unspecified formulation 107 Valid 05/31/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid03/09/2016 DTaP, unspecified formulation 107 Valid 05/09/2016 DTaP, unspecified formulation 107 Valid 12/10/2016 DTaP, unspecified formulation 107 Valid 12/04/2019

03/08/2016 DTaP, unspecified formulation 107 Valid 05/08/2016 DTaP, unspecified formulation 107 Valid 12/09/2016 DTaP, unspecified formulation 107 Valid 12/04/2019

05/17/2016 DTaP, unspecified formulation 107 Valid 08/06/2016 DTaP, unspecified formulation 107 Valid 02/22/2018 DTaP, unspecified formulation 107 Valid 12/04/2019Age: Too Young


07/26/2007 DTaP, unspecified formulation 107 Valid 09/26/2007 DTaP, unspecified formulation 107 Valid 06/29/2008 DTaP, unspecified formulation 107 Valid 06/23/2012Age: Too Young 10/04/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid

08/25/2019 DTaP, unspecified formulation 107 Not Valid Interval: too short 12/04/2019 DTaP, unspecified formulation 107 Valid02/08/2019 DTaP, unspecified formulation 107 Valid 03/05/2019 DTaP, unspecified formulation 107 Not Valid Age: Too Young 12/04/2019 DTaP, unspecified formulation 107 Valid

04/04/2016 DTaP, unspecified formulation 107 Valid 05/28/2016 DTaP, unspecified formulation 107 Valid 11/29/2016 DTaP, unspecified formulation 107 Not Valid Age: Too Young 12/04/201904/07/2009 DTaP, unspecified formulation 107 Valid 06/18/2009 DTaP, unspecified formulation 107 Valid 03/04/2010 DTaP, unspecified formulation 107 Valid 12/30/201112/04/2019 DTaP, unspecified formulation 107 Not Valid Interval: too short12/04/2019 DTaP, unspecified formulation 107 Valid12/03/2019 DTaP, unspecified formulation 107 Valid

11/11/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Not Valid Interval: too short11/08/2019 DTaP, unspecified formulation 107 Valid 12/02/2019 DTaP, unspecified formulation 107 Valid11/04/2019 DTaP, unspecified formulation 107 Valid 12/02/2019 DTaP, unspecified formulation 107 Valid04/03/2019 DTaP, unspecified formulation 107 Valid 06/08/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid03/29/2019 DTaP, unspecified formulation 107 Valid 06/03/2019 DTaP, unspecified formulation 107 Valid 12/03/2019 DTaP, unspecified formulation 107 Valid04/04/2019 DTaP, unspecified formulation 107 Valid 08/04/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid02/19/2019 DTaP, unspecified formulation 107 Not Valid Interval: too short 05/30/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid01/29/2019 DTaP, unspecified formulation 107 Valid 02/20/2019 DTaP, unspecified formulation 107 Not Valid Interval: too short 12/04/2019 DTaP, unspecified formulation 107 Valid

07/04/2019 DTaP, unspecified formulation 107 Valid 08/26/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Not Valid Interval: too short04/03/2009 DTaP, unspecified formulation 107 Valid 06/03/2009 DTaP, unspecified formulation 107 Valid 08/22/2012 DTaP, unspecified formulation 107 Valid 12/04/2012

Inadvertent Vaccine 03/06/2019 DTaP, unspecified formulation 107 Valid 05/08/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid04/06/2019 BOOSTRIX 115 SKB Not Valid Inadvertent Vaccine 06/08/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 DTaP, unspecified formulation 107 Valid08/04/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 BOOSTRIX 115 SKB Not Valid Inadvertent Vaccine01/30/2019 DTaP, unspecified formulation 107 Valid 05/30/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 BOOSTRIX 115 SKB Valid04/29/2016 DTaP, unspecified formulation 107 Valid 08/29/2016 DTaP, unspecified formulation 107 Valid 04/03/2017 DTaP, unspecified formulation 107 Valid 12/04/2019



12/04/2019 BOOSTRIX 115 SKB Valid

06/03/2019 DTaP, unspecified formulation 107 Valid 12/03/2019 BOOSTRIX 115 SKB ValidInadvertent Vaccine


09/05/1995 DTP-Hib 22 Valid 11/05/1995 DTP-Hib 22 Valid 10/05/1996 DTP-Hib 22 Valid04/15/2000 DTP-Hib 22 Valid 06/15/2000 DTP-Hib 22 Valid 02/15/2001 DTP-Hib 22 Valid 12/01/200408/08/1996 DTP-Hib 22 Valid 01/04/1997 DTP-Hib 22 Valid 04/04/1998 DTP-Hib 22 Valid 03/18/2007

06/06/2008 DTaP, unspecified formulation 107 Valid 08/08/2008 DTaP, unspecified formulation 107 Valid 05/19/2009 TRIHIBIT 50 PMC Valid01/29/2007 PEDIARIX 110 SKB Valid 03/29/2007 PEDIARIX 110 SKB Valid 02/02/2008 PEDIARIX 110 SKB Valid 10/09/201003/25/2019 DTAP/IPV/HIB - non-US 170 Valid 05/25/2019 DTAP/IPV/HIB - non-US 170 Valid 12/04/2019 DTAP/IPV/HIB - non-US 170 Valid

12/04/2019 KINRIX 130 SKB Valid10/08/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 KINRIX 130 SKB Valid04/08/2019 DTaP, unspecified formulation 107 Valid 05/27/2019 DTaP, unspecified formulation 107 Valid 12/04/2019 KINRIX 130 SKB Valid

04/04/2016 PEDIARIX 110 SKB Valid 06/06/2016 PEDIARIX 110 SKB Valid 12/04/2016 PEDIARIX 110 SKB Valid 12/04/201903/26/2016 PEDIARIX 110 SKB Valid 08/05/2016 PEDIARIX 110 SKB Valid 04/21/2017 PEDIARIX 110 SKB Valid 12/04/2019

03/25/2016 PEDIARIX 110 SKB Valid 05/25/2016 PEDIARIX 110 SKB Valid 02/17/2017 PEDIARIX 110 SKB Valid 12/04/2019

12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid11/07/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Not Valid Age: Too Young11/08/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid10/05/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid01/17/2017 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid04/09/2019 PEDIARIX 110 SKB Valid 06/15/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Not Valid Age: Too Young

Age: Too Young05/08/2019 PEDIARIX 110 SKB Valid 07/22/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid05/20/2016 PEDIARIX 110 SKB Valid 08/20/2016 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid

09/29/2016 PEDIARIX 110 SKB Valid 02/08/2018 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid03/09/2016 PEDIARIX 110 SKB Valid 07/10/2016 PEDIARIX 110 SKB Valid 03/18/2017 PEDIARIX 110 SKB Valid 12/04/2019



06/04/2013 PEDIARIX 110 SKB Valid 09/04/2013 PEDIARIX 110 SKB Valid 06/19/2014 PEDIARIX 110 SKB Valid 12/04/2019Age: Too Young 12/04/2019 PEDIARIX 110 SKB Valid

08/07/2019 PEDIARIX 110 SKB Not Valid Age: Too Young 12/04/2019 PEDIARIX 110 SKB Valid02/12/2019 PEDIARIX 110 SKB Valid 03/06/2019 PEDIARIX 110 SKB Not Valid Interval: too short 12/04/2019 PEDIARIX 110 SKB Valid

12/04/2019 PEDIARIX 110 SKB Not Valid Interval: too short12/04/2019 PEDIARIX 110 SKB Valid11/11/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Not Valid Interval: too short11/10/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid02/04/2019 PEDIARIX 110 SKB Valid 06/04/2019 PEDIARIX 110 SKB Valid 11/29/2019 PEDIARIX 110 SKB Valid02/04/2019 PEDIARIX 110 SKB Valid 06/04/2019 PEDIARIX 110 SKB Valid 11/30/2019 PEDIARIX 110 SKB Valid02/04/2019 PEDIARIX 110 SKB Valid 08/04/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid



10/23/2019 PEDIARIX 110 SKB Not Valid Interval: too short 12/04/2019 PEDIARIX 110 SKB Valid04/04/2019 PEDIARIX 110 SKB Valid 04/27/2019 PEDIARIX 110 SKB Not Valid Interval: too short 12/04/2019 PEDIARIX 110 SKB Valid

04/02/2016 PEDIARIX 110 SKB Valid 10/27/2016 PEDIARIX 110 SKB Valid 02/22/2017 PEDIARIX 110 SKB Not Valid Interval: too short 12/04/2019

12/04/2019 PEDIARIX 110 SKB Not Valid Age: Too Young12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid

11/18/2019 PENTACEL 120 PMC Valid12/04/2019 PENTACEL 120 PMC Valid12/04/2019 PENTACEL 120 PMC Valid11/07/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Not Valid Age: Too Young11/06/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid05/19/2016 DTaP-Hib-IPV 120 Valid 12/04/2019 PENTACEL 120 PMC Valid04/09/2019 PENTACEL 120 PMC Valid 06/09/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Not Valid Age: Too Young04/08/2019 PENTACEL 120 PMC Valid 06/08/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid04/04/2019 PENTACEL 120 PMC Valid 06/04/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid

11/26/2016 PENTACEL 120 PMC Valid 05/31/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid

01/12/2017 PENTACEL 120 PMC Valid 04/12/2017 PENTACEL 120 PMC Valid 09/13/2017 PENTACEL 120 PMC Valid 12/04/2019

10/01/2015 PENTACEL 120 PMC Valid 12/03/2015 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid02/05/2019 PENTACEL 120 PMC Not Valid Age: Too Young 04/22/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid01/02/2019 PENTACEL 120 PMC Valid 01/29/2019 PENTACEL 120 PMC Not Valid Age: Too Young 12/04/2019 PENTACEL 120 PMC Valid12/04/2019 PENTACEL 120 PMC Not Valid Interval: too short12/04/2019 PENTACEL 120 PMC Valid11/11/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Not Valid Interval: too short11/10/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid

04/08/2019 PENTACEL 120 PMC Valid 06/08/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid05/04/2019 PENTACEL 120 PMC Valid 08/04/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid09/05/2019 PENTACEL 120 PMC Not Valid Interval: too short 12/04/2019 PENTACEL 120 PMC Valid04/01/2019 PENTACEL 120 PMC Valid 04/22/2019 PENTACEL 120 PMC Not Valid Interval: too short 12/04/2019 PENTACEL 120 PMC Valid

12/04/2019 PENTACEL 120 PMC Not Valid Age: Too Young12/04/2019 PENTACEL 120 PMC Valid12/04/2019 PENTACEL 120 PMC Valid08/04/2013 DTaP, unspecified formulation 107 Valid 12/04/2014 DTaP, unspecified formulation 107 Valid 12/04/2015 DTaP, unspecified formulation 107 Valid02/18/2016 DTaP, unspecified formulation 107 Valid 05/04/2017 DTaP, unspecified formulation 107 Valid04/04/2013 DTaP, unspecified formulation 107 Valid 08/04/2013 DTaP, unspecified formulation 107 Valid

12/04/2013 DTaP, unspecified formulation 107 Valid 12/04/2014 DTaP, unspecified formulation 107 Valid 12/04/2015 DTaP, unspecified formulation 107 Valid11/24/2013 DTaP, unspecified formulation 107 Valid 12/04/2014 DTaP, unspecified formulation 107 Valid12/04/2014 DTaP, unspecified formulation 107 Valid 12/04/2017 DTaP, unspecified formulation 107 Valid12/04/2014 DTaP, unspecified formulation 107 Valid06/04/2013 DTaP, unspecified formulation 107 Valid 08/04/2013 DTaP, unspecified formulation 107 Valid 05/04/2014 DTaP, unspecified formulation 107 Valid09/04/2013 DTaP, unspecified formulation 107 Valid 12/16/2014 DTaP, unspecified formulation 107 Valid 01/18/2016 DTaP, unspecified formulation 107 Valid03/04/2019 DTaP, unspecified formulation 107 Valid 08/04/2019 DTaP, unspecified formulation 107 Valid 11/30/2019 DTaP, unspecified formulation 107 Valid03/04/2019 DTaP, unspecified formulation 107 Valid 08/04/2019 DTaP, unspecified formulation 107 Valid 11/29/2019 DTaP, unspecified formulation 107 Not Valid Interval: too short

12/29/2018 influenza, unspecified formulation 88 Valid


Age: Too Young

09/24/2019 influenza, unspecified formulation 88 Not Valid Interval: too short



10/13/2016 influenza, unspecified formulation 88 Valid 09/04/2019 influenza, unspecified formulation 88 Valid

12/04/2019 Hep A, unspecified formulation 85 Valid

Age: Too Young

12/04/2019 Hep A, unspecified formulation 85 Not Valid Interval: too short12/04/2019 Hep A, unspecified formulation 85 Valid12/04/2019 Hep A, unspecified formulation 85 Valid11/29/2019 Hep A, unspecified formulation 85 Not Valid Interval: too short

11/30/2019 Hep A, unspecified formulation 85 Valid

12/04/2019 RECOMBIVAX-PEDS 08 MSD Not Valid Interval: too short12/04/2019 Hep B, adolescent or pediatric 08 Valid12/04/2019 RECOMBIVAX-PEDS 08 MSD Valid

10/14/2019 RECOMBIVAX-PEDS 08 MSD Valid 12/04/2019 RECOMBIVAX-PEDS 08 MSD Valid10/11/2019 Hep B, adolescent or pediatric 08 Valid 12/02/2019 Hep B, adolescent or pediatric 08 Valid10/04/2019 Hep B, adolescent or pediatric 08 Valid 11/29/2019 Hep B, adolescent or pediatric 08 Valid

09/25/2019 RECOMBIVAX-PEDS 08 MSD Valid 12/04/2019 RECOMBIVAX-PEDS 08 MSD Valid10/11/2019 RECOMBIVAX-PEDS 08 MSD Valid 12/04/2019 RECOMBIVAX-PEDS 08 MSD Valid09/29/2019 Hep B, adolescent or pediatric 08 Valid 12/04/2019 Hep B, adolescent or pediatric 08 Valid

12/03/2019 RECOMBIVAX-ADULT 43 MSD Valid12/04/2019 RECOMBIVAX-ADULT 43 MSD Valid

10/04/2019 RECOMBIVAX-ADULT 43 MSD Valid 11/24/2019 RECOMBIVAX-PEDS 08 MSD Valid03/13/2004 COMVAX 51 MSD Valid 08/04/2004 COMVAX 51 MSD Valid03/02/2006 COMVAX 51 MSD Valid 08/02/2006 COMVAX 51 MSD Valid10/05/2006 COMVAX 51 MSD Valid 11/26/2006 COMVAX 51 MSD Valid

11/06/2006 COMVAX 51 MSD Valid 01/01/2007 COMVAX 51 MSD Valid

09/20/2002 COMVAX 51 MSD Valid 11/16/2002 COMVAX 51 MSD Valid12/09/2006 COMVAX 51 MSD Valid 02/03/2007 COMVAX 51 MSD Valid



12/22/2006 COMVAX 51 MSD Valid 02/20/2007 COMVAX 51 MSD Valid

12/04/2019 RECOMBIVAX-PEDS 08 MSD Not Valid Age: Too Young12/04/2019 RECOMBIVAX-PEDS 08 MSD Valid12/04/2019 RECOMBIVAX-PEDS 08 MSD Valid

07/22/2019 ENGERIX B-PEDS 08 SKB Valid 12/04/2019 ENGERIX B-PEDS 08 SKB Valid07/23/2019 RECOMBIVAX-PEDS 08 MSD Valid 12/04/2019 RECOMBIVAX-PEDS 08 MSD Valid08/19/2019 RECOMBIVAX-PEDS 08 MSD Valid 12/04/2019 Hep B, unspecified formulation 45 Valid

12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid11/07/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid11/08/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid10/04/2019 Hep B, adolescent or pediatric 08 Valid 12/04/2019 PEDIARIX 110 SKB Valid04/09/2019 PEDIARIX 110 SKB Valid 06/15/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Extraneous Series Already Complete

05/08/2019 PEDIARIX 110 SKB Valid 07/22/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Extraneous Series Already Complete05/20/2016 PEDIARIX 110 SKB Valid 08/20/2016 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Extraneous Series Already Complete09/29/2016 PEDIARIX 110 SKB Valid 02/05/2018 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Extraneous Series Already Complete03/09/2016 PEDIARIX 110 SKB Valid 07/10/2016 PEDIARIX 110 SKB Valid 03/18/2017 PEDIARIX 110 SKB Extraneous Series Already Complete 12/04/201903/08/2016 PEDIARIX 110 SKB Valid 07/09/2016 PEDIARIX 110 SKB Valid 03/17/2017 PEDIARIX 110 SKB Extraneous Series Already Complete 12/04/201904/20/2013 PEDIARIX 110 SKB Valid 06/20/2013 PEDIARIX 110 SKB Valid 01/20/2014 PEDIARIX 110 SKB Extraneous Series Already Complete 12/04/201906/04/2013 PEDIARIX 110 SKB Valid 09/04/2013 PEDIARIX 110 SKB Valid 06/19/2014 PEDIARIX 110 SKB Extraneous Series Already Complete 12/04/2019

12/04/2019 PEDIARIX 110 SKB Not Valid Interval: too short12/04/2019 PEDIARIX 110 SKB Valid

10/14/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid10/13/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid02/04/2019 PEDIARIX 110 SKB Valid 06/04/2019 PEDIARIX 110 SKB Valid 11/29/2019 PEDIARIX 110 SKB Extraneous Series Already Complete02/04/2019 PEDIARIX 110 SKB Valid 06/04/2019 PEDIARIX 110 SKB Valid 11/30/2019 PEDIARIX 110 SKB Extraneous Series Already Complete02/04/2019 PEDIARIX 110 SKB Valid 08/04/2019 PEDIARIX 110 SKB Valid 12/03/2019 PEDIARIX 110 SKB Extraneous Series Already Complete02/04/2019 PEDIARIX 110 SKB Valid 08/04/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Extraneous Series Already Complete10/23/2019 PEDIARIX 110 SKB Not Valid Interval: too short 12/04/2019 PEDIARIX 110 SKB Valid

12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid09/15/2019 RECOMBIVAX-PEDS 08 MSD Valid 11/03/2019 RECOMBIVAX-PEDS 08 MSD Valid 11/30/2019 RECOMBIVAX-PEDS 08 MSD Valid08/21/2019 PEDIARIX 110 SKB Valid 10/09/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid

12/04/2019 Hep B, adjuvanted 189 Valid12/04/2019 Hep B, adjuvanted 189 Not Valid Interval: too short12/04/2019 Hep B, adjuvanted 189 Valid

12/04/2019 HEPLISAV-B 189 DVX Valid

10/09/2019 HEPLISAV-B 189 DVX Valid 12/04/2019 HEPLISAV-B 189 DVX Valid

Inadvertent Vaccine12/04/2019 RECOMBIVAX-PEDS 08 MSD Valid

Age: Too Young

Age: Too Old

Age: Too Old12/04/2019 ACTHIB 48 PMC Not Valid Age: Too Young12/04/2019 ACTHIB 48 PMC Valid12/04/2019 ACTHIB 48 PMC Valid12/04/2019 ACTHIB 48 PMC Valid12/04/2019 ACTHIB 48 PMC Valid12/04/2019 ACTHIB 48 PMC Valid

12/04/2019 ACTHIB 48 PMC Valid12/04/2019 ACTHIB 48 PMC Valid12/04/2019 ACTHIB 48 PMC Valid

12/04/2019 ACTHIB 48 PMC Extraneous Age: Too Old12/04/2019 ACTHIB 48 PMC Not Valid Interval: too short12/04/2019 ACTHIB 48 PMC Valid12/04/2019 ACTHIB 48 PMC Valid11/07/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Not Valid Age: Too Young10/04/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid11/11/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Not Valid Interval: too short11/10/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid11/06/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid04/09/2019 ACTHIB 48 PMC Valid 06/09/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Not Valid Age: Too Young04/08/2019 ACTHIB 48 PMC Valid 06/08/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid04/07/2019 ACTHIB 48 PMC Valid 06/07/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid01/04/2019 ACTHIB 48 PMC Valid 03/04/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid04/04/2019 ACTHIB 48 PMC Valid 10/14/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Not Valid Interval: too short04/04/2019 ACTHIB 48 PMC Valid 10/13/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid01/04/2019 ACTHIB 48 PMC Valid 04/04/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid

04/04/2015 ACTHIB 48 PMC Valid 07/04/2015 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Extraneous Age: Too Old

04/04/2014 ACTHIB 48 PMC Valid 08/04/2014 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Extraneous Age: Too Old

12/04/2019 PEDVAXHIB 49 MSD Valid12/04/2019 PEDVAXHIB 49 MSD Valid12/04/2019 ACTHIB 48 PMC Valid11/04/2019 PEDVAXHIB 49 MSD Valid 12/04/2019 ACTHIB 48 PMC Valid04/25/2019 ACTHIB 48 PMC Valid 12/04/2019 PEDVAXHIB 49 MSD Valid05/04/2019 PEDVAXHIB 49 MSD Valid 12/04/2019 ACTHIB 48 PMC Valid04/09/2019 ACTHIB 48 PMC Valid 12/04/2019 PEDVAXHIB 49 MSD Valid

04/07/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid01/04/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid04/05/2015 PEDVAXHIB 49 MSD Valid 12/04/2019 ACTHIB 48 PMC Valid

10/12/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid



12/04/2019 ACTHIB 48 PMC Not Valid Interval: too short12/04/2019 ACTHIB 48 PMC Valid12/04/2019 ACTHIB 48 PMC Valid12/04/2019 ACTHIB 48 PMC Valid08/09/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Not Valid Age: Too Young08/08/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid08/07/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid09/04/2015 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Valid

08/04/2015 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Extraneous Age: Too Old10/11/2019 PEDVAXHIB 49 MSD Valid 12/01/2019 PEDVAXHIB 49 MSD Not Valid Interval: too short10/11/2019 PEDVAXHIB 49 MSD Valid 12/02/2019 PEDVAXHIB 49 MSD Valid

12/04/2019 PEDVAXHIB 49 MSD Not Valid Interval: too short12/04/2019 HIBERIX 48 SKB Valid12/04/2019 Hib (PRP-OMP) 49 Valid10/09/2019 ACTHIB 48 PMC Valid 12/04/2019 ACTHIB 48 PMC Extraneous Series Already Complete

12/04/2019 ACTHIB 48 PMC Extraneous Series Already Complete12/04/2019 ACTHIB 48 PMC Valid12/04/2019 PENTACEL 120 PMC Extraneous Series Already Complete11/07/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Not Valid Age: Too Young

Age: Too Young 10/04/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid12/04/2019 PENTACEL 120 PMC Valid11/11/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Not Valid Interval: too short

Age: Too Young12/04/2019 PENTACEL 120 PMC Valid12/04/2019 PENTACEL 120 PMC Not Valid Age: Too Young11/06/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid04/04/2019 PENTACEL 120 PMC Valid 06/04/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid04/08/2019 PENTACEL 120 PMC Valid 06/08/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid04/09/2019 PENTACEL 120 PMC Valid 05/21/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Not Valid Age: Too Young11/21/2016 PENTACEL 120 PMC Valid 07/06/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Extraneous Series Already Complete

10/01/2015 PENTACEL 120 PMC Valid 11/29/2015 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Extraneous Age: Too Old01/12/2017 PENTACEL 120 PMC Valid 04/12/2017 PENTACEL 120 PMC Valid 09/13/2017 PENTACEL 120 PMC Extraneous Series Already Complete 12/04/201912/04/2019 PENTACEL 120 PMC Not Valid Interval: too short11/10/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid02/05/2019 PENTACEL 120 PMC Not Valid Age: Too Young 04/22/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid01/02/2019 PENTACEL 120 PMC Valid 01/29/2019 PENTACEL 120 PMC Not Valid Age: Too Young 12/04/2019 PENTACEL 120 PMC Valid09/05/2019 PENTACEL 120 PMC Not Valid Interval: too short 12/04/2019 PENTACEL 120 PMC Valid

12/04/2019 PENTACEL 120 PMC Extraneous Age: Too Old

12/04/2019 HPV9 165 Valid12/04/2019 HPV9 165 Valid12/04/2019 HPV9 165 Valid12/04/2019 HPV9 165 Valid

12/04/2019 HPV9 165 Not Valid Interval: too short12/04/2019 HPV9 165 Valid12/04/2019 HPV9 165 Valid05/28/2011 GARDASIL 62 MSD Valid 08/20/2011 GARDASIL 62 MSD Valid07/17/2019 HPV9 165 Valid 12/04/2019 HPV9 165 Valid08/04/2019 HPV9 165 Valid 12/04/2019 HPV9 165 Valid05/28/2011 GARDASIL 62 MSD Valid 08/20/2011 GARDASIL 62 MSD Valid07/17/2019 HPV9 165 Valid 12/04/2019 HPV9 165 Valid08/04/2019 HPV9 165 Valid 12/04/2019 HPV9 165 Valid

Inadvertent VaccineInadvertent VaccineInadvertent VaccineInadvertent Vaccine

05/25/2011 CERVARIX 118 SKB Valid05/29/2011 CERVARIX 118 SKB Valid07/01/2011 CERVARIX 118 SKB Valid

Inadvertent Vaccine 05/22/2011 CERVARIX 118 SKB Not Valid Inadvertent Vaccine05/29/2011 CERVARIX 118 SKB Valid 10/16/2011 CERVARIX 118 SKB Valid07/01/2011 CERVARIX 118 SKB Valid 11/01/2011 CERVARIX 118 SKB Valid

Inadvertent Vaccine 05/29/2011 CERVARIX 118 SKB Not Valid Inadvertent Vaccine 10/19/2011 CERVARIX 118 SKB Not Valid Inadvertent VaccineInadvertent Vaccine 07/01/2011 CERVARIX 118 SKB Not Valid Inadvertent Vaccine 11/01/2011 CERVARIX 118 SKB Not Valid Inadvertent Vaccine

12/04/2019 HPV9 165 Valid12/04/2019 HPV9 165 Valid12/04/2019 HPV9 165 Not Valid Interval: too short12/04/2019 HPV9 165 Valid05/29/2011 HPV, unspecified formulation 137 Valid 08/21/2011 HPV, unspecified formulation 137 Valid06/06/2011 HPV, unspecified formulation 137 Valid 08/25/2011 HPV, unspecified formulation 137 Valid09/16/2019 HPV9 165 Valid 12/04/2019 HPV9 165 Not Valid Interval: too short08/04/2019 HPV9 165 Valid 12/04/2019 HPV9 165 Valid07/17/2019 HPV9 165 Valid 12/04/2019 HPV9 165 Valid05/29/2010 HPV, unspecified formulation 137 Valid 08/21/2010 HPV, unspecified formulation 137 Valid

Age: Too Young 12/04/2019 HPV9 165 Not Valid Age: Too YoungAge: Too Young 12/04/2019 HPV9 165 Valid

12/04/2019 HPV9 165 Not Valid Interval: too short12/04/2019 HPV9 165 Valid12/04/2019 HPV9 165 Valid

Age: Too Young 12/03/2019 HPV9 165 Not Valid Age: Too Young 12/04/2019 HPV9 165 Not Valid Age: Too YoungAge: Too Young 11/28/2019 HPV9 165 Not Valid Age: Too Young 12/04/2019 HPV9 165 ValidAge: Too Young 11/06/2019 HPV9 165 Valid 12/04/2019 HPV9 165 ValidAge: Too Young 05/29/2011 HPV, unspecified formulation 137 Valid 06/26/2011 HPV, unspecified formulation 137 Valid 10/19/2011 HPV, unspecified formulation 137 Valid

12/04/2019 HPV9 165 Valid12/04/2019 HPV9 165 Valid12/28/2010 HPV, unspecified formulation 137 Valid 03/22/2011 HPV, unspecified formulation 137 Valid12/29/2011 HPV, unspecified formulation 137 Valid 03/22/2012 HPV, unspecified formulation 137 Valid

12/04/2019 HPV9 165 Valid12/04/2019 HPV9 165 Not Valid Interval: too short12/04/2019 HPV9 165 Valid

09/16/2019 HPV9 165 Valid 12/04/2019 HPV9 165 Not Valid Interval: too short11/20/2010 HPV, unspecified formulation 137 Valid 02/08/2011 HPV, unspecified formulation 137 Valid11/20/2010 HPV, unspecified formulation 137 Valid 02/12/2011 HPV, unspecified formulation 137 Valid

05/16/2008 HPV, unspecified formulation 137 Valid 07/31/2008 HPV, unspecified formulation 137 Not Valid Interval: too short05/16/2008 HPV, unspecified formulation 137 Valid 08/08/2008 HPV, unspecified formulation 137 Valid09/12/2019 HPV9 165 Valid 12/01/2019 HPV9 165 Valid

Age: Too Young 05/20/2019 HPV9 165 Valid 12/04/2019 HPV9 165 Valid06/25/2019 HPV9 165 Not Valid Interval: too short 12/04/2019 HPV9 165 Valid



Inadvertent VaccineAge: Too Young

12/04/2019 HPV9 165 Valid

12/04/2019 HPV9 165 Valid07/02/2019 HPV9 165 Valid 12/02/2019 HPV9 165 Valid12/04/2019 HPV9 165 Valid

12/02/2019 HPV9 165 Valid12/02/2019 HPV9 165 Valid09/02/2019 Gardasil 9 165 MSD Valid 12/04/2019 Gardasil 9 165 MSD Valid

12/04/2019 MENACTRA 114 PMC Valid12/04/2019 MENACTRA 114 PMC Not Valid Age: Too Young12/04/2019 MENACTRA 114 PMC Valid12/04/2019 MENACTRA 114 PMC Valid

Age: Too Young 12/04/2019 MENACTRA 114 PMC Valid


Age: Too Young


12/04/2019 meningococcal MCV4, unspecified formulation 147 Not Valid Interval: too short12/01/2019 meningococcal MCV4, unspecified formulation 147 Valid11/29/2019 meningococcal MCV4, unspecified formulation 147 Valid

12/04/2019 M-M-R II 03 MSD Valid

11/01/2015 MERUVAX II 06 MSD Valid 11/29/2015 ATTENUVAX 05 MSD Valid 11/01/2019 MERUVAX II 06 MSD Valid 12/01/201901/01/2016 MERUVAX II 06 MSD Valid 01/29/2016 ATTENUVAX 05 MSD Valid 12/04/2019 mumps 07 Valid

12/04/2019 mumps 07 Valid

10/02/2015 MERUVAX II 06 MSD Valid 10/30/2015 ATTENUVAX 05 MSD Valid 09/04/2019 mumps 07 Valid 10/02/201909/11/2019 MERUVAX II 06 MSD Valid 12/04/2019 ATTENUVAX 05 MSD Valid12/04/2019 MERUVAX II 06 MSD Valid 12/04/2019 ATTENUVAX 05 MSD Valid11/06/2015 MERUVAX II 06 MSD Valid 12/04/2015 ATTENUVAX 05 MSD Valid 10/09/2019 mumps 07 Valid 11/06/201907/17/2019 MERUVAX II 06 MSD Valid 12/04/2019 ATTENUVAX 05 MSD Valid

Age: Too Young

12/04/2019 M-M-R II 03 MSD Valid12/04/2019 VARIVAX 21 MSD Valid11/04/2019 VARIVAX 21 MSD Valid 12/04/2019 M-M-R II 03 MSD Valid 12/04/2019 VARIVAX 21 MSD Valid12/04/2019 M-M-R II 03 MSD Not Valid Live Virus Conflict12/04/2019 M-M-R II 03 MSD Valid

Age: Too Young

12/04/2019 PROQUAD 94 MSD Valid12/04/2019 PROQUAD 94 MSD Valid12/04/2019 PROQUAD 94 MSD Not Valid Live Virus Conflict12/04/2019 PROQUAD 94 MSD Valid12/04/2019 PROQUAD 94 MSD Not Valid Live Virus Conflict12/04/2019 M-M-R II 03 MSD Valid12/04/2019 PROQUAD 94 MSD Valid

Age: Too Young 12/04/2019 PROQUAD 94 MSD ValidAge: Too Young 12/04/2019 PROQUAD 94 MSD Not Valid Live Virus ConflictAge: Too Young 12/04/2019 PROQUAD 94 MSD Not Valid Live Virus Conflict

04/03/2018 MERUVAX II 06 MSD Valid 12/03/2018 ATTENUVAX 05 MSD Valid 11/28/2017 M-M-R II 03 MSD Valid12/04/2019 M-M-R II 03 MSD Not Valid Age: Too Young12/04/2019 M-M-R II 03 MSD Valid12/04/2019 M-M-R II 03 MSD Valid12/04/2019 M-M-R II 03 MSD Not Valid Interval: too short12/04/2019 M-M-R II 03 MSD Valid

12/04/2019 MMR 03 Valid12/04/2019 MMR 03 Not Valid Interval: too short12/04/2019 MMR 03 Valid

12/04/2019 PREVNAR 13 133 PFR Not Valid Age: Too Young12/04/2019 PREVNAR 13 133 PFR Valid12/04/2019 PREVNAR 13 133 PFR Valid12/04/2019 PREVNAR 13 133 PFR Valid08/04/2019 PREVNAR 13 133 PFR Valid12/04/2019 PREVNAR 13 133 PFR Not Valid Interval: too short12/04/2019 PREVNAR 13 133 PFR Valid12/04/2019 PREVNAR 13 133 PFR Valid

11/08/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Not Valid Age: Too Young11/07/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Valid11/06/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Valid10/04/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Valid11/04/2010 PREVNAR 13 133 PFR Valid 03/04/2011 PREVNAR 13 133 PFR Valid02/01/2010 PREVNAR 7 100 WAL Valid 06/01/2010 PREVNAR 13 133 PFR Valid

Age: Too Young11/04/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Not Valid Interval: too short04/09/2019 PREVNAR 13 133 PFR Valid 06/09/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Not Valid Age: Too Young04/08/2019 PREVNAR 13 133 PFR Valid 06/08/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Valid04/04/2019 PREVNAR 13 133 PFR Valid 06/04/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Valid

10/01/2009 PREVNAR 7 100 WAL Valid 12/01/2009 PREVNAR 7 100 WAL Valid 07/01/2010 PREVNAR 7 100 WAL ValidAge: Too Young 09/19/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Valid

09/07/2019 PREVNAR 13 133 PFR Not Valid Age: Too Young 12/04/2019 PREVNAR 13 133 PFR Valid01/29/2019 PREVNAR 13 133 PFR Valid 02/09/2019 PREVNAR 13 133 PFR Not Valid Age: Too Young 12/04/2019 PREVNAR 13 133 PFR Valid12/04/2019 PREVNAR 13 133 PFR Not Valid Interval: too short12/04/2019 PREVNAR 13 133 PFR Valid

12/04/2019 PREVNAR 13 133 PFR Valid11/11/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Not Valid Interval: too short11/10/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Valid11/06/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Valid09/14/2019 PREVNAR 13 133 PFR Valid 10/14/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Not Valid Interval: too short



09/13/2019 PREVNAR 13 133 PFR Valid 10/13/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Valid09/09/2019 PREVNAR 13 133 PFR Valid 10/09/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Valid02/13/2019 PREVNAR 13 133 PFR Not Valid Interval: too short 06/04/2019 PREVNAR 13 133 PFR Valid 12/04/2019 PREVNAR 13 133 PFR Valid06/12/2019 PREVNAR 13 133 PFR Valid 07/04/2019 PREVNAR 13 133 PFR Not Valid Interval: too short 12/04/2019 PREVNAR 13 133 PFR Valid03/16/2019 PREVNAR 13 133 PFR Valid 09/05/2019 PREVNAR 13 133 PFR Valid 10/05/2019 PREVNAR 13 133 PFR Not Valid Interval: too short 11/30/2019

10/06/2008 PREVNAR 7 100 WAL Valid 12/06/2008 PREVNAR 7 100 WAL Valid 12/06/2009 PREVNAR 7 100 WAL Valid 03/05/2012

12/04/2019 PNEUMOVAX 23 33 MSD Valid

12/04/2019 IPOL 10 PMC Valid12/04/2019 IPOL 10 PMC Valid12/04/2019 IPOL 10 PMC Valid

12/04/2019 IPOL 10 PMC Valid11/07/2019 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Not Valid Age: Too Young11/10/2019 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid11/06/2019 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid10/04/2019 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid04/19/2016 IPOL 10 PMC Valid 11/24/2019 IPOL 10 PMC Valid04/09/2016 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid

12/04/2019 IPOL 10 PMC Valid07/08/2019 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid05/08/2019 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid

08/04/2019 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid04/04/2016 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid10/04/2018 IPOL 10 PMC Valid 12/04/2018 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid07/09/2016 IPOL 10 PMC Valid 12/10/2018 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid07/08/2016 IPOL 10 PMC Valid 12/09/2018 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid04/04/2016 IPOL 10 PMC Valid 08/05/2016 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid

Age: Too Young 09/27/2019 IPOL 10 PMC Valid 11/27/2019 IPOL 10 PMC Valid08/08/2019 IPOL 10 PMC Not Valid Age: Too Young 12/04/2019 IPOL 10 PMC Valid02/09/2016 IPOL 10 PMC Valid 03/06/2016 IPOL 10 PMC Not Valid Age: Too Young 12/04/2019 IPOL 10 PMC Valid12/04/2019 IPOL 10 PMC Not Valid Interval: too short12/04/2019 IPOL 10 PMC Valid12/04/2019 IPOL 10 PMC Valid11/11/2019 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Not Valid Interval: too short11/10/2019 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid11/06/2019 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid

11/04/2017 IPOL 10 PMC Valid 06/04/2019 IPOL 10 PMC Valid 11/29/2019 IPOL 10 PMC Valid12/04/2017 IPOL 10 PMC Valid 06/08/2019 IPOL 10 PMC Valid 12/04/2019 IPOL 10 PMC Valid11/30/2017 IPOL 10 PMC Valid 06/03/2019 IPOL 10 PMC Valid 12/03/2019 IPOL 10 PMC Valid

Age: Too Young08/26/2019 IPOL 10 PMC Not Valid Interval: too short 12/04/2019 IPOL 10 PMC Valid04/02/2016 IPOL 10 PMC Valid 04/25/2016 IPOL 10 PMC Not Valid Interval: too short 12/04/2019 IPOL 10 PMC Valid

02/16/2012 OPV 02 Valid 10/16/2016 IPOL 10 PMC Valid

08/13/2011 OPV 02 Valid 04/13/2014 IPOL 10 PMC Valid 04/17/2016 IPOL 10 PMC Valid

12/04/2019 KINRIX 130 SKB Valid10/08/2019 IPOL 10 PMC Valid 12/04/2019 KINRIX 130 SKB Valid

03/13/2019 IPOL 10 PMC Valid 05/02/2019 IPOL 10 PMC Valid 12/04/2019 KINRIX 130 SKB Valid04/04/2016 PEDIARIX 110 SKB Valid 06/06/2016 PEDIARIX 110 SKB Valid 12/04/2019 KINRIX 130 SKB Valid

03/27/2016 PEDIARIX 110 SKB Valid 08/06/2016 PEDIARIX 110 SKB Valid 12/04/2019 KINRIX 130 SKB Valid03/26/2016 PEDIARIX 110 SKB Valid 05/26/2016 PEDIARIX 110 SKB Valid 12/04/2019 KINRIX 130 SKB Valid

12/04/2019 IPOL 10 PMC Not Valid Age: Too Young12/04/2019 IPOL 10 PMC Valid

12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid

11/07/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Not Valid Age: Too Young11/08/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid10/05/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid10/04/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid01/17/2017 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid04/09/2019 PEDIARIX 110 SKB Valid 06/15/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid

Age: Too Young05/08/2019 PEDIARIX 110 SKB Valid 07/22/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid05/20/2016 PEDIARIX 110 SKB Valid 08/20/2016 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid09/30/2016 PEDIARIX 110 SKB Valid 02/06/2018 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid03/09/2016 PEDIARIX 110 SKB Valid 07/10/2016 PEDIARIX 110 SKB Valid 03/18/2017 PEDIARIX 110 SKB Valid 12/04/201903/08/2016 PEDIARIX 110 SKB Valid 07/09/2016 PEDIARIX 110 SKB Valid 03/17/2017 PEDIARIX 110 SKB Valid 12/04/201904/20/2013 PEDIARIX 110 SKB Valid 06/20/2013 PEDIARIX 110 SKB Valid 01/20/2014 PEDIARIX 110 SKB Valid 12/04/201906/04/2013 PEDIARIX 110 SKB Valid 09/04/2013 PEDIARIX 110 SKB Valid 06/19/2014 PEDIARIX 110 SKB Valid 12/04/2019

Age: Too Young 12/04/2019 PEDIARIX 110 SKB Valid

08/07/2019 PEDIARIX 110 SKB Not Valid Age: Too Young 12/04/2019 PEDIARIX 110 SKB Valid02/12/2019 PEDIARIX 110 SKB Valid 03/06/2019 PEDIARIX 110 SKB Not Valid Age: Too Young 12/04/2019 PEDIARIX 110 SKB Valid

12/04/2019 PEDIARIX 110 SKB Not Valid Interval: too short

12/04/2019 PEDIARIX 110 SKB Valid11/11/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Not Valid Interval: too short11/10/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid02/08/2019 PEDIARIX 110 SKB Valid 06/08/2019 PEDIARIX 110 SKB Valid 12/04/2019 PEDIARIX 110 SKB Valid

10/23/2019 PEDIARIX 110 SKB Not Valid Interval: too short 12/04/2019 PEDIARIX 110 SKB Valid04/04/2019 PEDIARIX 110 SKB Valid 04/27/2019 PEDIARIX 110 SKB Not Valid Interval: too short 12/04/2019 PEDIARIX 110 SKB Valid

12/04/2019 PEDIARIX 110 SKB Not Valid Age: Too Young12/04/2019 PEDIARIX 110 SKB Valid12/04/2019 PEDIARIX 110 SKB Valid

12/04/2019 PENTACEL 120 PMC Valid12/04/2019 PENTACEL 120 PMC Valid12/04/2019 PENTACEL 120 PMC Valid

11/07/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Not Valid Age: Too Young11/06/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid04/19/2013 IPOL 10 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid04/09/2019 PENTACEL 120 PMC Valid 06/09/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid04/08/2019 PENTACEL 120 PMC Valid 06/08/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid04/04/2019 PENTACEL 120 PMC Valid 06/04/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid11/26/2016 PENTACEL 120 PMC Valid 06/04/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid

Age: Too Young01/13/2017 PENTACEL 120 PMC Valid 04/13/2017 PENTACEL 120 PMC Valid 09/14/2017 PENTACEL 120 PMC Valid 12/04/2019



09/29/2015 PENTACEL 120 PMC Valid 12/01/2015 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC ValidAge: Too Young 10/04/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid

02/05/2019 PENTACEL 120 PMC Not Valid Age: Too Young 04/23/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid01/02/2019 PENTACEL 120 PMC Valid 01/29/2019 PENTACEL 120 PMC Not Valid Age: Too Young 12/04/2019 PENTACEL 120 PMC Valid12/04/2019 PENTACEL 120 PMC Not Valid Interval: too short12/04/2019 PENTACEL 120 PMC Valid11/11/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Not Valid Interval: too short11/10/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid

04/08/2019 PENTACEL 120 PMC Valid 06/08/2019 PENTACEL 120 PMC Valid 12/04/2019 PENTACEL 120 PMC Valid09/05/2019 PENTACEL 120 PMC Not Valid Interval: too short 12/04/2019 PENTACEL 120 PMC Valid04/01/2019 PENTACEL 120 PMC Valid 04/22/2019 PENTACEL 120 PMC Not Valid Interval: too short 12/04/2019 PENTACEL 120 PMC Valid

12/04/2019 PENTACEL 120 PMC Not Valid Age: Too Young12/04/2019 PENTACEL 120 PMC Valid12/04/2019 PENTACEL 120 PMC Valid

11/06/2019 ROTATEQ 116 MSD Valid 12/04/2019 ROTATEQ 116 MSD Valid10/04/2019 ROTATEQ 116 MSD Valid 12/04/2019 ROTATEQ 116 MSD Valid12/04/2019 ROTATEQ 116 MSD Not Valid Interval: too short12/04/2019 ROTATEQ 116 MSD Valid12/04/2019 ROTATEQ 116 MSD Valid11/11/2019 ROTATEQ 116 MSD Valid 12/04/2019 ROTATEQ 116 MSD Not Valid Interval: too short11/10/2019 ROTATEQ 116 MSD Valid 12/04/2019 ROTATEQ 116 MSD Valid11/06/2019 ROTATEQ 116 MSD Valid 12/04/2019 ROTATEQ 116 MSD Valid

Age: Too Young

Age: Too Young

12/04/2019 ROTARIX 119 SKB Not Valid Age: Too Young12/04/2019 ROTARIX 119 SKB Valid12/04/2019 ROTARIX 119 SKB Valid12/04/2019 ROTARIX 119 SKB Not Valid Interval: too short12/04/2019 ROTARIX 119 SKB Valid12/04/2019 ROTARIX 119 SKB Valid

12/04/2019 ROTARIX 119 SKB Valid12/04/2019 ROTATEQ 116 MSD Valid12/04/2019 rotavirus, unspecified formulation 122 Valid

12/04/2019 ROTATEQ 116 MSD Not Valid Age: Too Young12/04/2019 ROTATEQ 116 MSD Valid12/04/2019 ROTATEQ 116 MSD Valid11/08/2019 ROTATEQ 116 MSD Valid 12/04/2019 ROTATEQ 116 MSD Not Valid Age: Too Young11/10/2019 ROTATEQ 116 MSD Valid 12/04/2019 ROTATEQ 116 MSD Valid

Age: Too Young

12/04/2019 VARIVAX 21 MSD Valid12/04/2019 VARIVAX 21 MSD Not Valid Interval: too short12/04/2019 VARIVAX 21 MSD Valid12/04/2019 VARIVAX 21 MSD Not Valid Interval: too short12/04/2019 VARIVAX 21 MSD Valid12/04/2019 VARIVAX 21 MSD Valid12/04/2019 VARIVAX 21 MSD Valid11/06/2019 VARIVAX 21 MSD Valid 12/04/2019 M-M-R II 03 MSD Valid 12/04/2019 VARIVAX 21 MSD Not Valid12/04/2019 VARIVAX 21 MSD Not Valid Live Virus Conflict12/04/2019 VARIVAX 21 MSD Valid

Age: Too YoungAge: Too Young

12/04/2019 PROQUAD 94 MSD Valid12/04/2019 PROQUAD 94 MSD Valid12/03/2019 PROQUAD 94 MSD Not Valid Live Virus Conflict12/04/2019 PROQUAD 94 MSD Valid12/04/2019 PROQUAD 94 MSD Not Valid Live Virus Conflict11/27/2019 PROQUAD 94 MSD Valid12/04/2019 PROQUAD 94 MSD Valid

Age: Too Young 12/04/2019 PROQUAD 94 MSD ValidAge: Too Young 12/04/2019 PROQUAD 94 MSD Not Valid Live Virus Conflict

12/04/2019 VARIVAX 21 MSD Not Valid Live Virus Conflict12/04/2019 VARIVAX 21 MSD Valid

12/04/2019 VARIVAX 21 MSD Not Valid Age: Too Young12/04/2019 VARIVAX 21 MSD Valid

12/04/2019 VARIVAX 21 MSD Valid

12/04/2019 varicella 21 Valid12/04/2019 varicella 21 Valid12/04/2019 varicella 21 Not Valid Interval: too short

12/04/2019 ZOSTAVAX 121 MSD Valid

12/04/2019 ZOSTAVAX 121 MSD Not Valid Live Virus Conflict

12/04/2019 zoster recombinant 187 Valid12/04/2019 zoster recombinant 187 Valid12/04/2019 zoster recombinant 187 Valid

12/03/2019 zoster recombinant 187 Valid

12/04/2019 zoster recombinant 187 Valid12/04/2019 zoster recombinant 187 Valid10/09/2019 varicella 21 Valid 12/04/2019 SHINGRIX 187 SKB Valid11/06/2019 varicella 21 Valid 12/04/2019 SHINGRIX 187 SKB Valid12/04/2019 SHINGRIX 187 SKB Valid10/09/2019 SHINGRIX 187 SKB Valid 12/04/2019 SHINGRIX 187 SKB Valid11/29/2019 zoster recombinant 187 Not Valid Interval: too short11/30/2019 zoster recombinant 187 Valid10/09/2019 SHINGRIX 187 SKB Valid

Vaccine_Name_5 CVX_5 MVX_5 Evaluation_Status_5 Evaluation_Reason_5 Date_Administred_6 Vaccine_Name_6 CVX_6 MVX_6 Evaluation_Status_6 Evaluation_Reason_6 Date_Administred_7 Vaccine_Name_7 CVX_7 MVX_7 Evaluation_Status_7 Evaluation_Reason_7 Forecast_# Earliest_Date Recommended_Date Past_Due_Date Vaccine_Group Assessment_Date1 01/15/2020 02/04/2020 03/31/2020 DTAP 12/04/20192 01/01/2020 01/30/2020 03/28/2020 DTAP 12/04/20193 01/05/2020 03/29/2020 05/26/2020 DTAP 12/04/20193 01/01/2020 03/25/2020 05/22/2020 DTAP 12/04/20193 01/01/2020 02/04/2020 03/31/2020 DTAP 12/04/20193 01/01/2020 01/01/2020 01/01/2020 DTAP 12/04/20193 06/04/2020 06/04/2020 06/04/2020 DTAP 12/04/20193 06/04/2020 06/04/2020 06/04/2020 DTAP 12/04/20193 01/01/2020 03/02/2020 04/29/2020 DTAP 12/04/20191 01/15/2014 02/04/2014 03/31/2014 DTAP 12/04/20194 12/01/2020 12/01/2020 04/28/2021 DTAP 12/04/20194 11/28/2020 11/28/2020 04/24/2021 DTAP 12/04/20194 09/04/2020 09/04/2020 01/31/2021 DTAP 12/04/20194 06/04/2020 06/04/2020 06/04/2020 DTAP 12/04/2019

4 02/15/2023 02/15/2023 03/14/2025 DTAP 12/04/2019

4 05/04/2023 05/04/2023 05/31/2025 DTAP 12/04/20193 05/29/2020 05/29/2020 05/29/2020 DTAP 12/04/2019

4 04/04/2023 04/04/2023 05/01/2025 DTAP 12/04/20193 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20191 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20194 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20194 06/04/2020 06/04/2020 08/05/2020 DTAP 12/04/20195 12/08/2022 12/08/2022 12/07/2025 DTAP 12/04/20195 12/04/2022 12/04/2022 12/03/2025 DTAP 12/04/2019

5 12/04/2026 12/04/2026 12/31/2028 DTAP 12/04/2019

5 09/29/2024 09/29/2024 10/26/2026 DTAP 12/04/2019DTaP, unspecified formulation 107 Not Valid Age: Too Young 5 06/04/2020 06/04/2020 12/08/2022 DTAP 12/04/2019

DTaP, unspecified formulation 107 Valid 6 12/08/2026 12/08/2026 01/04/2029 DTAP 12/04/2019

DTaP, unspecified formulation 107 Valid 6 12/04/2026 12/04/2026 12/31/2028 DTAP 12/04/20191 12/09/2019 12/28/2019 02/24/2020 DTAP 12/04/2019

DTaP, unspecified formulation 107 Not Valid Age: Too Young 12/04/2019 DTaP, unspecified formulation 107 Not Valid Age: Too Young 5 06/04/2023 06/04/2023 06/04/2023 DTAP 12/04/2019

DTaP, unspecified formulation 107 Valid 12/04/2019 TD(GENERIC) 09 MBL Valid 7 12/04/2019 12/04/2019 04/22/2020 DTAP 12/04/20193 01/01/2020 01/01/2020 01/31/2020 DTAP 12/04/20193 01/01/2020 01/01/2020 01/31/2020 DTAP 12/04/20194 06/04/2020 06/04/2020 07/30/2020 DTAP 12/04/2019

DTaP, unspecified formulation 107 Valid 5 12/04/2026 12/04/2026 12/31/2028 DTAP 12/04/2019DTaP, unspecified formulation 107 Not Valid Age: Too Young 12/04/2019 BOOSTRIX 115 SKB Valid 6 12/04/2024 12/04/2029 12/31/2029 DTAP 12/04/2019

2 01/01/2020 01/11/2020 03/09/2020 DTAP 12/04/20193 01/01/2020 03/10/2020 05/07/2020 DTAP 12/04/20193 12/31/2019 02/12/2020 04/08/2020 DTAP 12/04/20192 01/05/2020 02/27/2020 04/23/2020 DTAP 12/04/20193 01/01/2020 01/11/2020 03/09/2020 DTAP 12/04/20194 11/22/2020 11/22/2020 04/18/2021 DTAP 12/04/20194 11/27/2020 11/27/2020 04/23/2021 DTAP 12/04/20195 12/02/2022 12/02/2022 12/01/2025 DTAP 12/04/20195 11/28/2022 11/28/2022 11/27/2025 DTAP 12/04/20195 12/04/2022 12/04/2022 12/03/2025 DTAP 12/04/20194 06/04/2020 06/04/2020 07/27/2020 DTAP 12/04/20194 06/04/2020 06/04/2020 06/04/2020 DTAP 12/04/20192 01/01/2020 02/23/2020 04/19/2020 DTAP 12/04/20194 06/04/2020 06/04/2020 07/31/2020 DTAP 12/04/2019

DTaP, unspecified formulation 107 Not Valid Interval: too short 12/04/2019 BOOSTRIX 115 SKB Valid 6 12/04/2024 12/04/2029 12/31/2029 DTAP 12/04/20194 06/04/2020 06/04/2020 07/01/2020 DTAP 12/04/20194 06/04/2020 06/04/2020 07/31/2020 DTAP 12/04/20193 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20195 08/30/2022 08/30/2022 08/29/2025 DTAP 12/04/2019

BOOSTRIX 115 SKB Not Valid Age: Too Young 5 06/04/2020 06/04/2020 12/08/2022 DTAP 12/04/2019

BOOSTRIX 115 SKB Valid 6 12/08/2026 12/08/2026 01/04/2029 DTAP 12/04/2019

BOOSTRIX 115 SKB Valid 6 12/04/2026 12/04/2026 12/31/2028 DTAP 12/04/20192 01/01/2020 01/01/2020 01/01/2020 DTAP 12/04/20192 01/01/2020 02/04/2020 03/31/2020 DTAP 12/04/20193 06/04/2020 06/04/2020 06/04/2020 DTAP 12/04/2019

4 04/26/2023 04/26/2023 05/23/2025 DTAP 12/04/20191 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/2019

DTaP, unspecified formulation 107 Valid 12/04/2019 BOOSTRIX 115 SKB Valid 7 12/04/2024 12/04/2029 12/31/2029 DTAP 12/04/2019

5 05/05/2002 05/05/2002 05/05/2002 DTAP 05/05/2002DTaP, unspecified formulation 107 Valid 6 12/12/2010 12/12/2010 01/08/2013 DTAP 12/01/2004BOOSTRIX 115 SKB Valid 6 03/18/2012 03/18/2017 04/14/2017 DTAP 03/18/2007

2 01/01/2020 01/01/2020 01/01/2020 DTAP 12/04/20192 07/29/2011 09/01/2011 10/28/2011 DTAP 07/01/20115 02/02/2012 02/02/2012 02/01/2015 DTAP 05/19/2009

TRIHIBIT 50 PMC Valid 6 10/08/2017 10/08/2017 11/04/2019 DTAP 10/09/20105 09/25/2022 09/25/2022 09/24/2025 DTAP 12/04/20192 01/01/2020 02/04/2020 03/31/2020 DTAP 12/04/20193 01/01/2020 02/04/2020 03/31/2020 DTAP 12/04/20194 09/04/2020 09/04/2020 01/31/2021 DTAP 12/04/20195 12/04/2022 12/04/2022 12/03/2025 DTAP 12/04/2019

KINRIX 130 SKB Valid 6 12/04/2026 12/04/2026 12/31/2028 DTAP 12/04/2019KINRIX 130 SKB Not Valid Age: Too Young 5 06/04/2020 06/04/2020 12/08/2022 DTAP 12/04/2019

2 01/01/2020 01/01/2020 01/01/2020 DTAP 12/04/2019

KINRIX 130 SKB Valid 6 12/08/2026 12/08/2026 01/04/2029 DTAP 12/04/20191 01/15/2020 02/04/2020 03/31/2020 DTAP 12/04/20193 06/04/2020 06/04/2020 06/04/2020 DTAP 12/04/20193 01/01/2020 01/01/2020 01/01/2020 DTAP 12/04/20193 06/04/2020 06/04/2020 06/04/2020 DTAP 12/04/20193 06/04/2020 06/04/2020 06/04/2020 DTAP 12/04/20193 01/01/2020 03/02/2020 04/29/2020 DTAP 12/04/20194 12/01/2020 12/01/2020 04/28/2021 DTAP 12/04/20194 09/24/2020 09/24/2020 02/20/2021 DTAP 12/04/20194 06/04/2020 06/04/2020 06/04/2020 DTAP 12/04/20194 06/04/2020 06/04/2020 08/05/2020 DTAP 12/04/20191 12/09/2019 12/28/2019 02/24/2020 DTAP 12/04/20195 12/08/2022 12/08/2022 12/07/2025 DTAP 12/04/20195 06/04/2020 06/04/2020 12/19/2022 DTAP 12/04/2019

5 12/04/2026 12/04/2026 12/31/2028 DTAP 12/04/2019PEDIARIX 110 SKB Not Valid Age: Too Young 5 06/04/2020 06/04/2020 12/08/2022 DTAP 12/04/2019

PEDIARIX 110 SKB Valid 6 12/08/2026 12/08/2026 01/04/2029 DTAP 12/04/2019

PEDIARIX 110 SKB Valid 6 12/20/2023 12/20/2023 01/16/2026 DTAP 12/04/2019

PEDIARIX 110 SKB Valid 6 12/04/2023 12/04/2023 12/31/2025 DTAP 12/04/20192 01/01/2020 01/04/2020 03/02/2020 DTAP 12/04/20193 01/01/2020 01/01/2020 01/31/2020 DTAP 12/04/20194 06/04/2020 06/04/2020 07/31/2020 DTAP 12/04/20192 01/05/2020 02/27/2020 04/23/2020 DTAP 12/04/20192 01/01/2020 01/09/2020 03/07/2020 DTAP 12/04/20193 01/01/2020 03/12/2020 05/09/2020 DTAP 12/04/20193 01/01/2020 01/11/2020 03/09/2020 DTAP 12/04/20194 10/10/2020 10/10/2020 03/09/2021 DTAP 12/04/20195 10/04/2022 10/04/2022 10/03/2025 DTAP 12/04/20195 10/04/2022 10/04/2022 10/03/2025 DTAP 12/04/20195 10/04/2022 10/04/2022 10/03/2025 DTAP 12/04/2019

Vaccine_Name_5 CVX_5 MVX_5 Evaluation_Status_5 Evaluation_Reason_5 Date_Administred_6 Vaccine_Name_6 CVX_6 MVX_6 Evaluation_Status_6 Evaluation_Reason_6 Date_Administred_7 Vaccine_Name_7 CVX_7 MVX_7 Evaluation_Status_7 Evaluation_Reason_7 Forecast_# Earliest_Date Recommended_Date Past_Due_Date Vaccine_Group Assessment_Date3 01/01/2020 02/04/2020 03/31/2020 DTAP 12/04/20194 06/04/2020 06/04/2020 07/31/2020 DTAP 12/04/20192 01/01/2020 02/23/2020 04/19/2020 DTAP 12/04/2019

PEDIARIX 110 SKB Valid 5 12/02/2026 12/02/2026 12/29/2028 DTAP 12/04/20192 01/01/2020 01/01/2020 01/01/2020 DTAP 12/04/20192 01/01/2020 01/01/2020 01/01/2020 DTAP 12/04/20192 01/01/2020 01/30/2020 03/28/2020 DTAP 12/04/20193 01/05/2020 03/29/2020 05/26/2020 DTAP 12/04/20193 01/01/2020 03/25/2020 05/22/2020 DTAP 12/04/20191 01/15/2020 02/04/2020 03/31/2020 DTAP 12/04/2019

3 05/18/2020 05/18/2020 05/18/2020 DTAP 12/04/20193 01/01/2020 01/01/2020 01/01/2020 DTAP 12/04/20193 06/04/2020 06/04/2020 06/04/2020 DTAP 12/04/20193 01/01/2020 03/02/2020 04/29/2020 DTAP 12/04/20194 12/01/2020 12/01/2020 04/28/2021 DTAP 12/04/20194 06/04/2020 06/04/2020 06/04/2020 DTAP 12/04/20194 06/04/2020 06/04/2020 08/05/2020 DTAP 12/04/20195 12/08/2022 12/08/2022 12/07/2025 DTAP 12/04/20195 12/04/2022 12/04/2022 12/03/2025 DTAP 12/04/2019

5 12/04/2026 12/04/2026 12/31/2028 DTAP 12/04/2019

PENTACEL 120 PMC Valid 6 11/12/2026 11/12/2026 12/09/2028 DTAP 12/04/2019

5 12/04/2025 12/04/2025 12/31/2027 DTAP 12/04/20194 06/04/2020 06/04/2020 07/29/2020 DTAP 12/04/20194 06/04/2020 06/04/2020 06/24/2020 DTAP 12/04/20192 01/01/2020 01/17/2020 03/15/2020 DTAP 12/04/20193 01/01/2020 03/08/2020 05/05/2020 DTAP 12/04/20193 01/01/2020 01/11/2020 03/09/2020 DTAP 12/04/20194 10/10/2020 10/10/2020 03/09/2021 DTAP 12/04/20192 01/05/2020 02/27/2020 04/23/2020 DTAP 12/04/20195 10/08/2022 10/08/2022 10/07/2025 DTAP 12/04/20195 11/04/2022 11/04/2022 11/03/2025 DTAP 12/04/20193 01/01/2020 01/01/2020 02/09/2020 DTAP 12/04/20194 06/04/2020 06/04/2020 07/28/2020 DTAP 12/04/20192 01/01/2020 02/23/2020 04/19/2020 DTAP 12/04/20192 01/01/2020 01/01/2020 01/01/2020 DTAP 12/04/20192 01/01/2020 01/01/2020 01/01/2020 DTAP 12/04/20192 01/01/2020 01/30/2020 03/28/2020 DTAP 12/04/20193 01/05/2020 03/29/2020 05/26/2020 DTAP 12/04/20193 01/01/2020 01/01/2020 01/01/2020 DTAP 12/04/20195 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20194 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20194 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20192 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20195 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20194 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20194 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20193 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20195 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20195 12/04/2019 12/04/2019 12/04/2019 DTAP 12/04/20195 11/04/2022 11/04/2022 11/03/2025 DTAP 12/04/20194 05/29/2020 05/29/2020 07/01/2020 DTAP 12/04/2019

1 02/01/2020 02/01/2020 FLU 08/01/2019

3 07/01/2019 07/01/2019 FLU 12/29/2018

2 09/29/2019 09/29/2019 FLU 09/01/2019

2 11/12/2019 11/12/2019 FLU 10/15/2019

FLU 11/27/2019

1 11/01/2019 11/01/2019 FLU 10/15/2019

2 10/25/2019 10/25/2019 FLU 09/27/2019

2 10/29/2019 10/29/2019 FLU 10/01/2019

2 10/22/2019 10/22/2019 FLU 09/24/2019

FLU 09/25/2019

3 09/29/2019 09/29/2019 FLU 09/01/2019

1 07/01/2019 07/01/2019 FLU 11/27/2019- FLU 09/10/2019- FLU 09/04/2019

FLU 08/18/20192 09/28/2019 09/28/2019 FLU 09/01/20191 07/01/2019 07/01/2019 FLU 09/01/2019- FLU 09/01/20191 12/04/2020 12/04/2020 12/31/2021 HepA 12/04/2019- HepA 12/04/20192 06/04/2020 06/04/2020 12/31/2020 HepA 12/04/20191 12/09/2019 12/09/2019 01/05/2021 HepA 12/04/20192 06/08/2020 06/08/2020 01/04/2021 HepA 12/04/20192 06/04/2020 06/04/2020 12/31/2020 HepA 12/04/20192 06/04/2020 06/04/2020 07/06/2020 HepA 12/04/2019- HepA 12/04/2019- HepA 12/04/20192 05/29/2020 05/29/2020 05/29/2020 HepA 12/04/2019

- HepA 12/04/20191 12/04/2019 12/04/2019 12/31/2019 HepB 12/04/20192 01/01/2020 01/01/2020 02/07/2020 HepB 12/04/20193 04/26/2020 05/10/2020 07/07/2021 HepB 12/04/20193 04/22/2020 05/06/2020 07/03/2021 HepB 12/04/2019

4 12/09/2019 12/09/2019 12/11/2020 HepB 12/04/2019- HepB 12/04/2019- HepB 12/04/2019

4 12/09/2019 12/09/2019 01/15/2021 HepB 12/04/2019- HepB 12/04/2019- HepB 12/04/20192 04/04/2020 04/04/2020 07/31/2020 HepB 12/04/20192 01/01/2020 01/04/2020 03/31/2020 HepB 12/04/2019- HepB 12/04/20193 01/29/2020 01/29/2020 01/29/2020 HepB 12/04/2019

4 11/29/2019 11/29/2019 11/29/2019 HepB 12/04/2019- HepB 08/04/2004- HepB 08/02/2006- HepB 11/26/20062 01/01/2020 01/03/2020 03/30/2020 HepB 12/04/2019- HepB 01/01/2007

4 11/21/2002 11/21/2002 01/11/2004 HepB 11/16/2002- HepB 02/03/2007

Vaccine_Name_5 CVX_5 MVX_5 Evaluation_Status_5 Evaluation_Reason_5 Date_Administred_6 Vaccine_Name_6 CVX_6 MVX_6 Evaluation_Status_6 Evaluation_Reason_6 Date_Administred_7 Vaccine_Name_7 CVX_7 MVX_7 Evaluation_Status_7 Evaluation_Reason_7 Forecast_# Earliest_Date Recommended_Date Past_Due_Date Vaccine_Group Assessment_Date- HepB 02/20/20072 11/07/2006 11/10/2006 02/06/2007 HepB 10/10/20062 01/01/2020 01/01/2020 03/09/2020 HepB 12/04/20193 04/26/2020 05/10/2020 07/07/2021 HepB 12/04/20193 04/22/2020 05/06/2020 07/03/2021 HepB 12/04/2019

4 12/09/2019 12/24/2019 02/20/2021 HepB 12/04/2019- HepB 12/04/2019- HepB 12/04/20191 12/04/2019 12/04/2019 12/31/2019 HepB 12/04/20193 01/29/2020 01/29/2020 01/29/2020 HepB 12/04/20193 01/29/2020 01/29/2020 01/29/2020 HepB 12/04/20193 01/29/2020 01/29/2020 01/29/2020 HepB 12/04/20193 02/26/2020 02/26/2020 02/26/2020 HepB 12/04/20194 02/17/2020 03/02/2020 04/29/2021 HepB 12/04/20194 02/16/2020 03/01/2020 04/28/2021 HepB 12/04/2019- HepB 12/04/2019- HepB 12/04/20192 01/01/2020 01/01/2020 02/24/2020 HepB 12/04/2019- HepB 12/04/2019- HepB 12/04/2019- HepB 12/04/2019

PEDIARIX 110 SKB Extraneous Series Already Complete - HepB 12/04/2019PEDIARIX 110 SKB Extraneous Series Already Complete - HepB 12/04/2019PEDIARIX 110 SKB Extraneous Series Already Complete - HepB 12/04/2019PEDIARIX 110 SKB Extraneous Series Already Complete - HepB 12/04/2019

2 01/01/2020 01/01/2020 02/23/2020 HepB 12/04/20192 01/01/2020 01/01/2020 01/07/2020 HepB 12/04/20193 03/01/2020 03/10/2020 05/07/2021 HepB 12/04/2019

4 12/09/2019 12/19/2019 02/15/2021 HepB 12/04/2019- HepB 12/04/2019- HepB 12/04/2019- HepB 12/04/2019- HepB 12/04/2019- HepB 12/04/20193 01/29/2020 02/04/2020 03/31/2021 HepB 12/04/20192 01/01/2020 01/01/2020 02/19/2020 HepB 12/04/20192 01/01/2020 01/01/2020 01/01/2020 HepB 12/04/20192 01/01/2020 01/01/2020 01/01/2020 HepB 12/04/20193 03/16/2020 03/30/2020 05/27/2021 HepB 12/04/20193 03/15/2020 03/29/2020 05/26/2021 HepB 12/04/20193 03/11/2020 03/25/2020 05/22/2021 HepB 12/04/2019- HepB 12/04/2019- HepB 12/04/20192 01/01/2020 01/01/2020 01/28/2020 HepB 12/04/2019- HepB 12/04/20192 01/01/2020 01/01/2020 01/28/2020 HepB 12/04/2019- HepB 12/04/20192 01/01/2020 01/01/2020 01/28/2020 HepB 12/04/20193 01/29/2020 01/29/2020 01/29/2020 HepB 12/04/2019

- HepB 12/04/2019

1 12/04/2019 12/04/2019 12/04/2019 HepB 12/04/20193 02/26/2020 02/26/2020 02/26/2020 HepB 12/04/20191 01/15/2020 02/04/2020 03/31/2020 HIB 12/04/20191 12/09/2019 12/28/2019 02/24/2020 HIB 12/04/20192 01/05/2020 02/27/2020 04/23/2020 HIB 12/04/20192 01/04/2020 02/26/2020 04/22/2020 HIB 12/04/20192 01/01/2020 01/04/2020 03/02/2020 HIB 12/04/20192 01/01/2020 01/01/2020 02/28/2020 HIB 12/04/20192 01/01/2020 01/01/2020 01/01/2020 HIB 12/04/20192 01/01/2020 01/01/2020 01/01/2020 HIB 12/04/20192 01/29/2020 01/29/2020 01/29/2020 HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/2019

- HIB 12/04/2019

- HIB 12/04/20192 01/01/2020 01/30/2020 03/28/2020 HIB 12/04/20193 01/05/2020 03/29/2020 05/26/2020 HIB 12/04/20193 01/04/2020 03/28/2020 05/25/2020 HIB 12/04/20193 01/01/2020 02/04/2020 03/31/2020 HIB 12/04/20193 01/01/2020 01/04/2020 03/02/2020 HIB 12/04/20193 01/01/2020 01/01/2020 02/28/2020 HIB 12/04/2019

3 01/29/2020 01/29/2020 05/06/2020 HIB 12/04/20193 01/29/2020 01/29/2020 05/05/2020 HIB 12/04/2019- HIB 12/04/2019

- HIB 12/04/20192 01/01/2020 01/11/2020 03/09/2020 HIB 12/04/20193 01/01/2020 03/10/2020 05/07/2020 HIB 12/04/20193 01/01/2020 03/09/2020 05/06/2020 HIB 12/04/20193 01/01/2020 03/02/2020 04/29/2020 HIB 12/04/20194 06/04/2020 06/04/2020 10/31/2020 HIB 12/04/20193 01/01/2020 01/11/2020 03/09/2020 HIB 12/04/20194 07/10/2020 07/10/2020 12/07/2020 HIB 12/04/20194 07/06/2020 07/06/2020 12/03/2020 HIB 12/04/20194 01/29/2020 01/29/2020 05/06/2020 HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/20194 01/29/2020 01/29/2020 05/01/2020 HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/2019

- HIB 12/04/2019

- HIB 12/04/20191 01/15/2020 02/04/2020 03/31/2020 HIB 12/04/20193 09/29/2020 09/29/2020 02/25/2021 HIB 12/04/20193 09/28/2020 09/28/2020 02/24/2021 HIB 12/04/20193 01/29/2020 01/29/2020 05/01/2020 HIB 12/04/20194 07/04/2020 07/04/2020 12/01/2020 HIB 12/04/20194 01/29/2020 01/29/2020 06/21/2020 HIB 12/04/20194 01/29/2020 01/29/2020 05/31/2020 HIB 12/04/20194 01/29/2020 01/29/2020 05/06/2020 HIB 12/04/2019

- HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/20192 01/01/2020 01/01/2020 01/01/2020 HIB 12/04/20192 01/01/2020 01/01/2020 01/01/2020 HIB 12/04/2019- HIB 12/04/20192 01/01/2020 01/01/2020 01/01/2020 HIB 12/04/20192 01/01/2020 01/01/2020 01/01/2020 HIB 12/04/20192 01/29/2020 01/29/2020 01/29/2020 HIB 12/04/20192 01/29/2020 01/29/2020 01/29/2020 HIB 12/04/2019

Vaccine_Name_5 CVX_5 MVX_5 Evaluation_Status_5 Evaluation_Reason_5 Date_Administred_6 Vaccine_Name_6 CVX_6 MVX_6 Evaluation_Status_6 Evaluation_Reason_6 Date_Administred_7 Vaccine_Name_7 CVX_7 MVX_7 Evaluation_Status_7 Evaluation_Reason_7 Forecast_# Earliest_Date Recommended_Date Past_Due_Date Vaccine_Group Assessment_Date2 01/01/2020 01/01/2020 01/01/2020 HIB 12/04/20193 04/10/2020 04/10/2020 09/06/2020 HIB 12/04/20193 01/29/2020 01/29/2020 05/31/2020 HIB 12/04/20193 01/29/2020 01/29/2020 05/01/2020 HIB 12/04/20193 01/29/2020 01/29/2020 05/06/2020 HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/2019

- HIB 12/04/20193 01/26/2020 01/26/2020 03/25/2020 HIB 12/04/2019- HIB 12/04/20192 01/29/2020 01/29/2020 01/29/2020 HIB 12/04/2019- HIB 12/04/20192 01/29/2020 01/29/2020 01/29/2020 HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/20193 01/01/2020 01/04/2020 03/02/2020 HIB 12/04/2019- HIB 12/04/20193 01/01/2020 03/02/2020 04/29/2020 HIB 12/04/20193 01/01/2020 01/01/2020 01/31/2020 HIB 12/04/20193 01/01/2020 03/08/2020 05/05/2020 HIB 12/04/20193 01/01/2020 01/11/2020 03/09/2020 HIB 12/04/20192 01/01/2020 02/23/2020 04/19/2020 HIB 12/04/20192 01/05/2020 02/27/2020 04/23/2020 HIB 12/04/20191 12/09/2019 12/28/2019 02/24/2020 HIB 12/04/20193 01/05/2020 03/29/2020 05/26/2020 HIB 12/04/20192 01/01/2020 01/30/2020 03/28/2020 HIB 12/04/20194 09/01/2020 09/01/2020 01/28/2021 HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/20194 01/29/2020 01/29/2020 05/06/2020 HIB 12/04/2019- HIB 12/04/2019

- HIB 12/04/2019PENTACEL 120 PMC Extraneous Series Already Complete - HIB 12/04/2019

2 01/01/2020 01/17/2020 03/15/2020 HIB 12/04/20194 07/10/2020 07/10/2020 12/07/2020 HIB 12/04/2019- HIB 12/04/2019- HIB 12/04/20193 01/01/2020 01/01/2020 02/09/2020 HIB 12/04/20191 01/15/2020 02/04/2020 03/31/2020 HIB 12/04/2019

- HIB 12/04/20192 05/04/2020 06/04/2020 01/31/2021 HPV 12/04/20192 05/04/2020 06/04/2020 01/31/2021 HPV 12/04/20192 05/04/2020 06/04/2020 01/31/2021 HPV 12/04/20192 05/04/2020 06/04/2020 01/31/2021 HPV 12/04/20192 05/04/2020 06/04/2020 01/31/2021 HPV 12/04/20192 05/04/2020 06/04/2020 01/31/2021 HPV 12/04/20193 04/06/2020 05/06/2020 01/02/2021 HPV 12/04/20193 04/06/2020 05/06/2020 01/02/2021 HPV 12/04/20193 03/04/2020 04/04/2020 12/01/2020 HPV 12/04/20193 04/07/2020 05/07/2020 01/03/2021 HPV 12/04/2019

2 04/11/2020 05/11/2020 01/07/2021 HPV 12/04/20193 04/06/2020 05/06/2020 01/02/2021 HPV 12/04/20193 03/04/2020 04/04/2020 12/01/2020 HPV 12/04/2019- HPV 08/20/2011- HPV 12/04/2019- HPV 12/04/2019- HPV 08/20/2011- HPV 12/04/2019- HPV 12/04/2019

2 01/01/2020 01/01/2020 03/24/2020 HPV 12/04/20192 09/27/2011 10/27/2011 06/23/2012 HPV 04/27/20112 10/01/2011 11/01/2011 06/28/2012 HPV 05/01/20112 10/01/2011 11/01/2011 06/28/2012 HPV 05/01/20111 05/01/2011 05/01/2013 05/28/2015 HPV 04/28/20111 05/01/2011 05/01/2013 05/28/2015 HPV 04/27/20111 05/01/2011 05/01/2013 05/28/2015 HPV 05/01/20111 05/01/2011 05/01/2011 05/28/2013 HPV 05/01/20113 09/28/2011 10/28/2011 06/24/2012 HPV 05/25/20113 10/01/2011 11/01/2011 06/28/2012 HPV 05/29/20113 10/01/2011 11/01/2011 06/28/2012 HPV 07/01/20111 05/22/2011 05/01/2013 05/28/2015 HPV 05/22/2011- HPV 10/16/2011- HPV 11/01/20111 10/19/2011 05/01/2013 05/28/2015 HPV 10/19/20111 11/01/2011 11/01/2011 05/28/2013 HPV 11/01/2011

2 05/30/2012 05/30/2012 08/21/2012 HPV 05/02/20123 04/06/2020 05/06/2020 01/02/2021 HPV 12/04/20193 04/10/2020 05/10/2020 01/06/2021 HPV 12/04/20192 04/11/2020 05/11/2020 01/07/2021 HPV 12/04/20193 03/04/2020 04/04/2020 12/01/2020 HPV 12/04/2019- HPV 08/21/2011- HPV 08/25/20113 02/26/2020 02/26/2020 10/08/2020 HPV 12/04/2019- HPV 12/04/2019- HPV 12/04/2019- HPV 08/21/20101 12/09/2019 12/09/2021 01/05/2024 HPV 12/04/20192 05/04/2020 06/04/2020 01/31/2021 HPV 12/04/20192 04/20/2020 05/20/2020 01/16/2021 HPV 12/04/2019- HPV 12/04/2019- HPV 12/04/20191 12/09/2019 12/09/2021 01/05/2024 HPV 12/04/20192 05/04/2020 06/04/2020 01/31/2021 HPV 12/04/20193 04/06/2020 05/06/2020 01/02/2021 HPV 12/04/2019- HPV 10/19/20111 01/08/2020 01/08/2022 02/04/2024 HPV 12/04/20193 04/09/2020 05/09/2020 01/05/2021 HPV 12/04/20193 04/06/2020 05/06/2020 01/02/2021 HPV 12/04/2019- HPV 03/22/2011- HPV 03/22/2012

HPV 12/04/20192 04/11/2020 05/11/2020 01/07/2021 HPV 12/04/20193 04/06/2020 05/06/2020 01/02/2021 HPV 12/04/20191 06/27/2020 06/27/2022 07/24/2024 HPV 12/04/20193 02/26/2020 02/26/2020 09/12/2020 HPV 12/04/2019- HPV 02/08/2011- HPV 02/12/2011

3 10/23/2008 10/23/2008 06/14/2009 HPV 08/07/2008- HPV 08/08/2008- HPV 12/04/2019- HPV 12/04/2019- HPV 12/04/2019- HPV 12/04/2019

Vaccine_Name_5 CVX_5 MVX_5 Evaluation_Status_5 Evaluation_Reason_5 Date_Administred_6 Vaccine_Name_6 CVX_6 MVX_6 Evaluation_Status_6 Evaluation_Reason_6 Date_Administred_7 Vaccine_Name_7 CVX_7 MVX_7 Evaluation_Status_7 Evaluation_Reason_7 Forecast_# Earliest_Date Recommended_Date Past_Due_Date Vaccine_Group Assessment_Date

- HPV 12/04/20191 12/04/2014 12/04/2016 12/31/2018 HPV 12/04/20191 06/20/2011 06/20/2011 07/15/2013 HPV 06/20/20111 12/09/2019 12/09/2021 01/05/2024 HPV 12/04/20192 05/04/2020 06/04/2020 01/31/2021 HPV 12/04/20192 05/04/2020 06/04/2020 01/31/2021 HPV 12/04/20191 12/04/2002 12/04/2004 12/31/2006 HPV 12/04/2019- HPV 12/04/20191 07/04/2013 07/04/2015 07/31/2017 HPV 12/04/20192 01/01/2020 01/01/2020 03/24/2020 HPV 12/04/20193 04/06/2020 05/06/2020 07/03/2020 HPV 12/04/2019- HPV 12/04/20193 03/04/2020 04/04/2020 12/01/2020 HPV 12/04/20191 12/05/2013 12/05/2015 01/01/2018 HPV 12/04/20193 02/24/2020 02/24/2020 09/03/2020 HPV 12/04/2019- HPV 12/04/2019- HPV 12/04/20192 01/01/2020 01/01/2020 03/24/2020 HPV 12/04/20191 12/04/2002 12/04/2004 12/31/2006 HPV 12/04/20192 12/04/2024 12/04/2024 12/31/2025 MCV 12/04/2019- MCV 12/04/20192 01/29/2020 01/29/2020 01/05/2021 MCV 12/04/2019- MCV 12/04/2019- MCV 12/04/2019

2 10/14/2025 10/14/2025 11/10/2026 MCV 12/04/2019

2 10/09/2025 10/09/2025 11/05/2026 MCV 12/04/2019

2 12/04/2025 12/04/2025 12/31/2026 MCV 12/04/20191 12/05/2020 12/05/2020 01/01/2023 MCV 12/04/2019

2 10/13/2025 10/13/2025 11/09/2026 MCV 12/04/20191 12/04/2020 12/04/2020 12/31/2022 MCV 12/04/20192 08/14/2024 08/14/2024 09/10/2025 MCV 12/04/2019- MCV 12/04/2019- MCV 12/04/20192 12/04/2024 12/04/2024 12/31/2025 MCV 12/04/2019- MCV 12/04/20192 11/26/2020 11/26/2020 12/23/2021 MCV 12/04/20192 01/29/2020 01/29/2020 01/05/2021 MCV 12/04/2019- MCV 12/04/2019- MCV 12/04/20192 01/01/2020 09/04/2022 10/01/2025 MMR 12/04/2019- MMR 12/04/20192 01/01/2020 01/01/2020 01/01/2020 MMR 12/04/2019

mumps 07 Valid 2 12/29/2019 12/29/2019 10/31/2021 MMR 12/04/20192 01/01/2020 01/01/2020 12/31/2021 MMR 12/04/20191 01/04/2020 01/04/2020 05/01/2020 MMR 12/04/20191 01/01/2020 01/01/2020 03/24/2020 MMR 12/04/2019

MERUVAX II 06 MSD Valid 10/30/2019 mumps 07 Extraneous Series Already Complete 12/04/2019 ATTENUVAX 05 MSD Valid - MMR 12/04/20192 01/01/2020 08/11/2022 09/07/2025 MMR 12/04/20192 01/04/2020 12/04/2022 12/31/2025 MMR 12/04/2019

MERUVAX II 06 MSD Valid 12/04/2019 ATTENUVAX 05 MSD Valid - MMR 12/04/20191 01/01/2020 01/01/2020 01/01/2020 MMR 12/04/20191 01/01/2020 01/01/2020 05/06/2020 MMR 12/04/20192 01/08/2020 12/08/2022 01/04/2026 MMR 12/04/20192 01/04/2020 12/04/2022 12/31/2025 MMR 12/04/20191 12/04/2020 12/04/2020 05/01/2021 MMR 12/04/2019- MMR 12/04/20192 01/04/2020 12/04/2022 12/31/2025 MMR 12/04/2019- MMR 12/04/20191 01/01/2020 01/01/2020 04/01/2020 MMR 12/04/20192 01/01/2020 11/06/2022 12/03/2025 MMR 12/04/20191 01/01/2020 01/01/2020 05/06/2020 MMR 12/04/20192 01/08/2020 12/08/2022 01/04/2026 MMR 12/04/2019- MMR 12/04/2019- MMR 12/04/20192 01/01/2020 10/10/2022 11/06/2025 MMR 12/04/2019- MMR 12/04/20192 01/01/2020 10/10/2022 11/06/2025 MMR 12/04/2019- MMR 12/04/20192 01/01/2020 10/27/2022 11/23/2025 MMR 12/04/20192 01/01/2020 11/11/2022 12/08/2025 MMR 12/04/20191 01/01/2020 01/01/2020 04/12/2020 MMR 12/04/20191 01/01/2020 01/01/2020 04/12/2020 MMR 12/04/2019- MMR 12/04/20192 01/01/2020 11/09/2022 12/06/2025 MMR 12/04/2019- MMR 12/04/2019- MMR 12/04/20192 01/01/2020 08/11/2021 09/07/2024 MMR 12/04/2019- MMR 12/04/2019- MMR 03/23/20151 12/04/1985 12/04/1985 05/01/1986 MMR 12/04/2019- MMR 12/04/20191 12/04/2004 12/04/2004 05/01/2005 MMR 12/04/20190 MMR 12/04/20192 01/01/2020 01/01/2020 01/01/2020 MMR 12/04/20190 MMR 12/04/20191 01/15/2020 02/04/2020 03/31/2020 PCV 12/04/20192 01/29/2020 01/29/2020 01/29/2020 PCV 12/04/20192 04/26/2010 04/26/2010 04/26/2010 PCV 03/01/2010- PCV 12/04/20192 01/01/2020 01/30/2020 03/28/2020 PCV 12/04/20193 01/05/2020 03/29/2020 05/26/2020 PCV 12/04/20193 01/01/2020 03/25/2020 05/22/2020 PCV 12/04/20193 01/01/2020 02/04/2020 03/31/2020 PCV 12/04/20193 12/04/2019 12/04/2019 05/01/2020 PCV 12/04/20192 01/29/2020 01/29/2020 01/29/2020 PCV 12/04/2019- PCV 12/04/2019- PCV 12/04/20192 01/29/2020 01/29/2020 01/29/2020 PCV 12/04/2019- PCV 12/04/20193 01/01/2020 03/02/2020 04/29/2020 PCV 12/04/20194 09/01/2020 09/01/2020 01/28/2021 PCV 12/04/20194 08/28/2020 08/28/2020 01/24/2021 PCV 12/04/20194 06/04/2020 06/04/2020 10/31/2020 PCV 12/04/2019- PCV 03/04/2011- PCV 06/01/20101 12/09/2019 12/28/2019 02/24/2020 PCV 12/04/20193 01/29/2020 01/29/2020 05/01/2020 PCV 12/04/20194 01/29/2020 01/29/2020 05/06/2020 PCV 12/04/2019- PCV 12/04/2019- PCV 12/04/2019

5 08/26/2010 08/26/2010 08/26/2010 PCV 07/01/20103 01/01/2020 01/01/2020 01/31/2020 PCV 12/04/20193 01/01/2020 01/04/2020 03/02/2020 PCV 12/04/2019- PCV 12/04/20192 01/01/2020 01/11/2020 03/09/2020 PCV 12/04/20193 01/01/2020 03/10/2020 05/07/2020 PCV 12/04/20192 01/05/2020 02/27/2020 04/23/2020 PCV 12/04/20193 01/01/2020 03/06/2020 05/03/2020 PCV 12/04/20193 01/01/2020 01/11/2020 03/09/2020 PCV 12/04/20194 06/10/2020 06/10/2020 11/06/2020 PCV 12/04/20194 06/06/2020 06/06/2020 11/02/2020 PCV 12/04/20194 01/29/2020 01/29/2020 04/10/2020 PCV 12/04/2019

Vaccine_Name_5 CVX_5 MVX_5 Evaluation_Status_5 Evaluation_Reason_5 Date_Administred_6 Vaccine_Name_6 CVX_6 MVX_6 Evaluation_Status_6 Evaluation_Reason_6 Date_Administred_7 Vaccine_Name_7 CVX_7 MVX_7 Evaluation_Status_7 Evaluation_Reason_7 Forecast_# Earliest_Date Recommended_Date Past_Due_Date Vaccine_Group Assessment_Date- PCV 12/04/2019- PCV 12/04/2019- PCV 12/04/2019- PCV 12/04/2019

PREVNAR 13 133 PFR Valid - PCV 12/04/20192 01/01/2020 02/23/2020 04/19/2020 PCV 12/04/2019

PREVNAR 13 133 PFR Valid - PCV 03/05/20122 01/01/2020 02/04/2020 03/31/2020 PCV 12/04/20192 01/01/2020 01/01/2020 01/01/2020 PCV 12/04/20192 01/29/2020 01/29/2020 01/29/2020 PCV 12/04/2019- PCV 12/04/20192 12/04/2020 12/04/2020 PCV 12/04/2019

PCV 12/04/20191 12/04/2019 12/04/2019 PCV 12/04/2019

PCV 12/04/20191 01/15/2020 02/04/2020 03/31/2020 POL 12/04/20193 01/01/2020 03/25/2020 05/22/2021 POL 12/04/20193 01/01/2020 02/04/2020 03/31/2021 POL 12/04/20193 01/01/2020 01/01/2020 01/01/2020 POL 12/04/2019

3 06/04/2020 06/04/2020 12/31/2022 POL 12/04/20193 01/01/2020 03/02/2020 04/29/2021 POL 12/04/20194 09/01/2023 09/01/2023 09/28/2026 POL 12/04/20194 08/28/2023 08/28/2023 09/24/2026 POL 12/04/20194 06/04/2023 06/04/2023 07/01/2026 POL 12/04/20194 05/24/2020 05/24/2020 01/15/2023 POL 12/04/20194 06/04/2020 06/04/2020 01/05/2023 POL 12/04/2019

3 06/04/2020 06/04/2020 12/03/2022 POL 12/04/20194 06/04/2020 06/04/2020 01/04/2023 POL 12/04/2019- POL 12/04/2019

4 06/04/2020 06/04/2020 12/31/2022 POL 12/04/2019- POL 12/04/20195 06/04/2022 06/04/2022 07/01/2025 POL 12/04/20195 06/04/2020 06/04/2020 01/05/2023 POL 12/04/2019- POL 12/04/2019- POL 12/04/20193 12/25/2019 12/25/2019 01/23/2021 POL 12/04/20193 01/01/2020 01/01/2020 01/31/2021 POL 12/04/2019- POL 12/04/20192 01/01/2020 01/11/2020 03/09/2020 POL 12/04/20193 01/01/2020 03/10/2020 05/07/2021 POL 12/04/20193 01/01/2020 03/06/2020 05/03/2021 POL 12/04/20193 01/01/2020 01/11/2020 03/10/2021 POL 12/04/20194 08/28/2023 08/28/2023 09/24/2026 POL 12/04/20194 07/06/2023 07/06/2023 08/02/2026 POL 12/04/2019

5 05/29/2020 05/29/2020 12/01/2022 POL 12/04/2019- POL 12/04/2019- POL 12/04/20191 12/09/2019 12/28/2019 02/24/2020 POL 12/04/20193 01/01/2020 01/01/2020 01/31/2021 POL 12/04/2019- POL 12/04/2019

- POL 10/16/2016

- POL 04/17/20162 01/01/2020 02/04/2020 03/31/2020 POL 12/04/20193 01/01/2020 02/04/2020 03/31/2021 POL 12/04/20194 06/04/2023 06/04/2023 07/01/2026 POL 12/04/2019

5 11/09/2022 11/09/2022 12/06/2025 POL 12/04/2019- POL 12/04/20192 01/05/2020 02/27/2020 04/23/2020 POL 12/04/2019

5 06/04/2020 06/04/2020 01/05/2023 POL 12/04/2019- POL 12/04/20192 01/01/2020 02/23/2020 04/19/2020 POL 12/04/20192 01/01/2020 02/04/2020 03/31/2020 POL 12/04/20192 01/01/2020 01/30/2020 03/28/2020 POL 12/04/20193 01/05/2020 03/29/2020 05/26/2021 POL 12/04/20191 01/15/2020 02/04/2020 03/31/2020 POL 12/04/20193 06/04/2020 06/04/2020 06/04/2020 POL 12/04/20193 06/04/2020 06/04/2020 06/04/2020 POL 12/04/20193 06/04/2020 06/04/2020 06/04/2020 POL 12/04/20193 06/04/2020 06/04/2020 06/04/2020 POL 12/04/2019

3 01/01/2020 03/02/2020 04/29/2021 POL 12/04/20194 09/01/2023 09/01/2023 09/28/2026 POL 12/04/20194 06/24/2023 06/24/2023 07/21/2026 POL 12/04/20194 06/23/2023 06/23/2023 07/20/2026 POL 12/04/2019- POL 12/04/20195 12/09/2022 12/09/2022 01/05/2026 POL 12/04/20191 12/09/2019 12/28/2019 02/24/2020 POL 12/04/20195 12/08/2022 12/08/2022 01/04/2026 POL 12/04/20195 06/04/2020 06/04/2020 01/16/2023 POL 12/04/2019- POL 12/04/2019

PEDIARIX 110 SKB Not Valid Age: Too Young 5 06/04/2020 06/04/2020 01/05/2023 POL 12/04/2019PEDIARIX 110 SKB Valid - POL 12/04/2019PEDIARIX 110 SKB Valid - POL 12/04/2019PEDIARIX 110 SKB Valid - POL 12/04/2019

2 01/01/2020 01/04/2020 03/02/2020 POL 12/04/2019

3 01/01/2020 01/01/2020 01/31/2021 POL 12/04/20194 12/04/2022 12/04/2022 12/31/2025 POL 12/04/20192 01/05/2020 02/27/2020 04/23/2020 POL 12/04/20192 01/01/2020 01/09/2020 03/07/2020 POL 12/04/2019

3 01/01/2020 03/10/2020 05/07/2021 POL 12/04/20193 01/01/2020 01/11/2020 03/10/2021 POL 12/04/20194 07/10/2023 07/10/2023 08/06/2026 POL 12/04/20195 10/08/2022 10/08/2022 11/04/2025 POL 12/04/2019

3 01/01/2020 02/04/2020 03/31/2021 POL 12/04/20194 12/04/2022 12/04/2022 12/31/2025 POL 12/04/20192 01/01/2020 02/23/2020 04/19/2020 POL 12/04/20192 01/01/2020 01/01/2020 01/01/2020 POL 12/04/20192 01/01/2020 01/01/2020 01/01/2020 POL 12/04/20192 01/01/2020 01/30/2020 03/28/2020 POL 12/04/20193 01/05/2020 03/29/2020 05/26/2021 POL 12/04/20193 01/01/2020 03/25/2020 05/22/2021 POL 12/04/20191 01/15/2020 02/04/2020 03/31/2020 POL 12/04/20193 06/04/2020 06/04/2020 06/04/2020 POL 12/04/20193 06/04/2020 06/04/2020 06/04/2020 POL 12/04/20193 06/04/2020 06/04/2020 06/04/2020 POL 12/04/2019

3 01/01/2020 03/02/2020 04/29/2021 POL 12/04/20194 09/01/2023 09/01/2023 09/28/2026 POL 12/04/2019- POL 12/04/20195 12/09/2022 12/09/2022 01/05/2026 POL 12/04/20195 12/08/2022 12/08/2022 01/04/2026 POL 12/04/20195 12/04/2022 12/04/2022 12/31/2025 POL 12/04/2019- POL 12/04/20191 12/09/2019 12/28/2019 02/24/2020 POL 12/04/2019

PENTACEL 120 PMC Valid - POL 12/04/2019

Vaccine_Name_5 CVX_5 MVX_5 Evaluation_Status_5 Evaluation_Reason_5 Date_Administred_6 Vaccine_Name_6 CVX_6 MVX_6 Evaluation_Status_6 Evaluation_Reason_6 Date_Administred_7 Vaccine_Name_7 CVX_7 MVX_7 Evaluation_Status_7 Evaluation_Reason_7 Forecast_# Earliest_Date Recommended_Date Past_Due_Date Vaccine_Group Assessment_Date- POL 12/04/20193 01/01/2020 01/01/2020 01/31/2021 POL 12/04/20194 12/02/2022 12/02/2022 12/29/2025 POL 12/04/20194 10/28/2022 10/28/2022 11/24/2025 POL 12/04/20192 01/01/2020 01/17/2020 03/15/2020 POL 12/04/20193 01/01/2020 03/08/2020 05/05/2021 POL 12/04/20193 01/01/2020 01/11/2020 03/10/2021 POL 12/04/20194 07/10/2023 07/10/2023 08/06/2026 POL 12/04/20192 01/05/2020 02/27/2020 04/23/2020 POL 12/04/20195 10/08/2022 10/08/2022 11/04/2025 POL 12/04/20193 01/01/2020 01/01/2020 02/09/2021 POL 12/04/20194 12/01/2022 12/01/2022 12/28/2025 POL 12/04/20192 01/01/2020 02/23/2020 04/19/2020 POL 12/04/20192 01/01/2020 01/01/2020 01/01/2020 POL 12/04/20192 01/01/2020 01/01/2020 01/01/2020 POL 12/04/20192 01/01/2020 01/30/2020 03/28/2020 POL 12/04/20193 01/05/2020 03/29/2020 05/26/2021 POL 12/04/20193 06/04/2020 06/04/2020 12/31/2020 POL 12/04/20191 01/15/2020 02/04/2020 ROTA 12/04/2019- ROTA 12/04/2019- ROTA 12/04/20192 01/01/2020 01/23/2020 03/21/2020 ROTA 12/04/20193 01/01/2020 03/22/2020 05/19/2020 ROTA 12/04/20193 01/01/2020 03/18/2020 05/15/2020 ROTA 12/04/20193 01/01/2020 02/10/2020 04/06/2020 ROTA 12/04/2019- ROTA 12/04/2019- ROTA 12/04/20191 12/09/2019 12/28/2019 ROTA 12/04/20192 01/05/2020 02/27/2020 04/23/2020 ROTA 12/04/20191 12/09/2019 12/28/2019 ROTA 12/04/20192 01/01/2020 02/23/2020 04/19/2020 ROTA 12/04/20192 01/01/2020 01/30/2020 03/28/2020 ROTA 12/04/2019- ROTA 12/04/2019- ROTA 12/04/20192 01/01/2020 01/11/2020 03/09/2020 ROTA 12/04/2019- ROTA 12/04/2019- ROTA 12/04/2019- ROTA 12/04/20192 01/01/2020 01/01/2020 02/13/2020 ROTA 12/04/20192 08/01/2019 08/04/2019 10/01/2019 ROTA 12/04/20192 01/05/2020 02/27/2020 04/23/2020 ROTA 12/04/20193 01/01/2020 02/04/2020 03/31/2020 ROTA 12/04/20193 01/01/2020 02/04/2020 03/31/2020 ROTA 12/04/20193 01/01/2020 02/04/2020 03/31/2020 ROTA 12/04/20192 01/01/2020 02/23/2020 04/19/2020 ROTA 12/04/20192 01/01/2020 01/30/2020 03/28/2020 ROTA 12/04/20193 01/05/2020 03/29/2020 05/26/2020 ROTA 12/04/20193 01/01/2020 03/25/2020 05/22/2020 ROTA 12/04/20193 01/01/2020 03/02/2020 04/29/2020 ROTA 12/04/2019- ROTA 12/04/20192 02/26/2020 09/04/2022 10/01/2025 VAR 12/04/20191 12/05/2007 12/05/2007 05/02/2008 VAR 12/04/20192 03/04/2020 12/04/2022 12/31/2025 VAR 12/04/20191 01/01/2020 01/01/2020 05/06/2020 VAR 12/04/20192 03/08/2020 12/08/2022 01/04/2026 VAR 12/04/20191 12/04/2020 12/04/2020 05/01/2021 VAR 12/04/2019- VAR 12/04/20192 02/26/2020 11/06/2022 12/03/2025 VAR 12/04/2019- VAR 12/04/20192 01/01/2020 01/01/2020 01/28/2020 VAR 12/04/2019- VAR 12/04/2019- VAR 12/04/20192 03/04/2020 12/04/2022 12/31/2025 VAR 12/04/20192 02/26/2020 11/06/2022 12/03/2025 VAR 12/04/20191 01/01/2020 01/01/2020 04/03/2020 VAR 12/04/20192 02/26/2020 11/06/2022 12/03/2025 VAR 12/04/20191 01/01/2020 01/01/2020 05/06/2020 VAR 12/04/20191 01/01/2020 01/01/2020 05/06/2020 VAR 12/04/20192 03/08/2020 12/08/2022 01/04/2026 VAR 12/04/20192 03/04/2020 12/04/2022 12/31/2025 VAR 12/04/2019- VAR 12/04/2019- VAR 12/04/20192 02/25/2020 02/25/2020 11/08/2022 VAR 12/04/20192 02/26/2020 11/06/2022 12/03/2025 VAR 12/04/20191 01/01/2020 01/01/2020 04/02/2020 VAR 12/04/2019- VAR 12/04/2019- VAR 12/04/20192 02/26/2020 11/11/2022 12/08/2025 VAR 12/04/20191 01/01/2020 01/01/2020 04/11/2020 VAR 12/04/20191 01/01/2020 01/01/2020 01/01/2020 VAR 12/04/20192 02/26/2020 11/06/2020 12/03/2023 VAR 12/04/20191 01/01/2020 01/01/2020 04/15/2020 VAR 12/04/20192 02/26/2020 11/06/2022 12/03/2025 VAR 12/04/2019- VAR 12/04/20192 01/01/2020 01/01/2020 01/28/2020 VAR 12/04/20192 01/01/2020 01/01/2020 01/28/2020 VAR 12/04/2019- VAR 12/04/20191 12/04/1998 12/04/1998 05/01/1999 VAR 12/04/2019

VAR 12/04/2019VAR 12/04/2019

01/01/2020 01/01/2020 01/28/2020 VAR 12/04/2019

2 01/29/2020 01/29/2020 ZOSTER 12/04/2019

2 01/29/2020 01/29/2020 ZOSTER 12/04/2019

1 11/18/2007 11/18/2007 ZOSTER 12/04/2019

2 01/29/2020 01/29/2020 ZOSTER 12/04/2019

1 01/29/2020 01/29/2020 ZOSTER 12/04/20192 01/29/2020 01/29/2020 07/31/2020 ZOSTER 12/04/2019- ZOSTER 12/04/2019- ZOSTER 12/04/2019- ZOSTER 12/04/2019

ZOSTER 12/04/20191 12/04/2019 12/04/2019 ZOSTER 12/04/2019

3 01/29/2020 01/29/2020 07/31/2020 ZOSTER 12/04/20193 01/29/2020 01/29/2020 07/31/2020 ZOSTER 12/04/20192 01/29/2020 01/29/2020 07/31/2020 ZOSTER 12/04/20192 01/29/2020 01/29/2020 07/31/2020 ZOSTER 12/04/20193 01/29/2020 01/29/2020 07/31/2020 ZOSTER 12/04/2019- ZOSTER 12/04/20192 01/24/2020 01/24/2020 07/26/2020 ZOSTER 12/04/2019- ZOSTER 12/04/20193 12/04/2019 12/04/2019 06/05/2020 ZOSTER 12/04/2019

Evaluation_Test_Type Date_Added Date_Updated Forecast_Test_Type Reason_For_ChangeNo Doses Administered 01/01/2013 04/05/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 04/05/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 10/31/2017 Recommended based on ageAge: At Minimum 01/01/2013 10/31/2017 Recommended based on ageAge: At Recommended 01/01/2013 10/31/2017 Recommended based on ageAge: At Minimum 01/01/2013 10/31/2017 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.Age: At Minimum 01/01/2013 10/31/2017 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.Interval: At Absolute Minimum 01/01/2013 10/31/2017 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.Age: Below Absolute Minimum 01/01/2013 10/31/2017 Recommended based on ageNo Doses Administered 01/01/2013 10/31/2017 Recommended based on ageAge: At Absolute Minimum 01/01/2013 11/01/2017 Recommended based on age V3.3: Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 monthsAge: At Minimum 01/01/2013 11/01/2017 Recommended based on age Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 monthsAge: At Recommended 01/01/2013 11/01/2017 Recommended based on age Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 monthsAll Valid: Forecast Test 01/01/2013 11/01/2017 Recommended based on minimum interval from previous dose (catch-up)

All Valid: Forecast Test 01/01/2013 02/08/2019 Recommended based on intervalV4.0: Updated Forecast per new Tdap Catch-up Job-Aid. Tdap is needed at 11 years.V1.1: Past Due Date was missing. Added past due date per NIPInfo guidance.

All Valid: Forecast Test 01/01/2013 02/08/2019 Recommended based on intervalV4.0: Updated Forecast per new Tdap Catch-up Job-Aid. Tdap is needed at 11 years.V1.1: Past Due Date was missing. Added past due date per NIPInfo guidance.

Interval: Below Absolute Minimum 01/01/2013 08/24/2018 Recommended based on minimum interval from invalid dose Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.

Interval: At Absolute Minimum 01/01/2013 11/15/2019 Recommended based on interval

V4.2: Mild adjustments to relative date settings to avoid administration dates in the future. Test case expectations (e.g, evaluation status or forecast) have not changed.V4.0: Updated Forecast per new Tdap Catch-up Job-Aid. Tdap is needed at 11 years.V1.1: Past Due Date was missing. Added past due date per NIPInfo guidance.

All Valid: Forecast Test 01/01/2013 11/01/2017 Recommended based on ageNo Doses Administered 01/01/2013 11/01/2017 Recommended based on age Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.All Valid: Forecast Test 01/01/2013 11/01/2017 Recommended based on minimum interval from previous dose (catch-up) V1.1: Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.Age: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on minimum interval from inValid doseAge: At Absolute Minimum 01/01/2013 11/01/2017 Recommended based on ageAge: At Recommended 01/01/2013 11/01/2017 Recommended based on age

All Valid: Forecast Test 01/01/2013 03/27/2018 Recommended based on ageV3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.


Age: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on minimum interval from invalid dose

Age: At Absolute Minimum 01/01/2013 03/27/2018 Recommended based on ageV3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.

Age: At Minimum 01/01/2013 03/27/2018 Recommended based on ageV3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.

Age: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on ageExtra Doses 01/01/2013 11/01/2017 Recommended based on age Updated Forecast number from 6 to 5

All Valid: Forecast Test 01/01/2013 03/27/2018 Recommended based on minimum interval from previous dose (catch-up)V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV2.2.: New logic concerning Tdap

Age: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on minimum interval from previous dose (catch-up)Interval: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on minimum interval from invalid doseAge: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on minimum interval from invalid dose

Age: Below Absolute Minimum 01/01/2013 03/27/2018 Recommended based on ageV3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.

Age: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on interval Past Due Date was missing. Added past due date per NIPInfo guidance.Interval: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 11/01/2017 Recommended based on ageInterval: At Minimum 01/01/2013 11/01/2017 Recommended based on ageAge: At Absolute Minimum 01/01/2013 11/01/2017 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 04/23/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 11/01/2017 Recommended based on age Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 monthsInterval: At Minimum 01/01/2013 11/01/2017 Recommended based on age Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 monthsAll Valid: Forecast Test 01/01/2013 11/08/2017 Recommended based on ageInterval: At Minimum 01/01/2013 11/01/2017 Recommended based on ageInterval: At Minimum 01/01/2013 11/01/2017 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on minimum interval from invalid doseInterval: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on minimum interval from invalid doseAge: At Minimum 01/01/2013 11/01/2017 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on minimum interval from inValid doseInterval: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on interval V1.4: Updated past due date to align with EIPB guidance clarification on past due date and other test cases.Vaccine: Invalid Usage 01/01/2013 11/01/2017 Recommended based on minimum interval from previous dose (catch-up)Vaccine: Invalid Usage 01/01/2013 11/01/2017 Recommended based on minimum interval from previous dose (catch-up)Vaccine: Invalid Usage 01/01/2013 11/01/2017 Recommended based on minimum interval from invalid doseVaccine: Off Label 01/01/2013 11/01/2017 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 11/01/2017 Recommended based on minimum interval from invalid dose

Age: At Absolute Minimum 01/01/2013 03/27/2018 Recommended based on ageV3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.

Vaccine: Off Label 01/01/2013 03/27/2018 Recommended based on ageV3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV1.1: Past Due Date was missing. Added past due date of 13 years - 1 day to be consistent with supporting data a logic specficiation business rule calculations.

All Valid: Forecast Test 01/01/2013 11/01/2017 Recommended based on minimum interval from previous dose (catch-up)Age: At Recommended 01/01/2013 11/01/2017 Recommended based on ageInterval: At Minimum 01/01/2013 11/01/2017 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.

Interval: At Minimum 01/01/2013 02/08/2019 Recommended based on intervalV4.0: Updated Forecast per new Tdap Catch-up Job-Aid. Tdap is needed at 11 years.V1.1: Past Due Date was missing. Added past due date per NIPInfo guidance.

Age: Below Absolute Minimum 01/01/2013 11/06/2017 Recommended based on age Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.All Valid: Forecast Test 01/01/2013 11/06/2017 Recommended based on interval Past Due Date was missing. Added past due date per NIPInfo guidance.

All Valid: Forecast Test 01/01/2013 11/06/2017 Recommended based on ageUpdated due to new conditional skip logic which caused the next forecast dose to be administered at age 7 rather than age 8 due to need Pertussis dose. V1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.

All Valid: Forecast Test 01/01/2013 03/23/2018 Recommended based on age V1.4: Updated past due date to shift 1 day earlier to align with business rule calculation and other similar tests in the DTaP/Tdap/Td forecasting at 11 years.All Valid: Forecast Test 01/01/2013 11/06/2017 Recommended based on interval Past Due Date was missing. Added past due date per NIPInfo guidance.All Valid: Forecast Test 01/01/2013 05/31/2018 Recommended based on minimum interval from previous dose (catch-up) V3.5: Test case Recommended and Past Due Dates were incorrectly mapped when moving to new test case management tool. These were corrected in this version.Vaccine: Off Label 01/01/2013 11/06/2017 Recommended based on ageVaccine: Off Label 01/01/2013 11/06/2017 Recommended based on ageAll Valid: Forecast Test 01/01/2013 03/23/2018 Recommended based on age V1.4: Updated past due date to align with ACIP and other test cases to be 1 day before the 13th birthday.Vaccine: Off Label 01/01/2013 11/06/2017 Recommended based on ageVaccine: Off Label 01/01/2013 11/06/2017 Recommended based on ageVaccine: Off Label 01/01/2013 11/06/2017 Recommended based on ageVaccine: Off Label 01/01/2013 11/06/2017 Recommended based on age Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 monthsAge: At Minimum 01/01/2013 11/15/2017 Recommended based on age

Age: At Minimum 01/01/2013 03/27/2018 Recommended based on ageV3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV1.4: Updated past due date to align with ACIP and other test cases to be 1 day before the 13th birthday.

Age: Below Absolute Minimum 01/01/2013 11/06/2017 Recommended based on minimum interval from invalid doseVaccine: Off Label 01/01/2013 11/15/2017 Recommended based on minimum interval from previous dose (catch-up)

Age: At Absolute Minimum 01/01/2013 03/27/2018 Recommended based on ageV3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV1.1: Past Due Date was missing. Added past due date of 13 years - 1 day to be consistent with supporting data a logic specficiation business rule calculations.

No Doses Administered 01/01/2013 11/15/2017 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/08/2019 Recommended based on minimum interval from previous dose (catch-up) V4.0: Forecast updated to reflect new Tdap catch-up Job Aid. Forecast should be in 6 months from previous dose.All Valid: Forecast Test 01/01/2013 11/15/2017 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.All Valid: Forecast Test 01/01/2013 11/15/2017 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.Interval: At Minimum 01/01/2013 11/15/2017 Recommended based on minimum interval from previous dose (catch-up)Age: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on ageAge: At Absolute Minimum 01/01/2013 11/15/2017 Recommended based on age Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 monthsAll Valid: Forecast Test 01/01/2013 11/15/2017 Recommended based on age Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 monthsAll Valid: Forecast Test 01/01/2013 11/15/2017 Recommended based on minimum interval from previous dose (catch-up)Age: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on minimum interval from inValid doseAge: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on ageAge: At Absolute Minimum 01/01/2013 11/15/2017 Recommended based on ageAll Valid: Forecast Test 01/01/2013 11/15/2017 Recommended based on minimum interval from previous dose (catch-up)

All Valid: Forecast Test 01/01/2013 03/27/2018 Recommended based on ageV3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV1.1: Past Due Date was missing. Added past due date of 13 years - 1 day to be consistent with supporting data a logic specficiation business rule calculations.

Age: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on minimum interval from invalid dose

Age: At Absolute Minimum 01/01/2013 03/27/2018 Recommended based on ageV3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versions. V1.1: Past Due Date was missing. Added past due date of 13 years - 1 day to be consistent with supporting data a logic specficiation business rule calculations.

All Valid: Forecast Test 01/01/2013 03/27/2018 Recommended based on ageV3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV1.1: Past Due Date was missing. Added past due date of 13 years - 1 day to be consistent with supporting data a logic specficiation business rule calculations.

Vaccine: Off Label 01/01/2013 02/08/2019 Recommended based on ageV4.0: Updated forecast to recommend Tdap at 11-12 year dose per new Tdap Catch-up Job AidV1.4: Updated to reflect 10 year recurring dose since the DTaP at age 7 can count as the adolescent (11 - 12 year) Tdap dose per conversation with EIPB and guidance in MMWRs

Age: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on minimum interval from previous dose (catch-up)Interval: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on minimum interval from previous dose (catch-up)Age: At Absolute Minimum 01/01/2013 11/16/2017 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 11/16/2017 Recommended based on minimum interval from invalid doseInterval: At Absolute Minimum 01/01/2013 11/16/2017 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 11/16/2017 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 11/16/2017 Recommended based on age Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 monthsAll Valid: Forecast Test 01/01/2013 11/16/2017 Recommended based on ageAll Valid: Forecast Test 01/01/2013 11/16/2017 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 11/16/2017 Recommended based on age

Evaluation_Test_Type Date_Added Date_Updated Forecast_Test_Type Reason_For_ChangeInterval: Below Absolute Minimum 01/01/2013 11/16/2017 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 11/16/2017 Recommended based on minimum interval from previous dose (catch-up)Age: At Minimum 01/01/2013 11/16/2017 Recommended based on age

Interval: Below Absolute Minimum 01/01/2013 06/01/2018 Recommended based on age

V3.5: Dose 4 - intended to be invalid - was modified to be 4 months - 5 days from the previous dose. V3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV3.3: Updated per 2017 General Best Practice Guidelines which allows for an allowable interval of 4 months - 4 days.

All Valid: Forecast Test 01/01/2013 11/16/2017 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 11/16/2017 Recommended based on minimum interval from previous dose (catch-up)Age: Below Absolute Minimum 01/01/2013 11/16/2017 Recommended based on ageAge: At Absolute Minimum 01/01/2013 11/16/2017 Recommended based on ageAge: At Minimum 01/01/2013 11/16/2017 Recommended based on ageNo Doses Administered 01/01/2013 02/13/2018 Recommended based on age

All Valid: Forecast Test 01/01/2013 02/08/2019 Recommended based on minimum interval from previous dose (catch-up)

V4.0: Updated forecast to align with new Tdap Catch-up Job Aid. Forecast in 6 months.Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.Interval Priority Flag with Override allows for a vaccine to be given sooner than a previous date set by multiple vaccines.

All Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.All Valid: Forecast Test 01/01/2013 03/12/2018 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was missing and child is in catch-up. Past Due Date added to align with Recommended Date.Age: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on age Updated per 2017 General Best Practice Guidelines which allows for an allowable interval of 4 months - 4days.All Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)Age: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on minimum interval from inValid doseAge: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAge: At Minimum 01/01/2013 02/13/2018 Recommended based on age


All Valid: Forecast Test 01/01/2013 03/27/2018 Recommended based on ageV3.4: Updated Past Due Date to include missing 4 week buffer all other past due dates have. This was simply missing since the earliest of versionsV1.4: Updated past due date to align with ACIP and other test cases to be 1 day before the 13th birthday.


Age: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)Age: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)Interval: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 05/16/2018 Recommended based on age Updated per 2017 General Best Practice Guidelines which allows for an allowable interval of 4 months - 4days.Age: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)Interval: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)Age: At Minimum 01/01/2013 02/13/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 03/15/2016 02/13/2018 Recommended based on age New logic concerning TdapAll Valid: Forecast Test 03/15/2016 02/13/2018 Recommended based on age New logic concerning TdapAll Valid: Forecast Test 03/15/2016 02/13/2018 Recommended based on age New logic concerning TdapAll Valid: Forecast Test 03/15/2016 02/13/2018 Recommended based on age New logic concerning TdapAll Valid: Forecast Test 03/15/2016 02/13/2018 Recommended based on age New logic concerning TdapAll Valid: Forecast Test 03/15/2016 02/13/2018 Recommended based on age New logic concerning TdapAll Valid: Forecast Test 03/15/2016 02/13/2018 Recommended based on age New logic concerning TdapAll Valid: Forecast Test 03/15/2016 02/13/2018 Recommended based on age New logic concerning TdapAll Valid: Forecast Test 03/15/2016 02/13/2018 Recommended based on age New logic concerning TdapAll Valid: Forecast Test 03/15/2016 02/13/2018 Recommended based on age New logic concerning TdapAll Valid: Forecast Test 06/12/2017 02/13/2018 Recommended based on interval Updated to allow the grace period for dose #4 of DTaP.Interval: Below Absolute Minimum 06/12/2017 02/13/2018 Recommended based on interval

No Doses Administered 01/01/2013 08/21/2019 Recommended based on ageV4.1: Rolled test cases forward from 2018-19 season to 2019-2020 season.V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.

Interval: At Minimum 01/01/2013 08/21/2019 Recommended based on seasonal start dateV4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.

All Valid: Forecast Test 01/01/2013 08/21/2019 Recommended based on intervalV4.1: Rolled test cases forward from 2018-19 season to 2019-2020 season.V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.

All Valid: Forecast Test 01/01/2013 08/21/2019 Recommended based on intervalV4.1: Rolled test cases forward from 2018-2019 season to 2019-2020 season.V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.

All Valid: Forecast Test 01/01/2013 08/21/2019 Recommended based on seasonal start dateV4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.V3.5: Rolled test cases forward from 2016-17 season to 2017-18 season.

Age: Below Absolute Minimum 01/01/2013 08/21/2019 Recommended based on ageV4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.

Age: At Absolute Minimum 01/01/2013 08/21/2019 Recommended based on intervalV4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.

Age: At Minimum 01/01/2013 08/21/2019 Recommended based on intervalV4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.

Interval: Below Absolute Minimum 01/01/2013 08/21/2019 Recommended based on minimum interval from invalid doseV4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.

Interval: At Absolute Minimum 01/01/2013 08/21/2019 Recommended based on seasonal start dateV4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.

Interval: At Minimum 09/27/2016 08/21/2019 Recommended based on intervalV4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.V3.5: Rolled test cases forward from 2017-18 season to 2018-19 season.

No Doses Administered 11/26/2018 09/23/2019 Recommended based on ageV4.2: Updated forecast dose number from #2 to #1V4.1: Rolled test case forward from 2018-19 season to 2019-20 season.

All Valid: Forecast Test 11/26/2018 09/23/2019 Recommended based on seasonal start date V4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.All Valid: Forecast Test 11/26/2018 09/23/2019 Recommended based on seasonal start date V4.1: Rolled test cases forward from 2018-19 season to 2019-20 season.All Valid: Forecast Test 11/26/2018 09/23/2019 Recommended based on seasonal start dateAll Valid: Forecast Test 11/26/2018 09/23/2019 Recommended based on interval.No Doses Administered 11/26/2018 11/14/2019 Recommended based on seasonal dateAll Valid: Forecast Test 11/26/2018 11/14/2019 Not Recommended: series completeNo Doses Administered 01/01/2013 11/15/2017 Recommended based on ageInterval: At Minimum 01/01/2013 11/15/2017 Not recommended: series completeVaccine: Off Label 01/01/2013 11/15/2017 Recommended based on age Past Due Date was previously calculated based on an interval, but should have been calculated based on age of 24 months + 4 weeks - 1 dayAge: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on ageAge: At Absolute Minimum 01/01/2013 11/15/2017 Recommended based on age V1.1: Past Due Date was previously calculated based on an interval, but should have been calculated based on age of 24 months + 4 weeks - 1 dayAge: At Minimum 01/01/2013 11/15/2017 Recommended based on age Past Due Date was previously calculated based on an interval, but should have been calculated based on age of 24 months + 4 weeks - 1 dayInterval: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on minimum interval from invalid dose V1.1: Past Due Date was previously calculated based on an interval, but should have been calculated based on age of 24 months + 4 weeks - 1 dayInterval: At Absolute Minimum 01/01/2013 05/31/2018 Not recommended: series complete V3.5: Lowered Age from 8 years to 4 years to better associate with new Age Groupings. No Effective change to test case other than Age of patient and vaccinations.Age: At Minimum 01/01/2013 11/15/2017 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 08/24/2018 Recommended based on minimum interval from invalid dose Child is lapse enough that the Past Due Date should have been aligned with the earliest and recommended.

Interval: At Absolute Minimum 01/01/2013 08/24/2018 Not recommended: series completeNo Doses Administered 01/01/2013 02/09/2018 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 02/09/2018 Recommended based on minimum interval from invalid doseInterval: At Absolute Minimum 01/01/2013 02/09/2018 Recommended based on ageInterval: At Minimum 01/01/2013 02/09/2018 Recommended based on age

All Valid: Forecast Test 01/01/2013 11/14/2019 Recommended based on interval

V4.2: Updated Forecast Test Type to "Recommended based on interval"V4.1: Changed forecast to reflect new 4-dose guidance from CEB.v3.1: Changed dose 3 from not valid to valid due to Hep B 4 dose series

Interval: At Absolute Minimum 01/01/2013 02/09/2018 Not recommended: series completeInterval: At Minimum 01/01/2013 08/24/2018 Not recommended: series complete


V4.2: Updated Forecast Test Type to "Recommended based on interval".V4.1: Changed forecast to reflect new 4 dose guidance from CEB.V3.1: Changed dose 3 from valid to not valid due to Hep B 4 dose series

Interval: At Absolute Minimum 01/01/2013 02/09/2018 Not recommended: series completeInterval: At Minimum 01/01/2013 02/09/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 03/20/2018 Recommended based on minimum interval from previous dose (catch-up)Age: At Minimum 01/01/2013 02/09/2018 Recommended based on ageInterval: At Minimum 01/01/2013 03/20/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 02/09/2018 Recommended based on minimum interval from previous dose (catch-up)


V4.2: Updated Forecast Test Type to "Recommended base on interval"V4.1: Changed forecast to reflect new 4-dose guidance from CEB.V3.1: Changed dose 3 from not valid to valid due to recent clarifications. Also changed test case name to reflect a 4th dose is required.

All Valid: Forecast Test 01/01/2013 02/26/2018 Not recommended: series completeInterval: At Minimum 01/01/2013 02/26/2018 Not recommended: series completeInterval: At Absolute Minimum 01/01/2013 03/01/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 08/21/2019 Recommended based on age V4.1: Updated Forecast Recommended Age to 1 month instead of 4 weeks after birth.Interval: At Minimum 01/01/2013 02/26/2018 Not recommended: series complete


V4.2: Updated Forecast Test Type to "Recommended based on interval"V4.1: Changed forecast to reflect new 4 dose guidance from CEB.v3.1: Changed dose 3 from not valid to valid due to recent clarifications.

Interval: At Absolute Minimum 01/01/2013 02/26/2018 Not recommended: series complete

Evaluation_Test_Type Date_Added Date_Updated Forecast_Test_Type Reason_For_ChangeInterval: At Minimum 01/01/2013 02/26/2018 Not recommended: series completeAge: At Minimum 01/01/2013 02/26/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 02/09/2018 Recommended based on minimum interval from invalid doseAge: At Absolute Minimum 01/01/2013 02/09/2018 Recommended based on ageInterval: At Minimum 01/01/2013 02/09/2018 Recommended based on age


V4.2: Updated Forecast Test Type to "Recommended based on interval".V4.1: Changed forecast to reflect new 4-dose guidance from CEB.V3.1: Changed dose 3 to valid due to recent clarifications.

Age: At Absolute Minimum 01/01/2013 02/09/2018 Not recommended: series completeAge: At Minimum 01/01/2013 02/09/2018 Not recommended: series completeNo Doses Administered 01/01/2013 02/09/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/09/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 02/09/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 02/09/2018 Recommended based on minimum interval from previous dose (catch-up)Interval: At Minimum 01/01/2013 02/09/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 02/09/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/09/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 02/09/2018 Not recommended: series completeExtra Doses 01/01/2013 02/09/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 02/09/2018 Recommended based on minimum interval from previous dose (catch-up)Extra Doses 01/01/2013 02/09/2018 Not recommended: series completeExtra Doses 01/01/2013 02/09/2018 Not recommended: series completeExtra Doses 01/01/2013 02/09/2018 Not recommended: series completeExtra Doses 01/01/2013 02/09/2018 Not recommended: series completeExtra Doses 01/01/2013 02/09/2018 Not recommended: series completeExtra Doses 01/01/2013 02/09/2018 Not recommended: series completeExtra Doses 01/01/2013 02/09/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 02/09/2018 Recommended based on minimum interval from previous dose (catch-up)Interval: Below Absolute Minimum 01/01/2013 02/09/2018 Recommended based on minimum interval from invalid doseInterval: At Absolute Minimum 01/01/2013 02/09/2018 Recommended based on age


V4.2: Updated Forecast Test Type to "Recommended based on interval"V4.1: Changed forecast to reflect new 4-dose guidance from CEB.V3.1: Changed dose 3 from not valid to valid due to recent clarifications.

Interval: At Absolute Minimum 01/01/2013 02/09/2018 Not recommended: series completeExtra Doses 01/01/2013 02/09/2018 Not recommended: series completeExtra Doses 01/01/2013 02/09/2018 Not recommended: series completeExtra Doses 01/01/2013 02/09/2018 Not recommended: series completeExtra Doses 01/01/2013 02/09/2018 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on ageAll Valid: Forecast Test 12/02/2016 02/13/2018 Recommended based on interval Updated the evaluation type to All Valid: Forecast TestAll Valid: Forecast Test 01/30/2016 04/23/2018 Recommended based on interval Updated dose #3 to valid since the interval is now at 0 days in the third dose of the HepB 4 dose series and the fourth dose was administered at least 16 weeks from dose #1..

03/28/2018 04/20/201803/28/2018 04/20/201803/28/2018 08/20/2018 V3.5: Updated the earliest and recommended forecast to reflect 4 weeks after the second dose.03/28/2018 04/20/201804/11/2018 04/20/201804/11/2018 04/20/2018

04/11/2018 11/15/2019

V4.2: Mild adjustments to relative date settings to avoid administration dates in the future. Test case expectations (e.g, evaluation status or forecast) have not changed.v4.1: Updated dose #1 to reflect a valid dose based on Ask the Expert guidancev3.5: Updated dose #1 to reflect an invalid dose reason of Vaccine Dose Administered was administered at too young of an age.

04/12/2018 08/21/2019

v4.1: Updated forecast dates to reflect a 0 day interval for administration of any age appropriate HepB vaccine. v4.0: Updated dose #1 to reflect an invalid dose reason of 'Vaccine product was not a preferable or allowable vaccine for this series'.v3.5: Updated dose #1 to reflect an invalid dose reason of Vaccine Dose Administered was administered at too young of an age.

04/12/2018 05/23/2019No Doses Administered 01/01/2013 01/04/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 01/09/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was incorrect. Should be in alignment with the earliest and recommended. Child is in catch-up schedule.All Valid: Forecast Test 01/01/2013 01/04/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 01/04/2018 Not recommended: series complete

Age: Too Old 01/01/2013 01/04/2018 Not recommended: too old

v1.6: Updated Series Status from "Not Complete" to "Aged Out" to align with updated CDSi Logic Specification Series Statuses.

v1.2:Within the scope of the CDSi effort, Hib on or after 5 years is not recommended. The last administered dose was changed to Extraneous to reflect this.


v3.5: Lowered Age to be 6 year old to better align with new Age Groupings. No real effective change in test case other than age of patient and vaccination. Expectations remained the same.v1.6: Updated Series Status from "Not Complete" to "Aged Out" to align with updated CDSi Logic Specification Series Statuses.v1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended. The last administered dose was changed to Extraneous to reflect this.

Age: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on ageAge: At Recommended 01/01/2013 01/04/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on minimum interval from previous dose (catch-up)

All Valid: Forecast Test 01/01/2013 08/21/2019 Recommended based on minimum interval from previous dose (catch-up)V4.1: updated forecast dose number from 4 to 3.V4.0: updated forecast to recommend a dose in 8 weeks - previously 4 weeks - since the patient will be over 12 months old at the time of the next dose and the spacing should be 8 weeks.

All Valid: Forecast Test 01/01/2013 02/08/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 01/09/2018 Not recommended: series complete



v1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended. The last administered dose was changed to Extraneous to reflect this.Interval: Below Absolute Minimum 01/01/2013 01/09/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 01/09/2018 Recommended based on ageInterval: At Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on age Changed Doses 2 and 3 to be ACTHIB rather than PRP-OMP vaccines to avoid possible confusion with PRP-OMP product specific scheduleAge: At Recommended 01/01/2013 03/12/2018 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 03/12/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 03/12/2018 Recommended based on ageInterval: At Minimum 01/01/2013 03/12/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 01/09/2018 Recommended based on minimum interval from inValid doseAge: At Absolute Minimum 01/01/2013 01/09/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 01/09/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 01/09/2018 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 04/23/2018 Recommended based on minimum interval from inValid doseInterval: At Absolute Minimum 01/01/2013 04/23/2018 Not recommended: series completeAge: At Recommended 01/01/2013 01/09/2018 Not recommended: series complete



v1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended. The last administered dose was changed to Extraneous to reflect this.


V3.5: Lowered age of last vaccination from 7 years to 6 years to better align with new Age Groupings. No impact on test case expectations.v1.6: Updated Series Status from "Not Complete" to "Aged Out" to align with updated CDSi Logic Specification Series Statuses.v1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended. The last administered dose was changed to Extraneous to reflect this.

No Doses Administered 01/01/2013 01/09/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 01/09/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 03/12/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 03/12/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 03/12/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 03/12/2018 Recommended based on minimum interval from previous dose (catch-up)

All Valid: Forecast Test 01/01/2013 05/31/2018 Not recommended: series completeV3.5: Patient's age was incorrect. Age should have been 12 Months, not 12 years. No effective change to test case.V1.1: This patient should have been marked complete for Hib. No Further Doses Needed.

All Valid: Forecast Test 01/01/2013 02/13/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 03/12/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was incorrect. Should be in alignment with the earliest and recommended. Child is in catch-up schedule.All Valid: Forecast Test 01/01/2013 04/23/2018 Not recommended: series complete This patient should have been marked complete for Hib. No Further Doses Needed.All Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was incorrect. Should be in alignment with the earliest and recommended. Child is in catch-up schedule.All Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was incorrect. Should be in alignment with the earliest and recommended. Child is in catch-up schedule.All Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was incorrect. Should be in alignment with the earliest and recommended. Child is in catch-up schedule.

Evaluation_Test_Type Date_Added Date_Updated Forecast_Test_Type Reason_For_ChangeInterval: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on minimum interval from invalid doseInterval: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)Age: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on minimum interval from invalid dose Dose 3 was too young by 1 day according to the cath-up schedule. Evaluation of dose 3 was changed from valid to not valid with a reason of Age: Too Young which aligns with original test case evaluation test type and forecast test typeAge: At Absolute Minimum 01/01/2013 02/13/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 02/13/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 02/13/2018 Not recommended: series complete



v1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended. The last administered dose was changed to Extraneous to reflect this.All Valid: Forecast Test 01/01/2013 03/12/2018 Recommended based on minimum interval from previous dose (catch-up) Dose 3 should be invalid due to an interval violationAll Valid: Forecast Test 01/01/2013 03/12/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was incorrect. Should be in alignment with the earliest and recommended. Child is in catch-up schedule.All Valid: Forecast Test 01/01/2013 02/13/2018 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on minimum interval from invalid dose Condensed the past due date to align with the earliest and recommended date since this child is in catch-upInterval: At Absolute Minimum 01/01/2013 03/12/2018 Not recommended: series completeInterval: At Absolute Minimum 01/01/2013 02/13/2018 Not recommended: series completeExtra Doses 01/01/2013 02/13/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 02/13/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 02/13/2018 Not recommended: series completeExtra Doses 01/01/2013 02/13/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 02/13/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 02/13/2018 Not recommended: series completeAge: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on age Past Due Date was incorrectly calculated as it was missing the 4 week buffer for overdue.Age: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)Interval: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on age Past Due Date was incorrectly calculated as it was missing the 4 week buffer for overdue.Interval: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on age Past Due Date was incorrectly calculated as it was missing the 4 week buffer for overdue.Age: At Minimum 01/01/2013 02/13/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on age Past Due Date was incorrect based on recommendations.Age: At Minimum 01/01/2013 02/13/2018 Not recommended: series completeAge: At Absolute Minimum 01/01/2013 02/13/2018 Not recommended: series completeAge: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on minimum interval from invalid dose Past Due Date was incorrect based on recommendations.Extra Doses 01/01/2013 02/13/2018 Not recommended: series complete



v1.1: Changed Dose 3 vaccination date from 2/7/08 to 2/3/08 to avoid completion of series on dose 3 to properly test off-label usage on dose 4 as test case name indicates. Within the scope of the CDSi effort, Hib on or after 5 years is not recommended. The last administered dose was changed to Extraneous to reflect this.

Extra Doses 01/01/2013 02/13/2018 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on age Past Due Date was incorrect based on recommendations.Age: Below Absolute Minimum 01/01/2013 02/13/2018 Not recommended: series complete This patient should have been marked complete for Hib. No Further Doses Needed.Age: Below Absolute Minimum 01/01/2013 02/13/2018 Not recommended: series complete This patient should have been marked complete for Hib. No Further Doses Needed.Interval: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on minimum interval from previous dose (catch-up)No Doses Administered 01/01/2013 02/13/2018 Recommended based on age


V3.5: Changed age of patient and vaccination from 7 years to 6 years to better align with new Age Groupings. No effective change of test case expectations.v1.6: Updated Series Status from "Not Complete" to "Aged Out" to align with updated CDSi Logic Specification Series Statuses.v1.2: Within the scope of the CDSi effort, Hib on or after 5 years is not recommended. The last administered dose was changed to Extraneous to reflect this.

Age: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.Age: At Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.Age: At Recommended 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.Age: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.Age: At Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.Age: At Recommended 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.Interval: At Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.Interval: At Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series.Interval: At Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.Interval: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.

Interval: Below Absolute Minimum 01/01/2013 06/01/2018 Recommended based on intervalV3.5: Updated test case Forecast number from 3 to 2. There is only 1 valid dose, so this should be forecast dose number 2.V3.3: Updated test case Forecast number from 2 to 3

Interval: At Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine.Interval: At Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series.Interval: At Absolute Minimum 01/01/2013 03/20/2018 Not recommended: series complete Removal of Age requirements to allow for a more aligned dosing schedule based on intervals rather than age.Age: At Minimum 01/01/2013 10/30/2019 Not recommended: series complete Added a description.Age: At Recommended 01/01/2013 10/30/2019 Not recommended: series complete Added Description.Interval: At Absolute Minimum 01/01/2013 03/20/2018 Not recommended: series complete Removal of Age requirements to allow for a more aligned dosing schedule based on intervals rather than age.Age: At Minimum 01/01/2013 02/13/2018 Not recommended: series complete Dose 1 must be gardasil for it to be valid and match test case purpose.Age: At Recommended 01/01/2013 02/13/2018 Not recommended: series complete

Age: At Recommended 01/01/2013 03/27/2018 Recommended based on intervalV3.4: Earliest Recommended Date was changed from 8 weeks to 4 weeks on Dose 2 per HPV MMWR language. V3.0 Updated test came name and date of birth to reflect the age of 26 and to reflect that the second dose of the HPV vaccine should be forecasted.

Age: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.Age: At Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.Age: At Recommended 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.Inadvertent vaccine 01/01/2013 02/13/2018 Recommended based on age Updated reason code on dose #1 to Inadvertent vaccine: Inadvertent administrationInadvertent vaccine 01/01/2013 02/13/2018 Recommended based on age Updated reason code on dose #1 to Inadvertent vaccine. Inadvertent Administration.Inadvertent vaccine 01/01/2013 02/13/2018 Recommended based on age Updated reason code on dose #1 to Inadvertent vaccine. Inadvertent Administration.Inadvertent vaccine 01/01/2013 02/13/2018 Recommended based on age Updated the Earliest date to 05/01/2011Interval: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series.Interval: At Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series.Interval: At Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series.Inadvertent vaccine 01/01/2013 02/13/2018 Recommended based on age Updated the Earliest date to 05/22/2011Interval: At Minimum 01/01/2013 02/13/2018 Not recommended: series completeAge: At Recommended 01/01/2013 02/13/2018 Not recommended: series completeInadvertent vaccine 01/01/2013 02/13/2018 Recommended based on age Updated the Earliest date to reflect the last dose received.Inadvertent vaccine 01/01/2013 02/13/2018 Recommended based on age Updated the Earliest Date to reflect the last dose received.

Age: At Recommended 01/01/2013 06/01/2018 Recommended based on intervalV3.5: Updated Recommended Date to reflect change in supporting data (v3.6) from 8 weeks to 4 weeks.V3.0 Updated test came name and date of birth to reflect the age of 26 and to reflect that the second dose of the HPV vaccine should be forecasted.

Interval: At Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series.Interval: At Absolute Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series.Interval: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.Interval: At Recommended 01/01/2013 02/13/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series.Interval: At Minimum 01/01/2013 03/20/2018 Not recommended: series completeInterval: At Absolute Minimum 01/01/2013 03/20/2018 Not recommended: series completeInterval: At Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on minimum interval from invalid dose Updated the Forecasted Recommended Date to reflect current ACIP recommendation for interval from invalid dose.Interval: At Recommended 01/01/2013 02/13/2018 Not recommended: series completeInterval: At Minimum 01/01/2013 02/13/2018 Not recommended: series completeInterval: At Minimum 01/01/2013 03/20/2018 Not recommended: series completeAge: Below Absolute Minimum 01/01/2013 02/13/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 02/20/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.Interval: Below Absolute Minimum 01/01/2013 02/20/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.All Valid: Forecast Test 01/01/2013 02/20/2018 Not recommended: series complete Updated to reflect ACIP recommendations for the HPV 2 dose series.All Valid: Forecast Test 01/01/2013 02/20/2018 Not recommended: series complete Updated to reflect ACIP recommendations for the HPV 2 dose series.Age: Below Absolute Minimum 01/01/2013 02/20/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 02/20/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.Age: At Minimum 01/01/2013 02/20/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series.Age: Below Absolute Minimum 01/01/2013 03/20/2018 Not recommended: series completeNo Doses Administered 01/01/2013 02/20/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 02/20/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series.Interval: At Minimum 01/01/2013 02/20/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series.Interval: At Absolute Minimum 01/01/2013 03/20/2018 Not recommended: series complete Removal of Age requirements to allow for a more aligned dosing schedule based on intervals rather than age.Age: At Absolute Minimum 01/01/2013 03/20/2018 Not recommended: series complete

All Valid: Forecast Test 01/01/2013 11/14/2019 Not recommended: too oldV4.2: Updated test case to remove forecast dose for the third dose of HPV because patient will have reached age 27 before administration of the dose based on newly published MMWR for Shared Clinical Decision Making starting at 27 years.V4.0: Updated recommended and past due to reflect general best practice recommendations timing and spacing table 3-1 (Rec. Date in 4 months)

Interval: Below Absolute Minimum 01/01/2013 02/20/2018 Recommended based on minimum interval from previous dose (catch-up) Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.Interval: At Minimum 01/01/2013 02/20/2018 Recommended based on minimum interval from previous dose (catch-up) Updated to reflect ACIP recommendations for the HPV 2 dose series.No Doses Administered 01/01/2013 02/20/2018 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 04/23/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.Interval: At Absolute Minimum 01/01/2013 03/20/2018 Not recommended: series completeInterval: At Minimum 01/01/2013 03/20/2018 Not recommended: series complete

Interval: Below Absolute Minimum 01/01/2013 08/21/2019 Recommended based on minimum interval from invalid doseV4.1: Updated to meet ACIP recommendation concerning the 4 day grace period for the third dose prior to December 16.2016. V3.2: Updated to reflect current ACIP recommendations for forecasting of the earliest and recommended date which is set by 12 weeks from invalid dose.

Interval: At Minimum 01/01/2013 03/20/2018 Not recommended: series completeInterval: At Absolute Minimum 01/01/2013 02/20/2018 Not recommended: series completeAge: Below Absolute Minimum 01/01/2013 02/20/2018 Not recommended: series complete Updated to reflect ACIP recommendations for the HPV 2 dose series.Interval: Below Absolute Minimum 01/01/2013 02/20/2018 Not recommended: series complete Updated to reflect ACIP recommendations for the HPV 2 dose series.No Doses Administered 01/01/2013 02/20/2018 Not recommended: too old v1.6: Updated Series Status from "Not Complete" to "Aged Out" to align with updated CDSi Logic Specification Series Statuses.

Evaluation_Test_Type Date_Added Date_Updated Forecast_Test_Type Reason_For_Change

No Doses Administered 01/01/2013 02/20/2018 Not recommended: too old


v1.1: Gender should be M rather than F based on test case name; Also changed birth date to make patient 27 years old based on MMWR language allowing Males to be vaccinated through 26 years.No Doses Administered 01/01/2013 02/20/2018 Recommended based on ageInadvertent vaccine 01/01/2013 02/13/2018 Recommended based on age Updated to reflect an inadvertent vaccine: Inadvertent administration reasonAge: Below Absolute Minimum 01/01/2013 02/20/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 02/20/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.Age: At Minimum 01/01/2013 02/20/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval.No Doses Administered 10/13/2016 02/20/2018 Recommended based on ageAll Valid: Forecast Test 12/02/2016 02/20/2018 Not recommended: series completeNo Doses Administered 12/02/2016 02/20/2018 Recommended based on ageAll Valid: Forecast Test 12/02/2016 03/27/2018 Recommended based on interval V3.4: Earliest Recommended Date was changed from 8 weeks to 4 weeks on Dose 2 per HPV MMWR language.All Valid: Forecast Test 12/02/2016 02/20/2018 Recommended based on intervalAll Valid: Forecast Test 12/02/2016 02/20/2018 Not recommended: series completeAll Valid: Forecast Test 12/02/2016 02/20/2018 Recommended based on interval Updated to reflect ACIP recommendations for the HPV 2 dose series.No Doses Administered 12/02/2016 02/20/2018 Recommended based on interval Corrected forecast dates to match test case titleInterval: Below Absolute Minimum 12/02/2016 02/20/2018 Recommended based on interval Updated to reflect current ACIP recommendations for forecasting of the earliest and recommended date which is set by 12 weeks from invalid dose.All Valid: Forecast Test 12/02/2016 02/20/2018 Not recommended: series completeAll Valid: Forecast Test 03/02/2017 02/20/2018 Recommended based on intervalAll Valid: Forecast Test 07/01/2019 11/14/2019 Recommended based on interval v4.2: Added past due date.No Doses Administered 07/01/2019 08/26/2019 Recommended based on ageAge: At Minimum 01/01/2013 11/15/2017 Recommended based on age v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated. The second dose must come on or after 16 years (- 4 days) of age to be considered valid.Age: At Absolute Minimum 01/01/2013 11/15/2017 Not recommended: series complete v1.6: Updated Test case to reflect new absolute minimum age on dose 2 based on EIPB clarificationAge: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on minimum interval from invalid dose v1.6: Updated Test case to reflect new absolute minimum age on dose 2 based on EIPB clarificationAge: At Recommended 01/01/2013 11/15/2017 Not recommended: series completeInterval: At Recommended 01/01/2013 11/15/2017 Not recommended: series complete Test case was set to have the first dose at age 16 and second dose at 21 years. Test case was adjusted to be at 13 years and 18 years to avoid the 16 year age skip dose which is tested in another test

Age: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on agev1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated. The second dose must come on or after 16 years (- 4 days) of age to be considered valid.v1.2: Same test case as previous version rolled younger to allow for the 10 year clarification by NIPInfo

Age: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on minimum interval from invalid dosev1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated. The second dose must come on or after 16 years (- 4 days) of age to be considered valid.v1.2: Same test case as previous version rolled younger to allow for the 10 year clarification by NIPInfo

Age: At Absolute Minimum 01/01/2013 11/15/2017 Recommended based on agev1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated. The second dose must come on or after 16 years (- 4 days) of age to be considered valid.v1.2: Same test case as previous version rolled younger to allow for the 10 year clarification by NIPInfo

Age: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on age Same test case as previous version rolled younger to allow for the 10 year clarification by NIPInfo

Age: Below Absolute Minimum 01/01/2013 11/15/2017 Recommended based on agev1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated. The second dose must come on or after 16 years (- 4 days) of age to be considered valid.v1.2: Same test case as previous version rolled younger to allow for the 10 year clarification by NIPInfo

No Doses Administered 01/01/2013 05/29/2018 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 04/23/2018 Recommended based on age v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated. The second dose must come on or after 16 years (- 4 days) of age to be considered valid.Interval: At Absolute Minimum 01/01/2013 11/15/2017 Not recommended: series complete v1.6: updated to reflect interval without also testing age attributes. Simply made the patient olderInterval: At Minimum 01/01/2013 11/15/2017 Not recommended: series complete v1.6: updated to reflect interval without also testing age attributes. Simply made the patient olderAge: At Minimum 01/01/2013 11/15/2017 Recommended based on age v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated. The second dose must come on or after 16 years (- 4 days) of age to be considered valid.No Doses Administered 01/01/2013 11/15/2017 Not recommended: too old v1.6: Updated Series Status from "Not Complete" to "Aged Out" to align with updated CDSi Logic Specification Series Statuses.All Valid: Forecast Test 01/01/2013 11/15/2017 Recommended based on age v1.6: An EIPB clarification has resulted in a change to when dose 2 of MCV should be forecasted and validated. The second dose must come on or after 16 years (- 4 days) of age to be considered valid.All Valid: Forecast Test 01/01/2013 11/15/2017 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 11/15/2017 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 11/15/2017 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on age Renamed to better reflect test case.Age: At Recommended 01/01/2013 01/04/2018 Not recommended: series complete Renamed to better reflect test case.All Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on minimum interval from previous dose (catch-up) Renamed to better reflect test case.Single Antigen Administration 01/01/2013 03/19/2018 Recommended based on minimum interval from live virus vaccine Renamed to better reflect test case.Single Antigen Administration 01/01/2013 03/19/2018 Recommended based on minimum interval from live virus vaccine Renamed to better reflect test case.Single Antigen Administration 01/01/2013 08/22/2019 Recommended based on minimum interval from previous dose (catch-up) Renamed to better reflect test case. V1.4: Updated Earliest and Recommended date to adjust dates out 3 days. Previous recommendation was 4 weeks from single dose administration, but this would result in the dose being forecasted too early for the second Measles at 13 months.Single Antigen Administration 01/01/2013 08/21/2019 Recommended based on minimum interval from live virus vaccine V1.1: Renamed to better reflect test case.

Single Antigen Administration 01/01/2013 03/19/2018 Not recommended: series complete Renamed to better reflect test case.Single Antigen Administration 01/01/2013 03/19/2018 Recommended based on age Renamed to better reflect test case.Single Antigen Administration 01/01/2013 03/19/2018 Recommended based on age V1.1: Renamed to better reflect test case. V1.4: Updated Earliest date to reflect the earliest date of 13 months and not 12 months + 4 weeks to align with ACIP.Single Antigen Administration 01/01/2013 03/19/2018 Not recommended: series complete Renamed to better reflect test case.Single Antigen Administration 01/01/2013 08/22/2019 Recommended based on minimum interval from live virus vaccine Renamed to better reflect test case.Age: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from live virus vaccineAge: At Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Minimum 01/01/2013 01/04/2018 Recommended based on ageNo Doses Administered 01/01/2013 01/04/2018 Recommended based on ageInterval: At Minimum 01/01/2013 01/04/2018 Not recommended: series completeAge: At Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Minimum 01/01/2013 01/04/2018 Not recommended: series completeLive Virus: Below Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from live virus vaccineLive Virus: At Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from live virus vaccineAge: At Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageInterval: At Minimum 01/01/2013 01/04/2018 Not recommended: series completeInterval: At Minimum 01/01/2013 01/04/2018 Not recommended: series completeLive Virus: Below Minimum 01/01/2013 01/04/2018 Recommended based on age Shifted dates of administration and forecast to strictly test the Live Virus conflict only. Previously it was testing a couple conditionsInterval: At Minimum 01/01/2013 01/04/2018 Not recommended: series completeLive Virus: Below Minimum 01/01/2013 01/04/2018 Recommended based on age V1.4: Final Guidance for MMRV live virus spacing is 28 days. Grace period can't be applied.Interval: At Minimum 01/01/2013 01/04/2018 Not recommended: series completeInterval: At Minimum 01/01/2013 01/04/2018 Recommended based on ageLive Virus: At Minimum 01/01/2013 01/04/2018 Recommended based on ageLive Virus: Below Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from live virus vaccineLive Virus: Below Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from live virus vaccineSingle Antigen Administration 01/01/2013 03/19/2018 Not recommended: series completeAge: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 01/04/2018 Not recommended: series completeAge: At Minimum 01/01/2013 01/04/2018 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 01/04/2018 Not recommended: series completeNo Doses Administered 06/23/2015 03/01/2018 Not recommended: immune New test case for version 2.0 which expanded scope into Adult recommendationsNo Doses Administered 10/17/2018 11/14/2019 Recommended based on ageAll Valid: Forecast Test 09/22/2019 11/14/2019 Not recommended: series completeNo Doses Administered 11/11/2019 11/14/2019 Recommended based on ageAll Valid: Forecast Test 11/11/2019 11/15/2019 Not recommended: series completeInterval: Below Absolute Minimum 11/11/2019 11/15/2019 Recommended based on intervalAll Valid: Forecast Test 11/11/2019 11/15/2019 Not recommended: series completeNo Doses Administered 01/01/2013 03/19/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 12/18/2017 Recommended based on minimum interval from previous dose (catch-up) V1.3: The first dose was PCV7 and was marked as not valid. This dose is valid, but the patient still needs a valid PCV13.All Valid: Forecast Test 01/01/2013 01/04/2018 Not recommended: series completeAge: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Recommended 01/01/2013 01/04/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 02/20/2018 Recommended based on minimum interval from invalid dose Condensed the past due date to align with the earliest and recommended date since this child is in catch-upInterval: At Absolute Minimum 01/01/2013 01/04/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 01/04/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 02/13/2018 Not recommended: series completeAge: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Recommended 01/01/2013 01/04/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 03/02/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 03/02/2018 Not recommended: series complete Minor typo in test case name corrected.Age: Below Absolute Minimum 01/01/2013 10/17/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on minimum interval from invalid dose V1.2: At 12 Months of age and after the spacing must be 8 weeks or more. Dose 3 was given on 12 Months, but wasn't spaced 8 weeks. The forecast in this case remains unchanged.Age: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from inValid doseAge: At Absolute Minimum 01/01/2013 01/04/2018 Not recommended: series completeAge: At Minimum 01/01/2013 01/04/2018 Not recommended: series complete

All Valid: Forecast Test 01/01/2013 03/02/2018 Recommended based on minimum interval from previous dose (catch-up)The fourth dose of PCV7 was marked as Not Valid. In fact this was a valid administration with a need for a subsequent PCV13 in 8 weeks time. V1.3: Updated Eval and Forecast Test Type and adjusted the past due date to align with the earliest and recommended date per the subsequent dose recommendations of ACIP.

Age: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from previous dose (catch-up)Age: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 01/04/2018 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageInterval: At Minimum 01/01/2013 01/04/2018 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageInterval: At Minimum 01/01/2013 01/04/2018 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 08/20/2018 Recommended based on minimum interval from inValid dose

Evaluation_Test_Type Date_Added Date_Updated Forecast_Test_Type Reason_For_ChangeInterval: At Absolute Minimum 01/01/2013 08/20/2018 Not recommended: series completeInterval: At Minimum 01/01/2013 04/23/2018 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 01/04/2018 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 01/04/2018 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 01/04/2018 Not recommended: series completeAge: At Minimum 01/01/2013 01/04/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 03/02/2018 Not recommended: series complete The fourth dose of PCV7 was marked as Not Valid. In fact this was a valid administration. The PCV13 which followed completed the series. V1.3 updated Evaluation Test TypeAge: At Recommended 01/01/2013 01/04/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was incorrect. Should be in alignment with the earliest and recommended. Child is in catch-up schedule.All Valid: Forecast Test 06/23/2015 01/04/2018 Not recommended: series complete New test case for version 2.0 which expanded scope into Adult recommendations. Update due to MMWR (9/4/2015 / Vol.64 / No. 34) changing the minimal and recommended interval from PCV13 to PPSV23 in adults 65+ from 6-12 months to 1 year.All Valid: Forecast Test 06/23/2015 03/08/2018 Recommended based on interval New test case for version 2.0 which expanded scope into Adult recommendations. Update due to MMWR (9/4/2015 / Vol.64 / No. 34) changing the minimal and recommended interval from PCV13 to PPSV23 in adults 65+ from 6-12 months to 1 year.All Valid: Forecast Test 06/23/2015 11/04/2019 Recommended based on interval Test case updated per the new PCV recommendation (June 2019, ACIP Meeting) for healthy individuals >- 65 years.

07/01/2019 12/04/201907/01/2019 12/04/2019

No Doses Administered 01/01/2013 12/08/2017 Recommended based on ageAge: At Minimum 01/01/2013 12/08/2017 Recommended based on age Typo on Past Due Date by one year. Age: At Recommended 01/01/2013 12/08/2017 Recommended based on age Typo on Past Due Date by one year. All Valid: Forecast Test 01/01/2013 12/08/2017 Recommended based on minimum interval from previous dose (catch-up) Rolled all birth dates forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.


Updated Forecast dose number to 3.

Polio should continue to be recommended in 4 weeks. The dose should not be skipped until 4 years AND 6 months from previous dose. V2.1Age: Below Absolute Minimum 01/01/2013 12/08/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: At Absolute Minimum 01/01/2013 12/08/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: At Minimum 01/01/2013 12/08/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: At Recommended 01/01/2013 12/08/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.All Valid: Forecast Test 01/01/2013 03/20/2018 Recommended based on minimum interval from previous dose (catch-up) Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.All Valid: Forecast Test 01/01/2013 03/20/2018 Recommended based on minimum interval from previous dose (catch-up) Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.


Updated Forecast dose number to 3.

All Valid: Forecast Test 01/01/2013 03/20/2018 Recommended based on minimum interval from previous dose (catch-up) Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.All Valid: Forecast Test 01/01/2013 12/08/2017 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.

All Valid: Forecast Test 01/01/2013 03/20/2018 Recommended based on minimum interval from previous dose (catch-up)Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.

All Valid: Forecast Test 01/01/2013 12/08/2017 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.All Valid: Forecast Test 01/01/2013 12/08/2017 Recommended based on age Updated the 4rth dose as valid due to the new 5 dose IPV supporting data documentAll Valid: Forecast Test 01/01/2013 12/08/2017 Recommended based on age Updated the 4rth dose as valid due to the new 5 dose IPV supporting data documentAge: At Absolute Minimum 01/01/2013 12/08/2017 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: At Minimum 01/01/2013 12/08/2017 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: Below Absolute Minimum 01/01/2013 08/20/2018 Recommended based on minimum interval from previous dose (catch-up)Age: Below Absolute Minimum 01/01/2013 12/08/2017 Recommended based on minimum interval from previous dose (catch-up)Age: Below Absolute Minimum 01/01/2013 12/08/2017 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: Below Absolute Minimum 01/01/2013 12/15/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: At Absolute Minimum 01/01/2013 12/15/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: At Minimum 01/01/2013 12/15/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: Below Absolute Minimum 01/01/2013 12/15/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: At Absolute Minimum 01/01/2013 12/15/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: At Minimum 01/01/2013 12/19/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.

All Valid: Forecast Test 01/01/2013 08/24/2018 Recommended based on minimum interval V3.1: Updated the 4th dose as valid due to the new 5 dose IPV supporting data11/17/2016 Updated the Forecast # to Dose number 5 due to vaccine being administered too early

Interval: At Absolute Minimum 01/01/2013 12/19/2017 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: At Minimum 01/01/2013 12/19/2017 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on minimum interval from previous dose (catch-up) Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: Below Absolute Minimum 01/01/2013 12/19/2017 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.

All Valid: Forecast Test 01/01/2013 03/14/2018 Not recommended: series completev3.3: Changed test case to mark patient complete per updated recommendations from ACIP in January 2017.v1.5:Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.

All Valid: Forecast Test 01/01/2013 06/01/2018 Not recommended: series completeV3.5: Updated Assessment Date which wasn't rolled forward when other dates were rolled forward.V1.5: Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.

Vaccine: Off Label 01/01/2013 12/19/2017 Recommended based on ageVaccine: Off Label 01/01/2013 12/19/2017 Recommended based on ageVaccine: Off Label 01/01/2013 12/19/2017 Recommended based on age

All Valid: Forecast Test 01/01/2013 12/19/2017 Recommended based on age

Updated the 4rth dose as valid due to the new 5 dose IPV supporting data documentPrevious dates were before the ACIP recommendations were published.11/17/2016 Updated the Forecast # to Dose number 5 due to vaccine being administered too early

Age: At Minimum 01/01/2013 12/19/2017 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: At Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.

All Valid: Forecast Test 01/01/2013 12/19/2017 Recommended based on age

Updated the 4th dose as valid due to the new 5 dose IPV supporting data documentPrevious dates were before the ACIP recommendations were published.11/17/2016 Updated the Forecast # to Dose number 5 due to vaccine being administered too early

Age: At Absolute Minimum 01/01/2013 12/19/2017 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: At Minimum 01/01/2013 12/19/2017 Recommended based on ageAge: At Recommended 01/01/2013 12/19/2017 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: At Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Typo on Past Due Date by one year. No Doses Administered 01/01/2013 12/19/2017 Recommended based on ageAll Valid: Forecast Test 01/01/2013 12/19/2017 Recommended based on minimum interval from previous dose (catch-up) Updated the Forecast number dose to 3. Updated DOB to curb future date issues.Vaccine: Off Label 01/01/2013 12/19/2017 Recommended based on minimum interval from previous dose (catch-up) Updated the Forecast number dose to 3. Updated DOB to curb future date issues.Vaccine: Off Label 01/01/2013 12/19/2017 Recommended based on minimum interval from previous dose (catch-up) Updated the Forecast number dose to 3. Updated DOB to curb future date issues.Vaccine: Off Label 01/01/2013 12/19/2017 Recommended based on minimum interval from previous dose (catch-up) Updated the Forecast number dose to 3. Updated DOB to curb future date issues.

Age: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on ageRolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published. Typo on Past Due Date by one year. V2.1

Age: At Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.All Valid: Forecast Test 01/01/2013 12/19/2017 Recommended based on ageAll Valid: Forecast Test 01/01/2013 12/19/2017 Recommended based on ageAll Valid: Forecast Test 01/01/2013 12/19/2017 Not recommended: series complete Update to curb future administration datesAll Valid: Forecast Test 01/01/2013 12/19/2017 Recommended based on age Updated the 4rth dose as valid due to the new 5 dose IPV supporting data documentAge: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on ageAll Valid: Forecast Test 01/01/2013 12/19/2017 Recommended based on age Updated the 4rth dose as valid due to the new 5 dose IPV supporting data documentAll Valid: Forecast Test 01/01/2013 12/19/2017 Recommended based on age Updated the 4rth dose as valid due to the new 5 dose IPV supporting data documentAge: At Minimum 01/01/2013 12/19/2017 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Updated the Forecast dose number to 5.All Valid: Forecast Test 01/01/2013 12/19/2017 Not recommended: series complete Updated the 4rth dose as valid due to the new 5 dose IPV supporting data documentAge: Below Absolute Minimum 01/01/2013 12/19/2017 Not recommended: series complete Update to curb future vaccine administration datesVaccine: Off Label 01/01/2013 12/19/2017 Not recommended: series complete Updated to curb future vaccine adminstration datesAge: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age

Age: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on minimum interval from previous dose (catch-up)Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published. Typo on Past Due Date by one year. V2.1

Age: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: At Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.

Interval: At Absolute Minimum 01/01/2013 12/19/2017 Recommended based on ageRolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published. Typo on Past Due Date by one year. V2.1

Interval: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Typo on Past Due Date by one year. Interval: At Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.All Valid: Forecast Test 01/01/2013 04/23/2018 Recommended based on age Updated the 4rth dose as valid due to the new 5 dose IPV supporting data document

Interval: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on ageRolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published. Typo on Past Due Date by one year. V2.1

Interval: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: At Minimum 01/01/2013 12/19/2017 Recommended based on ageAll Valid: Forecast Test 01/01/2013 12/19/2017 Recommended based on minimum interval from previous dose (catch-up) Updated DOB to curb future date issues.Vaccine: Off Label 01/01/2013 12/19/2017 Recommended based on minimum interval from previous dose (catch-up) Updated DOB to curb future date issues.Age: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on ageAge: At Absolute Minimum 01/01/2013 12/19/2017 Recommended based on age Typo on Past Due Date by one year. Age: At Minimum 01/01/2013 12/19/2017 Recommended based on age Typo on Past Due Date by one year. No Doses Administered 01/01/2013 12/19/2017 Recommended based on ageVaccine: Off Label 01/01/2013 12/19/2017 Recommended based on minimum interval from previous dose (catch-up) Updated the Forecast Dose number to 3. Updated DOB to curb future date issues.Vaccine: Off Label 01/01/2013 12/19/2017 Recommended based on minimum interval from previous dose (catch-up) Updated the Forecast Dose number to 3. Updated DOB to curb future date issues.Vaccine: Off Label 01/01/2013 12/19/2017 Recommended based on minimum interval from previous dose (catch-up) Updated the Forecast Dose number to 3. Updated DOB to curb future date issues.

Age: Below Absolute Minimum 01/01/2013 12/19/2017 Recommended based on ageRolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published. Typo on Past Due Date by one year. V2.1

Age: At Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Vaccine: Off Label 01/01/2013 01/02/2018 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.All Valid: Forecast Test 01/01/2013 01/02/2018 Recommended based on age Updated the 4rth dose as valid due to the new 5 dose IPV supporting data documentAll Valid: Forecast Test 01/01/2013 01/02/2018 Recommended based on age Updated the 4rth dose as valid due to the new 5 dose IPV supporting data documentAll Valid: Forecast Test 01/01/2013 01/02/2018 Recommended based on age Updated the 4rth dose as valid due to the new 5 dose IPV supporting data documentAge: At Minimum 01/01/2013 01/02/2018 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: Below Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.All Valid: Forecast Test 01/01/2013 01/02/2018 Not recommended: series complete Updated the 4rth dose as valid due to the new 5 dose IPV supporting data document

Evaluation_Test_Type Date_Added Date_Updated Forecast_Test_Type Reason_For_ChangeVaccine: Off Label 01/01/2013 01/02/2018 Not recommended: series complete Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: Below Absolute Minimum 01/01/2013 01/02/2018 Recommended based on minimum interval from previous dose (catch-up) Typo on Past Due Date by one year. Age: Below Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: Below Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: Below Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: At Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: Below Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: At Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: At Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.All Valid: Forecast Test 01/01/2013 04/23/2018 Recommended based on age Updated the 4rth dose as valid due to the new 5 dose IPV supporting data documentInterval: Below Absolute Minimum 01/01/2013 01/02/2018 Recommended based on minimum interval from previous dose (catch-up) Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Interval: Below Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: At Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Vaccine: Off Label 01/01/2013 01/02/2018 Recommended based on minimum interval from previous dose (catch-up) Updated DOB to curb future date issues.Vaccine: Off Label 01/01/2013 01/02/2018 Recommended based on minimum interval from previous dose (catch-up) Updated DOB to curb future date issues.Age: Below Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Age: At Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age Rolled birth date forward to 2011 to ensure test was relevant to when ACIP recommendations were made. Previous dates were before the ACIP recommendations were published.Vaccine: Off Label 01/01/2013 01/02/2018 Recommended based on minimum interval from previous dose (catch-up) Updated the Forecast Dose number to 3. Updated DOB to curb future date issues.No Doses Administered 01/01/2013 11/15/2017 Recommended based on ageAge: At Minimum 01/01/2013 12/07/2017 Not recommended: series completeAge: At Recommended 01/01/2013 12/07/2017 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 12/07/2017 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 12/07/2017 Recommended based on ageInterval: At Minimum 01/01/2013 12/07/2017 Recommended based on ageInterval: Below Absolute Minimum 01/01/2013 12/07/2017 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 12/07/2017 Not recommended: series completeInterval: At Minimum 01/01/2013 12/07/2017 Not recommended: series completeAge: Below Absolute Minimum 01/01/2013 12/07/2017 Recommended based on ageAge: At Absolute Minimum 01/01/2013 12/07/2017 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 12/07/2017 Recommended based on ageAge: At Minimum 01/01/2013 12/07/2017 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 12/07/2017 Recommended based on ageAge: At Absolute Minimum 01/01/2013 12/07/2017 Not recommended: series completeAge: At Minimum 01/01/2013 12/07/2017 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 12/07/2017 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 12/07/2017 Not recommended: series completeInterval: At Minimum 01/01/2013 12/07/2017 Not recommended: series completeNo Doses Administered 01/01/2013 12/07/2017 Not recommended: too old v1.6: Updated Series Status from "Not Complete" to "Aged Out" to align with updated CDSi Logic Specification Series Statuses.All Valid: Forecast Test 01/01/2013 12/07/2017 Recommended based on minimum interval from previous dose (catch-up)All Valid: Forecast Test 01/01/2013 01/09/2018 Recommended based on age Child is exactly 8 months old based on the Assessment Date and should still be recommended for administration.Age: At Absolute Minimum 01/01/2013 12/07/2017 Recommended based on ageAge: At Recommended 01/01/2013 12/07/2017 Recommended based on ageAge: At Recommended 01/01/2013 12/07/2017 Recommended based on ageAge: At Recommended 01/01/2013 12/07/2017 Recommended based on ageAge: At Minimum 01/01/2013 12/08/2017 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 12/08/2017 Recommended based on ageAge: At Absolute Minimum 01/01/2013 12/08/2017 Recommended based on ageAge: At Minimum 01/01/2013 12/08/2017 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 12/08/2017 Recommended based on ageAge: At Absolute Minimum 01/01/2013 12/08/2017 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 01/02/2018 Recommended based on age Improved test case name and forecast test type to acurately reflect what was being testedNo Doses Administered 01/01/2013 01/03/2018 Recommended based on ageAge: At Minimum 01/01/2013 01/02/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 01/02/2018 Recommended based on minimum interval from live virus vaccineAge: At Absolute Minimum 01/01/2013 01/02/2018 Recommended based on ageNo Doses Administered 01/01/2013 01/02/2018 Recommended based on ageAge: At Minimum 01/01/2013 01/02/2018 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 01/02/2018 Recommended based on age v1.6: Incorrect Forecast Test Type was used and has been updated to reflect how the recommended date was forecasted.Interval: At Absolute Minimum 01/01/2013 01/02/2018 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from invalid dose Past Due Date was updated to reflect an 8 week interval per ACIP guidelines after last administered dose.Interval: At Absolute Minimum 01/01/2013 01/04/2018 Not recommended: series completeInterval: At Absolute Minimum 01/01/2013 01/04/2018 Not recommended: series completeAge: At Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Absolute Minimum 01/01/2013 01/04/2018 Recommended based on interval Updated per the 2017 General Best Practice Guidelines (Table 3-1, footnote (x) which indicates a 13 month aboslute minimum age for Varicella-2.Live Virus: Below Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from live virus vaccineLive Virus: At Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from live virus vaccineAge: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from live virus vaccineAge: At Absolute Minimum 01/01/2013 01/04/2018 Recommended based on ageAge: At Minimum 01/01/2013 01/04/2018 Recommended based on ageInterval: At Absolute Minimum 01/01/2013 01/04/2018 Not recommended: series completeInterval: At Minimum 01/01/2013 01/04/2018 Not recommended: series completeInterval: Below Absolute Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from invalid doseLive Virus: At Minimum 01/01/2013 01/04/2018 Recommended based on ageLive Virus: Below Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from live virus vaccineInterval: At Minimum 01/01/2013 01/04/2018 Not recommended: series completeInterval: At Minimum 01/01/2013 01/04/2018 Not recommended: series completeLive Virus: At Minimum 01/01/2013 01/04/2018 Recommended based on ageLive Virus: Below Minimum 01/01/2013 01/04/2018 Recommended based on minimum interval from live virus vaccine Forecast Dates were forecasting Dose 2, but the patient is still trying to satisfy target dose #1. Dates were updated to reflect a forecast for dose 1 based on live virus spacing.Live Virus: Below Minimum 01/01/2013 03/12/2018 Recommended based on minimum interval from live virus vaccineLive Virus: At Minimum 01/01/2013 03/12/2018 Recommended based on ageAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on minimum interval from live virus vaccineAge: At Absolute Minimum 01/01/2013 01/04/2018 Recommended based on interval Updated per the 2017 General Best Practice Guidelines (Table 3-1, footnote (x) which indicates a 13 month aboslute minimum age for Varicella-2.Age: At Minimum 01/01/2013 01/04/2018 Not recommended: series completeAll Valid: Forecast Test 01/01/2013 01/04/2018 Recommended based on minimum interval from previous dose (catch-up) Past Due Date was updated to reflect an 8 week interval per ACIP guidelines after last administered dose.Vaccine: Off Label 06/23/2015 02/12/2019 Recommended based on interval Past Due Date was updated to reflect an 8 week interval per ACIP guidelines after last administered dose.All Valid: Forecast Test 06/23/2015 01/04/2018 Not recommended: series complete New test case for version 2.0 which expanded scope into Adult recommendationsNo doses administered 11/13/2019 11/15/2019 Recommended based on ageAll Valid: Forecast Test 11/13/2019 11/15/2019 Not recommended: series completeAll valid: Forecast Test 11/13/2019 11/15/2019 Not recommended: series completeInterval: Below Absolute Minimum 11/13/2019 11/15/2019 Recommended based on interval

All Valid: Forecast Test 06/23/2015 04/19/2018 Recommended based on ageV3.4: Test case updated to accommodate new ACIP Zoster recommendations.V2.0: New test case for version 2.0 which expanded scope into Adult recommendations

All Valid: Forecast Test 06/23/2015 04/19/2018 Recommended based on ageV3.4: Test case updated to accommodate new ACIP Zoster recommendations.V2.0: New test case for version 2.0 which expanded scope into Adult recommendations

No Doses Administered 06/23/2015 04/19/2018 Recommended based on ageV3.4: Test case updated to accommodate new ACIP Zoster recommendations.V2.0: New test case for version 2.0 which expanded scope into Adult recommendations

Live Virus: At Minimum 06/23/2015 04/19/2018 Recommended based on ageV3.4: Test case updated to accommodate new ACIP Zoster recommendations.V2.0: New test case for version 2.0 which expanded scope into Adult recommendations

Live Virus: Below Minimum 06/23/2015 04/19/2018 Recommended based on minimum interval from live virus vaccineV3.4: Updated test case to reflect updated Zoster recommendations for Shingrix.V2.0: New test case for version 2.0 which expanded scope into Adult recommendations

All Valid: Forecast Test 03/27/2018 04/19/2018 Recommended based on intervalAll Valid: Forecast Test 03/27/2018 04/19/2018 Not recommended: series completeAll Valid: Forecast Test 03/27/2018 04/19/2018 Not recommended: series complete

03/27/2018 04/19/2018

All Valid: Forecast Test 03/27/2018 02/04/2019 Recommended based on minimum interval from invalid doseV3.5: Previous version was calculating the forecast from the first dose. This has been corrected to be from the previous dose (invalid dose #2).V4.0 Per email Dr Kroger, the four day grace period can be used. Second dose has been changed to "valid".

No Doses Administered 03/27/2018 04/19/2018 Recommended based on age

Interval: At Absolute Minimum 03/28/2018 04/09/2019 Recommended based on minimum interval Age: At Recommended 03/28/2018 04/19/2018 Recommended based on intervalAll Valid: Forecast Test 04/11/2018 04/19/2018 Recommended based on minimum intervalAll Valid: Forecast Test 04/11/2018 04/19/2018 Recommended based on minimum interval

04/11/2018 04/19/201804/18/2018 09/20/2019 v4.2: Added description

Interval: Below Absolute Minimum 03/27/2018 02/07/2019 Recommended based on minimum interval from invalid doseAll Valid: Forecast Test 03/27/2018 02/12/2019 Recommended based on minimum interval from invalid dose

04/11/2018 08/22/2019

Changed_In_Version General_Description1.01.01.01.01.01.11.11.11.01.03.33.33.31.0

4.0

4.01.1

4.21.01.11.11.01.01.0

3.4

3.41.0

3.4

3.41.03.2

3.41.01.01.0

3.41.11.01.01.01.01.03.33.31.01.01.01.01.01.01.01.41.01.01.01.01.0

3.4

3.41.01.01.1

4.01.11.1

2.21.41.13.51.01.01.41.01.01.03.31.0

3.41.01.0

3.41.04.01.11.11.01.03.33.31.01.01.01.01.0

3.41.0

3.4

3.4

4.01.01.01.01.01.01.01.03.31.01.01.0

Changed_In_Version General_Description1.01.01.0

3.5 This test case describes when the fourth dose of DTaP is administered at less than 4 months - 4 days from dose #3, that the dose is not valid.1.01.01.01.01.01.0

4.01.11.11.03.31.01.01.01.0

3.4

3.4

3.41.01.01.01.01.03.31.01.01.01.01.01.01.01.01.01.01.02.22.22.22.22.22.22.22.22.22.23.3 This test case describes when dose #4 of DTaP is administered at least 4 months -4 days from Dose #3 that the dose is considered to be valid.3.3 This test case describes when dose #4 of DTaP is administered at least 4 months -5 days from Dose #3 that the dose is not valid.

4.1 This test case describes when assessing a newborn for the first dose of the Influenza vaccine that it should be administered at the recommended age of 6 months.

4.1 This test case describes when a newborn receives the first dose of the Influenza vaccine at 6 months and a second dose at 28 days later that the next dose of influenza is recommended at the next seasonal flu begin date.

4.1 This test case describes when a child under the age of 9 receives dose 1 of the influenza vaccine in his first season, that a second dose is recommended at 4 weeks later.

4.1 This test case describes when a child under the age of 9 receives only one influenza dose in his first season, that a second dose is recommended at 4 weeks later.

4.1 This test case describes when a child under 9 years of age receives two doses of the Influenza vaccine in his first season, that no additional doses are needed during that season.

4.1 This test case describes when a child receives his first dose of the influenza vaccine before the age of 6 months, that the dose is not valid and should be repeated at the recommended age.

4.1 This test case describes when a child receives his first dose of the influenza vaccine at 6 months - 4 days, that the dose is considered to be valid, and the next dose should be forecasted.

4.1 This test case describes when a child receives his first dose of the Influenza vaccine at 6 months of age, that the dose is considered to be valid, and the second dose should be forecasted.

4.1 This test case describes when a child receives the second dose of the Influenza vaccine at less than 4 weeks - 4 days from the previous dose, that the dose is not valid and a repeat dose should be recommended at 4 weeks later.

4.1 This test case describes when a child receives the second dose of the influenza vaccine 24 days after the first dose, that the dose is considered to be valid.

4.1 This test case describes when a child under 9 years of age received one dose of the Influenza vaccine in a previous season and one in the current season that an additional dose is recommended in the current season. Forecast second dose at 4 weeks later.

4.2 This test case describes when a patient is 9 years or older and does not have a current seasonal dose that a dose should be forecast.4.1 This test case describes when a patient is 9 years or older and has been administered a dose of the flu vacccine in the current season that no additional doses should be forecast for the season.4.1 This test case describes when a child under 9 years of age receives a flu vaccine in the current season and two vaccine doses in previous different season, that the series is complete for the season.4.1 This test case describes when a child age 9 receives his first dose of the Flu vaccine that no additional doses are needed. Series is complete for season.4.1 This test case describes when a child enters the flu season at age 8 years, received their first dose, but is now 9 years old. Per 2019-20 ACIP flu recommendations, the patient needs a second dose.4.2 This test case describes when an adult patient has not received any doses of the influenza vaccine, that a dose should be forecast.4.2 This test case describes when an adult patient has received a dose of the influenza vaccine, that no additional doses are needed. Series is complete for the season.1.0 This test case describes when assessing a newborn for the first dose of the 2-dose Hep A vaccine that it is not recommended until at least 12 months of age.1.0 This test case describes when the second dose of the 2 dose Hep A vaccine is administered at least 6 months after the first dose, that no additional doses are recommended and that the series is considered complete.1.1 This test case describes when an adult dose of the Hep A vaccine is erroneously administered to a child, that the dose is considered valid. The second (age appropriate ) dose should be forecasted.1.0 This test case describes when a dose of the Hep A 2 dose vaccine is administered to a child at 12 months - 5 days, that the dose is not considered to be valid.1.1 This test case describes when a first dose of the Hep A 2 dose vaccine is administered to a child at 12 months - 4 days, that the dose is considered to be valid. The second dose should be forecasted.1.1 This test case describes when a first dose of the Hep A 2 dose vaccine is administered to a child at 12 months of age, that the dose is considered to be valid. Forecast second dose.1.1 This test case describes when the second dose of the 2 dose Hep A vaccine is administered at 6 months - 5 days after the first dose, that the dose is not considered to be valid. A repeat dose should be forecasted.3.5 This test case describes when the second dose of the HepA 2 dose vaccine is administered at 6 months - 4 days, that the dose is considered valid and the series is considered complete.1.0 This test case describes when the second dose of a HepA 2 dose vaccine is administered to child at 18 months of age and at an interval of 6 months from the previous dose, that the dose is considered valid and the series is considered complete.1.1 This test case describes when a second dose of the Hep A 2 dose vaccine is administered to a child at 6 months -5 days, that the dose is not considered valid. A repeat dose should be forecasted.

1.0This test case describes when a second dose of the Hep A 2 dose vaccine is administered to a child at 18 months age and with an interval of at least 6 months -4 days after the previous dose, that the dose is considered valid and no additional doses are recommended. The series is complete.

1.0 This test case describes the forecasting of the Hep B vaccine for a newborn.1.0 This test case desribes when dose #2 of the Hep B vaccine was administered at an interval 28-5 days after dose #1. 1.0 This test case desribes when dose #2 of the Hep B vaccine is administered at an interval of 28-4 days after dose #1 that the dose is considered to be valid.1.0 This test case desribes when dose #2 of the Hep B vaccine is administered at an interval of 28 days after dose #1 that the dose is considered to be valid.

4.2 This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 8 weeks - 5 days after dose #2, that the dose is considered valid, but a 4th dose is needed to complete the series.1.0 This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 8 weeks - 4 days after dose #2, that the dose is considered to be valid. The series is complete.1.0 This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 8 weeks after dose #2, that the dose is considered to be valid. The series is complete.

4.2 This test case describes when dose #3 of the Hep B vaccine is administered at an interval less than 16 weeks - 4 days from dose #1 that the dose is considered to be valid, but a 4th dose is needed to complete the series.1.0 This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks - 4 days from dose #1 that the dose is considered to be valid. The series is complete.1.0 This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks from dose #1 that the dose is considered to be valid. The series is complete.1.0 This test case describes when dose #1 of the Hep B Recombivax vaccine is administered at age 12 years, that dose #2 should be administered at 4 months - 6 months later1.0 This test case describes when dose #1 of the Hep B vaccine is administered at 0 days that the dose is considered to be valid. 1.0 This test case describes when dose #2 of the Hep B Recombivax vaccine is administered at an interval of 6 months from dose #1 to a child age 12 years, that dose is considered to be valid. The series is complete.1.0 This test case describes when dose #2 of the Hep B Recombivax vaccine is administered at an interval of 4 months - 5 days after dose #1 to a child age 11 years of age, that dose is not valid.

4.2 This test case describes when dose #3 of the Hep B Recomibivax vaccine is administered at an interval of 8 weeks - 5 days from dose #2 to an adolescent child, that the dose is valid, but a fourth dose is required.1.0 This test case describes when dose #1 of the Hep B vaccine is administered at birth, dose #2 is administered at an interval of 6 weeks after previous dose , and dose #3 is administered at 6 months after dose #2, that the series is complete. 1.0 This test case describes when dose #1 of the Hep B vaccine is administered at birth, dose #2 is administered at an interval of 4 weeks after previous dose , and dose #3 is administered at 6 months after dose #2, that the series is complete. 1.0 This test case describes when dose #1 of the Hep B vaccine is administered at birth, dose #2 is administered at an interval of 5 months after previous dose , and dose #3 is administered at 8 weeks - 4 days after dose #2, that the series is complete. 4.1 This test case describes when a newborn is administered dose #1 for he Hep B vaccine at age 1 day that the dose is considered to be valid.1.0 This test case describes when dose #1 of the Hep B vaccine is administered at birth, dose #2 is administered at an interval of 5 months after previous dose , and dose #3 is administered at 8 weeks after dose #2, that the series is complete.

4.2 This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks - 5 days from dose #1 that the dose is valid, but a 4th dose is needed to complete the series.1.0 This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks - 4 days from dose #1 that the dose is considered to be valid. The series is complete.

Changed_In_Version General_Description1.0 This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks from dose #1 that the dose is considered to be valid. The series is complete.1.0 This test case describes when dose #1 of the Hep B vaccine (Comvax) is administered at birth that the dose is considered to be valid. 1.0 This test case describes when dose #2 of the Hep B vaccine is administered at an interval of 28 - 5 days that the dose is not valid. 1.0 This test case describes when dose #2 of the Hep B vaccine is administered at an interval of 28 - 4 days that the dose is considered to be valid.1.0 This test case describes when dose #2 of the Hep B vaccine is administered at an interval of 28 days that the dose is considered to be valid.

4.2 This test case describes when dose #3 of the Hep B vaccine is administered at 24 weeks - 5 days of age, that the dose is valid, but a 4th dose is needed to completed the series.1.0 This test case describes when dose #3 of the Hep B vaccine is administered at 24 weeks - 4 days of age, that the series is complete. 1.0 This test case describes when dose #3 of the Hep B vaccine is administered at 24 weeks of age, that the series is complete. 1.0 This test case describes the forecasting of the Hep B vaccine for a newborn.1.0 This test case describes when dose #2 of the Hep B vaccine is administered at 6 years and 11 months after dose #1, that the dose is considered to b valid.1.0 This test case describes when dose #2 of the Hep B vaccine is administered at 7 years after dose #1 (child less than 12 months), that the dose is considered to b valid.1.0 This test case describes when dose #2 of the Hep B vaccine is administered at 7 years after dose #1 (child is 12 months of age), that the dose is considered to b valid.1.0 This test case describes when dose #2 of the Hep B Vaccine (Pediarix) is administered at an interval of 28 days after dose #1 that the dose is considered to be valid. 1.0 This test case describes when dose #3 of the HepB vaccine (Pediarix) is administered at 14 weeks - 5 days from dose #2 that the dose is not valid. 1.0 This test case describes when dose #3 of the HepB vaccine (Pediarix) is administered at 14 weeks - 4 days from dose #2 that the dose is not valid.1.0 This test case describes when dose #3 of the HepB vaccine (Pediarix) is administered at 24 weeks - 4 days from dose #2, that the dose is considered to be valid.1.0 This test case describes when an extra dose (#4) of the HepB vaccine (Pediarix) is administered at age 1 yr - 5 days, that the dose is considered to be extraneous. The series is complete.1.0 This test case describes when dose #1 is administered to a patient at 6 weeks - 5 days, that the dose is considered to be valid.1.0 This test case describes when an extra dose (#4) of the HepB vaccine (Pediarix) is administered at age 1 yr - 4 days, that the dose is considered to be extraneous. The series is complete.1.0 This test case describes when an extra dose (#4) of the HepB vaccine (Pediarix) is administered at 3 yr - 11.5 monts from dose #3, that the dose is considered to be extraneous. The series is complete.1.0 This test case describes when extra doses (#4) of the HepB vaccine (Pediarix) is administered at age 4 years, that the dose is considered to be extraneous. The series is complete.1.0 This test case describes when extra doses (#4 and #5) of the HepB vaccine (Pediarix) is administered at age 4 years - 5 days, that the dose is considered to be extraneous. The series is complete.1.0 This test case describes when extra doses (#4 and #5) of the HepB vaccine (Pediarix) is administered at age 4 years - 4 days, that the dose is considered to be extraneous. The series is complete.1.0 This test case describes when dose # 5 of the HepB vaccine (Pediarix) is administered at age 6 years and 11 months, that the dose is considered to be extraneous. The series is complete.1.0 This test case describes when dose # 5 of the HepB vaccine (Pediarix) is administered at age 7 years, that the dose is considered to be extraneous. The series is complete.1.0 This test case describes when dose #1 of the HepB vaccine is administered at 6 weeks - 4 days that the dose is considered to be valid.1.0 This test case describes when dose #2 of the HepB vaccine is administered at an interval of 28 - 5 days that the dose is not valid.1.0 This test case describes when dose #2 of the HepB vaccine is administered at an interval of 28 - 4 days that the dose is considered to be valid.

4.2 This test case describes when dose #3 of the HepB vaccine is administered at an interval of 8 weeks - 5 days that the dose is valid, but a 4th dose is needed to complete the series.1.0 This test case describes when dose #3 of the HepB vaccine (Pediarix) is administered at an interval of 8 weeks - 4 days that the dose is considered to be valid. The series is complete.1.0 This test case describes when an extra dose ( dose #4) of the HepB vaccine is administered at an interval of 6 months - 5 days, that the dose is considered to be extraneous. The series is complete.1.0 This test case describes when an extra dose ( dose #4) of the HepB vaccine is administered at an interval of 6 months - 4 days, that the dose is considered to be extraneous. The series is complete.1.0 This test case describes when an extra dose ( dose #4) of the HepB vaccine is administered at an interval of 4 months - 1 day, that the dose is considered to be extraneous. The series is complete.1.0 This test case describes when an extra dose ( dose #4) of the HepB vaccine is administered at an interval of 4 months, that the dose is considered to be extraneous. The series is complete.1.0 This test case describes when dose #2 of the HepB vaccine is administered at an interval less than 4 weeks - 4 days in the midst of other valid doses (first and third), that the dose is not valid. 1.0 This test case describes when dose # 1 of the HepB vaccine is administered at 6 weeks, that the dose is considered to be valid. 1.0 This test case describes when dose # 1 of the HepB vaccine is administered at 6 years and 11.5 months that the dose is considered to be valid.1.0 This test case describes when dose #1 of the HepB vaccine (Pediarix) is administered at 7 years that the dose is considered to be valid.1.0 This test case describes when dose #2 of the HepB vaccine is administered at an interval of 10 weeks - 5 days, that the dose is considered to be valid. 1.0 This test case describes when dose #2 of the HepB vaccine is administered at an interval of 10 weeks - 4 days, that the dose is considered to be valid. 1.0 This test case describes when dose #2 of the HepB vaccine is administered at an interval of 10 weeks, that the dose is considered to be valid. 3.33.3 This test case describes when dose #4 of the HepB vaccine is administered at least 24 weeks of age and at least 16 weeks from dose #1, that the dose is considered to be valid. Patient series is complete.3.4 This test case describes when a patient is administered the first dose of the Hep B (Heplisav) vaccine that the second dose should be forecasted.3.4 This test case describes that when a patient is administered the second dose of the Hep B (Heplisav) vaccine at 4 weeks that the dose is considered to be valid, and the series is Complete.3.5 This test case describes when a patient is administered the second dose of the Hep B (Heplisav) vaccine at 4 weeks - 5 days that the vaccine dose is not valid. A repeat dose is recommended.3.4 This test case describes when a patient is administered the second dose of the Hep B (Heplisav) vaccine at 4 weeks - 4 days that the dose is considered to be valid. The series is complete.3.4 This test case describes when a patient is administered the first dose of the Hep B (Heplisav) vaccine at 18 years - 4 days, that the dose is considered to be valid.3.4 This test case describes when a patient is administered a previous dose of Hep B Vaccine, (at age 15) and one dose of the Hep B (Heplisav) vaccine that the doses are considered to be valid. Another dose of the vaccine should be forecasted.

4.2 This test case describes when a patient is administered a previous dose of Hep B vaccine (at age 15) and two doses of the Hep B (Heplisav) vaccine at 8 weeks a part, that the doses are considered valid. The series is complete.

4.1 This test cases describes when a patient is administered a dose of the Hep B (Heplisav) vaccine at 18 years - 5 days that the dose is not valid.3.4 This test case describes when a patient is administered Hep B (Heplisav) as a first dose, and Hep B (alum) as a second dose, that a third dose should be forecasted.1.01.01.01.01.01.01.01.01.11.01.0

1.6

3.51.01.01.01.01.01.0

4.1 This test case describes when a second dose of Hib is administered to a child at age 12 m- 5 days that the dose is valid. Forecast another dose.1.01.0

1.61.01.01.01.11.01.01.01.01.01.01.01.01.01.01.0

1.6

3.51.01.01.01.01.01.01.01.0

3.51.01.01.01.11.11.11.01.11.1

Changed_In_Version General_Description1.01.01.01.01.21.01.01.0

1.61.11.01.11.01.21.01.01.01.01.01.01.01.01.11.01.11.11.01.01.01.01.01.11.01.01.11.0

1.61.01.01.11.11.11.01.0

3.53.2 This test case describes when the first dose of the HPV vaccine is administered at 9 years - 4 days that the CDSi engine forecasts the second dose of the HPV 2 dose series.3.2 This test case describes whether or not the first dose is valid at age 9 years - 0 days and thus forecast the second dose of the HPV 2 dose series.3.2 This test case describes whether or not the first dose is valid at age 11 years - 0 days and thus forecast the second dose.3.2 This test case describes whether or not the first dose is valid at age 9 years - 4 days and thus forecast the second dose of the HPV 2 dose series.3.2 This test case describes when the first dose is administered at age 9 years - 0 days that the CDS engine should forecast a second dose of the HPV 2 dose series.3.2 This test case describes when the first dose is administered at age 11 years - 0 days that the second dose of the HPV 2 dose series should be forecasted.3.2 This test case describes when the second dose is administered at an interval of 4 weeks - 4 days (less than 5 months) that a third dose of the HPV vaccine should be forecasted at 5 to 6 months from the first dose.3.2 This test case describes when the second dose is administered 4 weeks (less than 5 months) after the first dose, that a third dose of the HPV vaccine should be forecasted.3.2 This test case describes when the second dose is administered 2 months (less than 5 months) after the first dose, that a third dose of the HPV vaccine should be forecasted.3.2 This test case describes when the second dose is administered at an interval of 4 weeks - 4 days that a repeat dose of the HPV vaccine should be forecasted 5 to 6 months from the first dose.

3.5 This test case describes when the second dose is administered at an interval of 4 weeks - 5 day that a repeat dose of the HPV vaccine should be forecasted at least 5 to 6 months from the first dose.3.2 This test case describes when the second dose is administered at an interval of 4 weeks that a repeat dose of the HPV vaccine should be forecasted at least 5 to 6 months from the first dose.3.2 This test case describes when the second dose is administered 2 months (less than 5 months) after the first dose, that a third dose of the HPV vaccine should be forecasted.2.14.2 This test case describes when a third dose of the HPV vaccine is administered at 24 weeks from dose number 1, that the dose is valid. The series is complete.4.2 This test case describes when the third dose of the HPV vaccine is administered at 6 months from dose number 1, that the dose is valid. The series is complete.2.11.11.0

3.4 This test case describes when a female receives the first dose of the HPV vaccine at age 26 years that a second dose should forecast at an interval of 4 - 8 weeks.3.23.23.23.2 This test case describes when a male receives Cervarix that the dose should not count as a valid dose and a repeat dose should be given at the correct age or interval.3.2 This test case describes when a vaccine dose is given less than the vaccine grace period and that vaccine (Cervarix) is administered to a male that the dose is not valid and that a subsequent dose of a preferred or allowed vaccine should be administered as soon as possible.3.2 This test case describes when the Cervarix vaccine is administered to a male that the dose is not valid and that a subsequent dose of a preferred or allowed vaccine should be administered as soon as possible.3.3 This test case describes when a male receives Cervarix that the dose should not count as a valid dose and a repeat dose should be given at the correct age or interval.3.2 This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose or third dose should be forecasted.3.2 This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose or third dose should be forecasted.3.2 This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose or third dose should be forecasted.3.3 This test case describes when the first and second dose are given at an invalid age or interval and the vaccine administered was to a male that the vaccine dose should be repeated as soon as possible.1.01.03.3 This test case describes when an invalid vaccine is administered in doses 1, 2, and 3 that a repeat dose should be administered as soon as possible.3.3 This test case describes when an invalid vaccine is administered in doses 1, 2, and 3 that a repeat dose should be administered as soon as possible.

3.53.2 This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose or third dose should be forecasted.3.2 This test case describes when a second dose is administered at an interval of 4 weeks -4 days ( less than 5 months) that a repeat or third dose should be forecasted.3.23.2 This test case describes when a second dose is administered at an interval of 4 weeks -4 days (less than 5 months) that a repeat or third dose should be forecasted.1.01.03.2 This test case describes when a third dose is administered an at an interval of 12 weeks - 5 days that a repeat dose should be forecasted 12 weeks later.1.01.01.01.03.23.23.23.21.03.23.2 This test case describes when a valid second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose should be forecasted.1.01.03.2 This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose should be forecasted.3.2 This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose should be forecasted.2.11.0

4.2 This test case describes when the first and second dose is given after age 15 years that the third dose of the vaccine should be given at the recommended minimum interval.3.23.2 This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose should be forecasted.1.03.2 This test case describes when a second and third dose is administered less than 5 months- 4 days from target dose #1, that a repeat dose of the vaccine should be give 12 weeks later. 1.01.0

4.1 This test case describes when the third dose of the HPV vaccine is administered at 16 weeks - 5 days from target dose #1, that a repeat dose of the vaccine should be give 12 weeks later.1.01.03.23.21.6

Changed_In_Version General_Description

1.61.03.2 This test case describes when an invalid vaccine is administered (Cervarix) that a repeat dose should be administered as soon as possible.1.03.23.21.01.01.03.41.01.03.2 This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose should be forecasted.1.03.2 This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose should be forecasted.1.03.2 This test case describes when a third dose is administered an at an interval at least 5 months from the first dose and 12 weeks from the previous dose that no further doses are recommended. Series is complete.4.2 This test case describes when a male receives the first dose of the HPV vaccine at age 26 years that a second dose should be forecast.4.1 This test case describes when a male, age 26 years has no previous doses of the HPV vaccine that the first dose should be forecast.1.6 This test case describes when dose 1 of a Mening vaccine is given at 11 years that the dose is considered to be valid.1.6 This test case describes when dose #2 of a Mening vaccine is given at 16 years - 4 days, that the dose is considered valid. The series is complete. 1.6 This test case describes when dose #2 of a Mening vaccine is given at 16 years - 5 days, that the dose is considered invalid. 1.0 This test case describes when dose #1 and dose #2 of a Mening vaccine are administered at the recommended ages (11 and 16 years), that the doses are considered valid. The series is complete.1.2 This test case describes when dose #2 of a Mening vaccine is administered 5 years after dose #1 (age 13), that the dose in considered valid. The series is complete.

1.6 This test case describes when dose #1 of a Mening vaccine is administered before 10 years of age and a repeat dose is administered at one month + 20 days later that the dose is considered valid.

1.6 This test case describes when dose #1 of a Mening vaccine is administered at 10 years - 1 day and a repeat dose is administered at one month + 25 days later that the dose is considered valid.

1.6 This test case describes when dose #1 of a Mening vaccine is administered at age 10 years + 0 months that the dose is considered valid.1.2 This test case describes when dose #1 of a Mening vaccine is administered at 10 years-1 day that the dose is considered invalid.

1.6 This test case describes when dose #1 of a Mening vaccine is administered at 10 years - 1 day and a repeat dose is administered at one month + 21 days later that the dose is considered valid.1.0 This test case describes when a newborn is assessed for the first dose of a Mening that a CDS engine should forecast the dose at the recommended age.1.6 This test case describes when dose #2 of a Mening vaccine is administered too early (8 weeks - 5 days after dose #1), that the dose is not valid.1.6 This test case describes when dose #2 of a Mening vaccine is administered at an interval of 8 wks - 4 days from dose #1 (age 15 years + 11 months) that the dose is considered valid. The series is complete.1.6 This test case describes when dose #2 of a Mening vaccine is administered at an interval of 8 wks from dose #1 (age 15 years + 11 months) that the dose is considered valid. The series is complete.1.6 This test case describes when dose #1 of a Mening vaccine is administered at age 11 years + 0 days that the dose is considered to be valid. 1.6 This test case describes when an individual, age 22 years, is assessed for the first dose of a Mening vaccine that a CDS engine should not forecast a dose. A dose is not recommended. The series status is Aged Out.1.6 This test case describes when the first dose of a Mening vaccine is administered at 15 years + 8 days, that the dose is considered to be valid.1.0 This test case describes when a first dose of a Mening vaccine is administered at 16 years - 5 days that the dose is considered to be valid.1.0 This test case describes when a dose of a Mening vaccine is administered at 16 years - 4 days, that the dose is considered to be valid. The series is complete.1.0 This test case describes when a dose of a Mening vaccine is administered at 16 years + 0 days, that the dose is considered to be valid. The series is complete.1.1 This test case describes when a child receives the first dose of the MMR vaccine at 15 months of age, that the dose is considered to be valid.1.1 This test case describes when the second dose of the MMR vaccine is administered at 4 years of age, that the dose is considered valid. The series is complete.1.1 This test case describes when a child receives the first dose of the MMR vaccine at 7 years, that the dose is considered to be valid.1.1 This test case describes when a child is administered single antigen doses of Measles, Mumps, and Rubella, at the minimum age of 12 months and a second dose of the Mumps and Rubella antigens at 5 years of age, that the second dose of the Measles vaccine is recommended.1.1 This test case describes when a child is administered single antigen doses of Measles, Mumps, and Rubella, at the minimum age of 12 months and a second dose of the Mumps antigen at 5 years of age, that the second dose of the Measles and Rubella vaccine is recommended.1.4 This test case describes when a child is administered single antigen dose of Measles, at the minimum age of 12 months that the a second dose is recommended.1.1 This test case describes when a child is administered single antigen dose of Measles and Mumps, at the minimum age of 12 months, that the second dose of the vaccines is recommended.

1.1This test case describes when a child is administered single antigen doses of Measles, Mumps, and Rubella at the minimum age of 12 months, a second dose of the Measles, Mumps, and Rubella antigens at 5 years of age, and an inadvertentent dose of the Mumps vaccine that the series is complete.

1.1 This test case describes when a child is administered single antigen doses of Measles, Mumps, and Rubella, at the minimum age of 12 months, that a second doses of the vaccines are recommended.1.4 This test case describes when a child is administered single antigen doses of Measles, Mumps, and Rubella, at the minimum age of 12 months, on the same day, that a second dose of the vaccines are recommended.1.1 This test case describes when a child is administered single antigen doses of Measles, Mumps, and Rubella at the minimum age of 12 months, a second dose of the Measles, Mumps, and Rubella antigens at 5 years of age, that the series is complete.1.1 This test case describes when a child is administered single antigen dose of Measles and Rubella, at the minimum age of 12 months, and a second dose of the Measles vaccine at least 4 weeks later, that a second dose of the Rubella vaccine is recommended.1.0 This test case describes when a child is administered the first dose of the MMR vaccine before 12 months of age, that the dose is not valid. 1.0 This test case describes when a child is administered the first dose of the MMR vaccine at 12 months - 4 days, that the dose is considered to be valid. 1.0 This test case describes when a child is administered the first dose of the MMR vaccine at 12 months, that the dose is considered to be valid. 1.0 This test case describes the forecasting of the first dose of the MMR vaccine for a newborn.1.0 This test case describes when the second dose of the MMR vaccine is administered to a 2 year old child at 28 days after the first dose, that the dose is considered to be valid. The series is complete.1.0 This test case describes when a dose of the Varicella vaccine is administered at the same time of a MMR vaccine, both are valid.1.0 This test case describes when the first doses of the MMR and Varicella vaccines are administered at 12 months of age, and the second doses of those vaccines are administered at 13 months of age, that the doses are considered to be valid. The series are complete.1.0 This test case describes when the first doses of the Varicella vaccine is administered at 12 months of age, and the first dose of the MMR vaccine is administered at an interval of 28-1 day that the MMR vaccine dose is not valid.1.0 This test case describes when the first dose of the Varicella vaccine is administered at 12 months of age and the first dose of the MMR vaccine is administered at 28 days later, that the doses are considered to be valid.1.0 This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 12 months -5 days, that the dose is not valid.1.0 This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 12 months -4 days, that the dose is considered to be valid.1.0 This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 12 months and the second dose at 28 days later, that the doses are considered to be valid. The series is complete.1.0 This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 3 years of age and the second dose at 28 days later, that the doses are considered to be valid. The series is complete.1.1 This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 13 months of age and the second dose at 24 days later, that the second dose is not valid. 1.0 This test case describes when a child is administered the first dose of the MMR vaccine at 12 months of age and the second dose (ProQuad) at 28 days later, that the doses are considered to be valid. The series is complete.1.4 This test case describes when a child is administered the first dose of the MMR vaccine at 12 months of age and the second dose (ProQuad) at 24 days later, that the second dose is not valid.1.0 This test case describes when a child is administered the first dose of the MMR vaccine (ProQuad) at 13 months of age and the second dose (MMR II) at 28 days later, that the doses are considered to be valid. The series is complete.1.0 This test case describes when a child is administered the first dose of the Varicella vaccine at 12 months of age and a dose of the MMRV vaccine at 4 weeks later, that the doses are considered to be valid. 1.0 This test case describes when the first dose of the Varicella vaccine is administered before 12 months - 4 days and a MMRV vaccine is administered at 28 days later, that the MMRV (PRoQuad) vaccine dose is considered to be valid. 1.0 This test case describes when the first dose of the MMR vaccine is administered before 12 months - 4 days and a MMRV vaccine (ProQuad) is administered less than 28 days later, that neither are the doses are valid.1.0 This test case describes when the first dose of the Varicella vaccine is administered before 12 months - 4 days and a MMRV (ProQuad) vaccine is administered less than 28 days later, that the doses are not valid.1.0 This test case describes when single antigens M, M, and R are administered to a child > 12 months of age followed by a MMR (4rth )dose a year later, that the doses are considered to be valid. The series is complete. 1.0 This test case describes when a child is administered the second dose of the MMR vaccine at 13 months - 5 days, that the dose is not valid.1.0 This test case describes when a child is administered the second dose of the MMR vaccine at 13 months - 4 days, that the dose is considered to be valid. The series is complete.1.0 This test case describes when a child is administered the second dose of the MMR vaccine at 13 months, that the dose is considered to be valid. The series is complete.1.0 This test case describes when a child is administered the second dose of the MMR vaccine at an interval of 28 -5 days, that the dose is not valid. 1.0 This test case describes when a child is administered the second dose of the MMR vaccine at an interval of 28 -4 days, that the dose is considered to be valid. The series is complete. 1.0 This test case describes when a patient was born before January 1, 1957, that the patient is considered to be Immune.4.24.2 This test case describes when an adult patient received a dose of the MMR vaccine, that no additional doses are needed. Series is complete.4.24.2 This test case describes when a patient receives the 2nd dose of the MMR vaccine at 4 weeks after the first dose, that the dose is considered to be valid. The series is complete.4.2 This test case describes when a patient is administered the second dose of the MMR vaccine at less than 4 weeks - 4 days, that another dose should be forecast.4.2 This test case describes when a patient receives the 2nd dose of the MMR vaccine at 4 weeks - 4 days after the first dose, that the dose is considered to be valid. The series is complete.1.0 This test case describes the forecasting of a newborn for the first dose of the Pneumoccocal vaccine.1.0 This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at age 18 months that the dose is considered to be valid and the patient is on a catch-up schedule1.3 This test case describes when dose #1 of the Pneumococcal 7 vaccine is administered at age 24 months that the dose is considered to be valid. Forecast another dose.1.0 This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at age 24 months that the dose is considered to be valid. No additional dose should be forecasted. The series is complete.1.0 This test case describes when dose #2 of the Pneumococcal 13 vaccine is administered at age 10 weeks - 5 days, that the dose is not valid. 1.0 This test case describes when dose #2 of the Pneumococcal 13 vaccine is administered at age 10 weeks - 4 days, that the dose is considered to be valid. 1.0 This test case describes when dose #2 of the Pneumococcal 13 vaccine is administered at age 10 weeks, that the dose is considered to be valid. 1.0 This test case describes when dose #2 of the Pneumococcal 13 vaccine is administered at age 4 months, that the dose is considered to be valid. 1.0 This test case describes when a child is currently 12 months of age and was administered dose #1 at age 7 months and dose #2 at age 8 months of age that the doses are considered to be valid. 1.2 This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at 12 months, and the #2 of the Pneumococcal 13 vaccine is administered at 1 yr, 8 weeks - 5 days, that the second dose is not valid.1.0 This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at 12 months, and the #2 dose of the Pneumococcal 13 vaccine is administered at 1 yr, 8 weeks - 4 days, that the second dose is not valid.1.0 This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at 12 months, and the #2 dose of the Pneumococcal 13 vaccine is administered at 14 months, that the second dose is considered to be valid.1.0 This test case describes when a child is administered the first dose of the Pneumococcal 13 vaccine at 24 months - 5 days, that the dose is considered to be valid, but a second dose is still needed.1.0 This test case describes when a child is administered the first dose of the Pneumococcal 13 vaccine at 24 months - 4 days, that the dose is considered to be valid. No additional doses are recommended. The series is complete.1.0 This test case describes when dose #3 of the Pneumococcal 13 vaccine is administered to a child at 14 weeks- 5 days, that the dose is not valid.1.0 This test case describes when dose #3 of the Pneumococcal 13 vaccine is administered to a child at 14 weeks- 4 days, that the dose is considered to be valid.1.0 This test case describes when dose #3 of the Pneumococcal 13 vaccine is administered to a child at 14 weeks, that the dose is considered to be valid.1.0 This test case describes when dose #3 of the Pneumococcal 13 vaccine is administered to a child at 6 months, that the dose is considered to be valid.1.0 This test case describes when dose #1 of PCV 7 is administered at 6 months, dose #2 of PCV 13 is administered at 8 months, and dose #3 of PCV 13 is administered at 12 months, that the doses are considered to be valid. The series is complete.1.1 This test case describes when dose #1 of PCV 7 is administered at 7 months, dose #2 of PCV 13 is administered at 8 months, and dose #3 of PCV 13 is administered at 12 months, that the doses are considered to be valid. The series is complete.1.0 This test case describes when dose #1 of the Pneumococcal vaccine is administered at age 6 weeks - 5 days that the dose is not valid.1.2 This test case describes when dose #1 of PCV 13 is administered at 6 months, dose #2 of PCV 13 is administered at 11 months, and dose #3 of PCV 13 is administered at 12 months, that dose #3 is not valid.1.0 This test case describes when dose #4 of the PCV13 vaccine is administered at age 12 months - 5 days that the dose is not valid.1.0 This test case describes when dose #4 of the PCV13 vaccine is administered at age 12 months - 4 days that the dose is considered to be valid. The series is complete.1.0 This test case describes when dose #4 of the PCV13 vaccine is administered at age 12 months that the dose is considered to be valid. The series is complete.

1.3 This test case describes when 4 doses of PCV 7 is administered that one dose of Pneumococcal 13 is needed.1.0 This test case describes when the first dose of the Pneumococcal vaccine is not valid.1.0 This test case describes when the second dose of the Pneumococcal vaccine is not valid.1.0 This test case describes when the third dose of the Pneumococcal vaccine is not valid.1.0 This test case describes when the interval between dose #1 and dose #2 of the Pnuemococal vaccine is 28 - 5 days that the second dose is not valid.1.0 This test case describes when dose #1 and dose #2 of the Pnuemococal 13 vaccine is administered at 28 - 4 days that the second dose is considered to be valid.1.0 This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at 6 weeks - 4 days that the dose is considered to be valid.1.0 This test case describes when dose #1 to dose #2 of the Pneumococcal 13 vaccine is administered at an interval of 28 days, that the second dose is considered to be valid.1.0 This test case describes when dose #2 to dose #3 of the Pnuemococcal 13 vaccine is administered at 28-5 days that dose #3 is not valid.1.0 This test case describes when dose #2 to dose #3 of the Pnuemococcal 13 vaccine is administered at an interval of 28-4 days that dose #3 is considered to be valid.1.0 This test case describes when dose #2 to dose #3 of the Pnuemococcal vaccine is administered at an interval of 28 days that dose #3 is considered to be valid.1.0 This test case describes when dose #3 to dose #4 of the Pnuemococcal 13 vaccine is administered at an interval of 8 weeks -5 days that dose #4 is not valid.

Changed_In_Version General_Description1.0 This test case describes when dose #3 to dose #4 of the Pnuemococcal 13 vaccine is administered at an interval of 8 weeks -4 days that dose #4 is considered to be valid. The series is complete.1.0 This test case describes when dose #3 to dose #4 of the Pnuemococcal 13 vaccine is administered at an interval of 8 weeks that dose #4 is considered to be valid. The series is complete.1.0 This test case describes when the second dose of the Pneumococcal vaccine is not valid, but the patient is still complete since the last was after 12 months and 8 weeks from the previous dose.1.0 This test case describes when the third dose of the Pneumococcal 13 vaccine is not valid, but the patient is still complete since the last dose was after 12 months of age and 8 weeks since the previous dose.1.0 This test case describes when the fourth dose of the Pneumococcal 13 vaccine is not valid.1.0 This test case describes when the dose #1 of the Pneumococcal 13 vaccine is administered at age 6 weeks, that the dose is considered to be valid.1.3 This test case describes when 4 doses of the PCV 7 vaccine and 1 dose of the PCV13 vaccine has been administered that the doses are considered to be valid. The series is complete.1.0 This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at age 2 months, that the dose is considered to be valid.1.0 This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at age 11 months, that the dose is considered to be valid, but the patient is now on the catch-up schedule.1.1 This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at age 12 months, that the dose is considered to be valid.1.0 This test case describes the assessment of a patient > age 65 years with a history of PCV13 and PPSV23 vaccine, that no additional doses are recommended. The series is complete.1.0 This test case describes the assessment of a patient > age 65 years with a history of PCV13 vaccine, but no history of the PPSV23 vaccine. 4.2 This test case describes when a patient age 65 years with a history of PCV23 vaccine, but has not received the PCV 13 series that no additional dose are recommended. The PCV series is complete.4.2 This test cases describes when an adult is age 65 years or older with no history of the PPSV vaccine, that a dose should be forecast.4.2 This test cases describes when an adult age 65 years with history of the PPSV23 vaccine, that no additional doses of the PCV vaccine should be forecast. Series is complete.1.01.11.11.5

3.31.51.51.51.51.51.5

3.31.51.5

1.51.53.13.11.51.51.01.01.51.51.51.51.51.51.5

3.11.51.51.51.51.5

3.3

3.51.01.01.0

3.11.51.5

3.11.51.01.01.51.11.03.33.33.33.3

1.51.51.01.03.33.11.03.13.11.53.33.13.33.31.0

1.51.51.51.5

2.11.11.53.1

1.51.51.03.33.31.01.11.11.03.33.33.3

1.51.51.53.13.13.11.51.53.1

Changed_In_Version General_Description1.51.11.51.51.51.51.51.51.53.11.51.51.53.33.31.51.53.31.0 This test case describes when a newborn is assessed for the first dose of a Rotavirus vaccine. 1.0 This test case describes when dose #3 of RotaTeq vaccine is administered at 14 weeks of age that the dose is considered to be valid. The series is complete.1.0 This test case describes when dose #3 of a RotaTeq vaccine is administered at 6 months of age that the dose is considered to be valid. The series is complete.1.0 This test case describes when dose #2 of a RotaTeq vaccine is administered less than 4 weeks - 4 days from the previous dose that the dose is not valid.1.0 This test case describes when dose #2 of a RotaTeq vaccine is administered at least 4 weeks - 4 days from dose #1 that the dose is considered to be valid. 1.0 This test case describes when dose #2 of a RotaTeq vaccine is administered at least 4 weeks from dose #1 that the dose is considered to be valid. 1.0 This test case describes when dose #3 of a RotaTeq vaccine is administered at 4 weeks - 5 days from dose #2 that the dose is not valid.1.0 This test case describes when dose #3 of a RotaTeq vaccine is administered at 4 weeks - 4 days from dose #2 that the dose is considered to be valid. The series is complete.1.0 This test case describes when dose #3 of a RotaTeq vaccine is administered at, at least 14 weeks of age and at least 4 weeks (28 days) from dose #2, that the dose is considered to be valid. The series is complete.1.0 This test case describes when a Rotarix vaccine dose is administered at an age of 6 weeks - 5 days, that the dose is not valid.1.0 This test case describes when a Rotarix vaccine dose is administered at an age of 6 weeks - 4 days, that the dose is considered to be valid.1.0 This test case describes when dose #1 of the RotaTeq vaccine is administered at 6 weeks - 5 days that the dose is not valid.1.0 This test case describes when dose #1 of the Rotarix vaccine is administered at 6 weeks of age, that the dose is considered to be valid.1.0 This test case describes when dose #2 of Rotarix is administered at 10 weeks - 5 days of age that the dose is not valid.1.0 This test case describes when dose #2 of Rotarix is administered at 10 weeks - 4 days of age that the dose is considered to be valid.1.0 This test case describes when dose #2 of Rotarix is administered at 10 weeks of age that the dose is considered to be valid.1.0 This test case describes when dose #2 of Rotarix is administered at an interval of 28 - 5 days that the dose is not valid.1.0 This test case describes when dose #2 of Rotarix is administered at an interval of 28 - 4 days that the dose is considered to be valid.1.0 This test case describes when dose #2 of Rotarix is administered at an interval of 28 days that the dose is considered to be valid.1.6 This test case describes when a infant reaches 15 weeks of age at assessment, with no previous doses administered, that a Rotavirus vaccine should not be recommended. Patient is Aged Out.1.0 This test case describes when a infant has received dose #1 of a Rotavirus vaccine at age 15 weeks that dose #2 should be forecasted. 1.1 This test case describes when an 8 month old infant was administered a previous dose of a Rotavirus vaccine at 3 months of age, that a second dose should be forecasted.1.0 This test case describes when an infant is administered a dose of RotaTeq at age 6 weeks - 4 days that the dose is considered to be valid.1.0 This test case describes when an infant is administered doses of RotaTeq at 2 and 4 months of age that the doses are considered to be valid.1.0 This test case describes when an infant is administered a dose of Rotarix at 2 months of age and a dose of RotaTeq at 4 months of age that the doses are considered to be valid.1.0 This test case describes when an infant is administered doses of Unspecified Rotavirus vaccines at 2 and 4 months of age that the doses are considered to be valid. Forecast a third dose.1.0 This test case describes when an infant is administered a dose of RotaTeq at age 6 weeks, that the dose is considered to be valid.1.0 This test case describes when dose #2 of RotaTeq is administered at 10 weeks - 5 days of age that the dose is not valid.1.0 This test case describes when dose #2 of RotaTeq is administered at 10 weeks - 4 days of age that the dose is considered to be valid.1.0 This test case describes when dose #2 of RotaTeq is administered at 10 weeks of age that the dose is considered to be valid.1.0 This test case describes when dose #3 of RotaTeq vaccine is administered at 14 weeks - 5 days of age that the dose is not valid. 1.0 This test case describes when dose #3 of RotaTeq vaccine is administered at 14 weeks - 4 days of age that the dose is considered to be valid. The series is complete.1.1 This test case describes the administering of dose #1 of varicella at 15 months. 1.0 This test case describes the forecasting of dose #1 of varicella at the age of 13 years - 1 day.1.0 This test case describes the administering of dose #1 of varicella at 12 months or 1 year of age.1.0 This test case describes that the administering of dose #1 of varicella at 12 months - 5 days is considered not valid.1.0 This test case describes the administering of dose #1 of varicella at 12 months - 4 days to be considered as a valid dose.1.0 This test case describes the forecasting of dose #1 of varicella at 12 months of age for a newborn. 1.0 This test case describes when the second dose of the Varicella vaccine is administered at 13 years + 28 days that the dose is considered to be valid.1.6 This test case describes when the 2nd dose of varicella vaccine is administered at 28-1 day in a child < 13 years of age that the dose is considered not valid.1.0 This test case describes the administering of the 2nd dose of varicella 28 days after the first dose.3.1 This test case describes when the 2nd dose of varicella vaccine is administered at 28-5 days after the 1st dose in a child that is 13 years of age that the dose is considered to be not valid.1.0 This test case describes when the 2nd dose of varicella is administered at 28-4 days after the 1st dose in a child that is 13 years of age that the dose is considered to be valid.1.0 This test case describes when the 2nd dose of varicella vaccine is administered at least 28 days after the first dose, in a child that is 13 years of age, that the dose is considered valid.1.0 This test case describes that when two live virus vaccines (MMR and Varicella) are administered on the same date, that a second dose of the vaccines are recommended.3.3 This test case describes when dose #2 of the varicella vaccine is administered at less than 13 months of age, that the dose is considered to be invalid and a repeat dose should be administered at 12 weeks later. 1.0 This test case describes when a MMR vaccine is administered first and a Varicella vaccine is administered at 28-1 days after the MMR vaccine dose that the varicella vaccine dose is not valid.1.0 This test case describes when a MMR vaccine is administered at age 12 months and a Varicella vaccine is administered at 28 days later that the doses are valid and that a second dose of the varicella vaccine should be forecasted.1.0 This test case describes when the first dose of the varicella vaccine is administered at 12 months - 5 days of age, that the vaccine dose is not valid.1.0 This test case describes when a varicella vaccine (ProQuad) is administered at 12 months - 5 days of age, that the vaccine dose is not considered to be valid, and that the dose should be repeated.1.0 This test case describes when the first dose of varicella vaccine (ProQuad) is administered at 12 months - 4 days of age, that it is considered to be valid, and a second dose should be forecasted.1.0 This test case describes when the first dose of the varicella vaccine (PROQUAD) is administered at 12 months that the dose is considered to be valid.1.0 This test case describes when the second dose of the varicella vaccine (PROQUAD) is administered at 13 months + 28 days that the dose is considered valid.1.0 This test case describes when the second dose of the varicella vaccine (PROQUAD) is administered at 15 months +11 days that the dose is considered valid.1.0 This test case describes when the second dose of the varicella vaccine (PROQUAD)is administered at 28 - 1 days that the dose is not valid.1.0 This test case describes when a MMR vaccine is given at 12 months and a MMRV (PROQUAD) vaccine is administered at one month later that the doses are considered to be valid.1.0 This test case describes when a MMR vaccine is given at 12 months + 1 day and a MMRV (PROQUAD) vaccine is administered at one year and 28 days, that that the MMR vaccine is not valid..1.0 This test case describes when the second dose of a MMR vaccine (PROQUAD) is administered > 28 days that the series is considered complete.1.0 This test case describes when a MMRV (PROQUAD) vaccine is administered at least 4 week after a varicella vaccine dose that the Varicella two dose series is considered complete.1.0 This test case describes when a MMRV (PROQUAD) vaccine is administered at least 4 week after an invalid varicella vaccine dose that the PROQUAD vaccine dose is considered valid. Forecast dose 2.1.1 This test case describes when a MMRV (PROQUAD) vaccine is administered less than 24 days from an invalid dose of varicella vaccine dose, that the dose is not valid. Forecast dose #1 of varicella vaccine.1.0 This test case describes when a varicella vaccine dose is administered at less than 28 days after an Influenza (LAIV) vaccine dose , that the Varicella dose is not valid.1.0 This test case describes when a Varicella vaccine is administered at least 28 days after an Influenza (LAIV) vaccine that the Varicella vaccine dose is considered to be valid. Forecast 2nd dose.1.0 This test case describes when an MMR vaccine is administered at 12.5 months of age, that a Varicella vaccine should be forecast at 28 days later to provide live virus vaccine spacing.3.3 This test case describes when dose 2 of the Varicella vaccine is administered at less than 13 months of age, that the dose is not valid. 1.0 This test case describes when the second dose of Varicella Vaccine is administered at age 15 months that the dose is considered valid and the series is complete.3.1 This test case describes when a Varicella vaccine is administered at age 13 years that the second dose is considered to be valid and a second dose should be forecasted at 4 weeks later.1.0 This test case describes when a ZVL vaccine dose is given in lieu of a Varicella vaccine to an adult less than 50 years, that the dose should be considered as a valid first dose of the Varicella vaccine.1.0 This test case describes when 2 dose of the Varicella vaccine has been administered to an Adult at least 4 weeks apart that the doses are considered valid and the series is complete.4.2 This test cases describes when an adult patient has not been administered any doses of the Varicella vaccine that the first dose should be forecast.4.2 This test cases describes when an adult patient has been administered the second dose of the Varicella vaccine at 4 weeks that no additional doses should be forecast. Series is complete.4.2 This test cases describes when an adult patient has been administered the second dose of the Varicella vaccine at 4 weeks - 4 days, that no additional doses should be forecast. Series is complete.4.2 This test cases describes when an adult patient has been administered the second dose of the Varicella vaccine at 4 weeks - 5 days, that another dose should be forecast.

3.4 This test case describes when a patient is administered ZVL at age 50 years, that the first dose of the RZV vaccine should be forecasted at 8 weeks later.

3.4 This test case describes when a patient is administered a dose of ZVL (Zostavax) at age 60 years, that the first dose of the RZV (Shingrix) vaccine should be forecasted.

3.4 This test case describes when a patient is 62 years of age and has not been administered a Zoster vaccine, that dose 1 (Shingrix) of the 2 dose series should be forecasted.

3.4 This test case describes when a patient is administered a Zoster (ZVL) vaccine dose 28 days after a MMR vaccine dose, that the Zoster vaccine dose in considered valid. The engine should forecast dose #1 of the Zoster (Shingrix) vaccine.

3.4 This test case describes when a patient is in early 50's and is administered a Zoster vaccine dose 28 -1 days after a MMR vaccine dose that the ZVL (Zostavax) vaccine dose is considered invalid. Zoster should be forecast in the future.3.4 This test case describes when a patient is administered dose #1 of the RZV vaccine, that a second dose should be forecast.3.4 This test case describes when a patient is administered dose #2 of the RZV vaccine at two months after dose #1, that the dose is considered to be valid.3.4 This test case describes when a patient is administered dose #2 of the RZV vaccine 4 weeks after the first dose that the series is considered complete.3.4 This test case describes when a patient is administered the second dose, of the Shingrix vaccine, at one year later that the dose is considered to be valid. Series is complete.

4.0 This test case describes that when a patient is administered the second dose of Shingrix vaccine at 4 weeks - 1 day, that the dose is considered to be valid.3.4 This test case describes when a patient is age 50 that dose 1 of the Shringrix vaccine should be forecasted.

3.4This test case describes when a patient is administered the first dose of RZV (Shingrix) at 4 weeks after a previous dose of ZVL (Zostavax), that the dose is considered valid. Per current guidance, RZV is recommended to be spaced 8 weeks after ZVL, but it does not need to be repeated if administered at any point prior to that 8 weeks up to and including the same day.

3.4 This test case describes when a patient receives a dose of ZVL (Shingrix) and RZV (Zostavax) on the same day, that the doses are considered to be valid.3.4 This test case describes when a patient is administered a dose of Zoster (Shingrix) vaccine 8 weeks after the second dose of Varicella vaccine, that the doses are considered to be valid.3.4 This test case describes when dose #1 of the Shingrix vaccine is administered less than 8 weeks after the 2nd dose of the Varicella vaccine that the doses are considered to be valid.3.4 This test case describes when a patient is administered the first dose of RZV 8 weeks after a previous dose of ZVL, that the doses are valid.4.0 This test case describes when a patient receives three (valid) doses of the Zoster vaccine that the series is considered Complete.4.0 This test case describes that when a patient is administered the second dose of Shingrix vaccine at less than 4 weeks - 4 days, that the dose is considered not valid.4.0 This test case describes that when a patient is administered the second dose of Shingrix vaccine at 4 weeks - 4 day, that the dose is considered to be valid.4.1 This test case describes when a patient is administered the first dose of RZV 0 days after a previous dose of ZVL, that the doses are valid.

med history te med history co med history cod …...2013-0016 doses # 2 and #3 at ≥ age 7 years; #...

Documents